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Abstract 
Spinal Muscular Atrophy (SMA) is an autosomal, recessive form of childhood motor 
neuron disease and the most common genetic cause of infant mortality in the western 
world. SMA displays the characteristic hallmarks of a motor neuron disease, 
including loss of motor neurons in the spinal cord and atrophy of skeletal muscles. 
However, mounting evidence suggests that multiple tissues and body systems, 
beyond the neuromuscular system, are affected in SMA. Previous studies have 
highlighted alterations in the vascular system in both SMA patients and in a variety 
of mouse models of the disease, reporting alterations in vessel structure and 
perfusion abnormalities in peripheral tissues. In this project a detailed morphological 
investigation of the capillary beds of skeletal muscle and the spinal cord, two of the 









;SMN2;Δ7 mouse models of SMA. 
Significant alterations in the form and extent of the skeletal muscle and spinal cord 
capillary bed in SMA mice were identified, the most striking of which being a 
reduction in capillary density in SMA tissue when compared to control littermate 
tissue. In skeletal muscle, this reduction in capillary density was found to be a 
postnatal phenomenon, which occurred independently of denervation, in a variety of 
phenotypically distinct muscles and in all three SMA mouse models investigated. In 
the spinal cord, the capillary defect was seen to develop in a similar postnatal pattern 
to that observed in skeletal muscle. Importantly, a reduction in capillary density was 
observed in the ventral horn of the spinal cord, which houses motor neuron cell 
bodies, a known pathological target in SMA. These motor neurons were seen to be 
surrounded by fewer capillaries than their control counterparts. Using an injectable 
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marker of hypoxia, it was determined that the cells of the ventral horn of SMA spinal 
cords are hypoxic. This suggests that the capillary defect identified has a functional 
impact on the tissues it is observed in. Having established the presence of capillary 
defect in SMA tissue, the effect of potential SMA therapeutics on the capillary defect 
was then investigated. The effect of HDAC inhibitors, which have been successfully 
shown to increase the levels of the disease causing Smn protein, was investigated. 
Treatment with the HDAC inhibitor SAHA was found to ameliorate the capillary 
defect, significantly improving capillary density in SMA skeletal muscle. This 
implies that the capillary defect is related to Smn levels in tissue and is amenable to 
therapeutics which increase Smn levels. Having characterised the capillary defect in 
SMA tissues in detail, a selection of tools were then used to investigate the 
underlying mechanisms resulting in the defect. First, using primary cell cultures, the 
growth and morphology of the key cellular component of capillaries, the endothelial 
cell, was examined. While displaying reduced levels of the Smn protein, endothelial 
cells isolated from SMA tissues showed no difference in growth rate, morphology or 
endothelial cell marker expression when compared to endothelial cells isolated from 
control tissue. This suggests that the defects seen in SMA capillary beds are not the 
result of defects in the structure and growth of endothelial cells. Second, retinas from 
SMA mice were found to exhibit similar capillary defects to those observed in SMA 
skeletal muscle and spinal cord. Given the entirely postnatal development of the 
retinal capillary network, the retina was identified as a useful experimental 
preparation for the further investigation of the mechanisms underlying the capillary 
defect in SMA. In summary, this work highlights the incidence and importance of 
capillary defects in mouse models of spinal muscular atrophy. 
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1.1 Autosomal Recessive Proximal Spinal Muscular Atrophy 
The term motor neuron disease encompasses a variety of disorders which are caused 
by the degeneration and loss of motor neurons in the brain and spinal cord. This loss 
of motor neurons results in a progressive weakening and wasting of skeletal muscles 
which leads to paralysis and, in the most severe disorders, death (Rezania & Ross, 
2013). Included in this collection of disorders is Autosomal Recessive Proximal 
Spinal Muscular Atrophy (SMA), a childhood form of motor neuron disease. Initially 
characterised by physicians Werdnig and Hoffman in 1891, SMA has since been 
identified as the most common genetic cause of infant death in the western world, 
with an incidence rate of 1 in 6000-10000 live births and a carrier frequency of 1 in 
38 (Pearn, 1978; Feldkotter et al., 2002; Lunn &Wang, 2008). 
1.1.2 Clinical Classifications 
SMA can be classified into four distinct disease types based on the age of symptom 
onset and the motor milestones achieved by the patient. Of these four classifications, 
Type I SMA is the most common and most severe (Markowitz et al., 1990; Lunn & 
Wang, 2008). 
Type I SMA, also referred to as Werdnig-Hoffman disease, is characterised by a 
profound infantile hypotonia. Type I infants display flaccid paralysis of muscles on 
both sides of the body within the first six months of life. This weakness affects the 
muscles of the limbs and trunk, preventing patients from sitting unaided and from 
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supporting their own heads. While the intercostal muscles, involved in breathing, are 
affected in SMA, the diaphragm is spared. This results in characteristic paradoxical 
breathing, where the normal movements of the chest wall during breathing are 
reversed. These breathing difficulties are the main cause of death in Type I patients 
within the first two years of life (Lunn & Wang, 2008), though this lifespan can be 
extended with respiratory support (Bach, 2007). 
Type II SMA is of an intermediate severity, with symptoms becoming apparent 
within 7–18 months of age (Lunn & Wang, 2008). Type II patients are capable of 
sitting without support and some patients have been reported to stand with the 
support of leg braces. However, the motor milestone of independent walking is never 
achieved. Other motor symptoms, particularly finger tremors, are observed. 
Weakness of the tongue is also commonly reported, with patients experiencing 
difficulties chewing and swallowing, affecting the nutritional status and the ability of 
patients to gain weight as they grow (Messina et al., 2008). Scoliosis, the abnormal 
curvature of the spine, is also observed in Type II patients, in particular 
Kyphoscoliosis which affects both the coronal and sagittal planes of the spine and so 
compromises lung ventilation. This, combined with the weakness of the intercostal 
muscles, results in respiratory insufficiency, the most frequent cause of death in Type 
II patients (Lunn & Wang, 2008). 
Type III SMA, also referred to as Kugelberg-Welander disease, is the most variable 
form of SMA. Symptom presentation and age of onset vary greatly, with most 
patients displaying muscle weakness after 18 months of age. The majority of patients 
reach all major motor milestones, including independent walking. Some patients will 
require wheelchair assistance in childhood, while others will continue to walk 
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unaided into adult life. Some patients display joint overuse, as a result of muscle 
weakness. Scoliosis is often observed in Type III patients. However, this does not 
develop as early or progress as rapidly as the scoliosis observed in Type II patients 
(Fujak et al., 2013). 
Finally, in addition to these childhood forms of SMA, a fourth adult onset form of 
the disease has also been identified (Lunn & Wang, 2008). In Type IV SMA, muscle 
weakness develops in the second and third decades of life. This weakness is mild, 
resulting in slight motor impairments but without any additional respiratory or 
nutritional impairment. As a result, Type IV patients lead relatively normal lives 
(Zerres et al., 1995; Lunn & Wang, 2008). 
1.1.3 Genetics 
SMA is caused by mutations in the Survival Motor Neuron (SMN) gene (Lefebrve et 
al., 1995). Early linkage analysis of Type II and Type III SMA patients determined 
that, although distinct in phenotype, these different forms of SMA were genetically 
homogenous (Brzustowicz et al., 1990; Melki et al., 1990). These linkage analyses 
identified the 5q12-13 region on the long arm of chromosome five as the location of 
the SMA causing defect (Brzustowicz et al., 1990; Melki et al., 1990). Further 
physical and genetic mapping of the region highlighted inherited and de novo 
deletions in the region (Melki et al., 1994). Genomic DNA from this candidate 
region was used to probe a human foetal brain cDNA library, identifying SMN as the 
disease causing gene (Lefebvre et al., 1995). Restriction mapping revealed the 
structure and organisation of the SMN gene (Lefebvre et al., 1995; Bürglen et al., 
1995). 
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In the human genome, a large inverted duplication was found within the 5q13 region 
(Lefebrve et al., 1995). This duplication resulted in numerous copies of the SMN 
gene: a single telomeric copy, known as the SMN1 gene, and varying numbers of 
centromeric copies, known as the SMN2 gene. The SMN gene itself is approximately 
20kb in length and consists of 9 exons interrupted by 8 introns (Bürglen et al., 1995). 
Further amplification and sequence analysis revealed that the telomeric SMN1 and 
the centromeric SMN2 genes differed from one another by only 5 nucleotides in their 
3” ends, allowing SMN1 to be distinguished from SMN2. Full length cDNA from 
SMN1 and SMN2 is almost completely identical save for a single nucleotide 
difference in both exon7 and exon 8 (Monani et al., 1999). These differences result in 
two gene transcripts: full length Smn protein from the SMN1 gene and truncated 
SMN2 product which lacks exon 7 (Lefebvre et al., 1995). This suggests that the 
critical nucleotide exchange occurs in exon 7. Complete sequencing of the genes 
identified this key difference to be a C to T base exchange, 6 base pairs inside exon 7 
(Monani et al., 1999). This single alteration is sufficient to alter the splicing pattern 
of the genes, resulting in the loss of exon 7 from the SMN2 product. This shortened 
SMN2 product is non-functional and degrades rapidly in comparison to the full 
length, fully functioning SMN1 product (Lorson & Androphy, 2000). In healthy 
individuals this altered splicing is inconsequential. In SMA patients however this 
difference is crucial. 
In SMA, the SMN1 gene is lost or disrupted. In more than 98% of SMA patients the 
SMN1 gene is homozygously deleted. In the remaining cases the instability of the 
5q12-13 region results in gene conversions or mutations which disrupt the SMN1 
gene (Melki et al., 1994; Prior, 2007). While SMN1 is lost, each patient retains at 
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least one copy of SMN2 and while the majority of the SMN2 transcripts are 
erroneously spliced, correct splicing occurs in approximately 10% of SMN2 
transcripts. These transcripts are translated into functioning, full length Smn protein 
(Lefebvre et al., 1995), as shown in Figure 1 taken from the 2009 review by Burghes 
and Beattie.  
 
Figure 0.1 SMN1 and SMN2 genes, structure and splicing. The SMN1 and 
SMN2 have identical gene structure and are 99.9% identical at the sequence level. 
The essential difference between the two genes is a single nucleotide change in 
exon 7 (C or T as indicated). This single nucleotide change affects the splicing of the 
gene. Thus the majority of SMN transcripts from SMN2 lack exon 7 whereas those 
from SMN1 contain exon 7. However, because SMN2 does produce some full-
length SMN it can be viewed as a gene with reduced function but not loss of 
function. The loss of amino acids that are encoded by exon 7 results in the 
production of SMN protein with severely decreased stability. (Burghes & Beattie, 
2009)  
The very low levels of Smn produced from the SMN2 gene cannot fully compensate 
for the loss of SMN1 in SMA and so Smn levels are drastically reduced in SMA 
patients. However, SMN2 copy number has been identified as a positive modifier of 
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disease severity, with patients possessing increased SMN2 copy number showing 
later symptom onset and an improved prognosis (Wirth et al., 2006). In SMA 
patients a clear correlation is observed between SMN2 copy number and disease 
severity (Wirth et al., 2006). Clinical reports have shown that 80-95% of Type I 
SMA patients possess one or two copies of SMN2. In Type II patients this number is 
increased to 3 copies in 96% of patients and 96% of Type III patients were found to 
carry 3 or 4 copies of SMN2 (Feldkotter et al., 2002; Mailman et al., 2009; Wirth et 
al 2006; Arkblad et al., 2009). 
1.1.4 Role of Smn protein 
Smn is an ubiquitously expressed 294 amino acid, 38 kDa protein encoded for by 9 
exons interrupted by 8 introns (Bürglen et al., 1995; Lefebvre et al., 1995). 
Homozygous deletion of murine SMN is embryonic lethal, with massive cell death 
occurring early in development in SMN
-/- 
embryos (Schrank et al., 1997). This 
emphasises the essential role of Smn in normal cell function. 
Immunolocalisation studies indentified Smn presence in both the cytoplasm 
(Battaglia et al., 1997) and the nucleus (Lui & Dreyfuss, 1996). In the nucleus Smn is 
highly enriched within bodies called Gems, which show close association with Cajal 
bodies (Lui & Dreyfuss, 1996). Cajal bodies contain high concentrations of the 
elements involved in the transcription and processing of nuclear RNAs (Gubitz et al., 
2004). Cajal bodies are thought to be the site where the machinery responsible for 
transcription and processing is assembled and modified (Gubitz et al., 2004). This 
suggested a potential role for the Smn protein in similar functions. 
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Within the nuclear Gems, Smn forms a stable complex with an array of Gemin 
proteins (Gubitz et al., 2004). This Smn-Gemin complex plays a key role in the 
assembly of splicesomal small nuclear ribonucleoproteins (snRNPs) which are 
responsible for splicing pre-mRNA. snRNPs recognise intron splice sites and 
catalyse splicing, resulting in mature, spliced mRNAs (Will & Lührmann, 2001; 
Nilson, 2003). snRNPs are composed of 7 common core Smn proteins and one 
uridine-rich small nuclear RNA (snRNA). The Smn-Gemin complex is responsible 
for assembling these two constituent components to form the snRNP. This is 
achieved by the binding of the Smn-Gemin complex to the Sm protein core and the 
snRNA. The Smn-Gemin complex then joins the snRNA onto the Sm protein core in 
an ATP-dependent manner to form the snRNP (Lui & Dreyfuss 1996; Pellizzoni et 
al., 2002; Workman et al., 2012). These investigations detail the essential cellular 
function of Smn. The characteristic degeneration and loss of motor neurons in SMA 
has prompted the investigation for motor neuron specific roles of Smn. 
Smn protein has been identified in the growth cones and filopodia of cultured motor 
neurons (Fan et al., 2002), suggesting a role for Smn in neuronal outgrowth. In fact, 
investigations of SMA model zebrafish with reduced Smn levels have reported 
aberrant outgrowth of motor axons and defects in motor axon pathfinding 
(McWhorter et al., 2003; Beattie et al., 2007). The Smn protein has also been 
reported to be involved in the transport of axonal mRNAs along axons (Rossoll et al., 
2003) particularly β-actin mRNA, which is important in the outgrowth and 
pathfinding of motor axons during development (Rossoll et al., 2003). These 
additional functions of Smn in axon outgrowth and pathfinding could explain why 
spinal motor neurons, particularly their distal axons, are vulnerable in SMA. 
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1.2 Animal Models of SMA 
As the genetic basis of SMA is well characterised and understood, it has been 
possible to generate a variety of transgenic animals which recapitulate the human 
disease. 
1.2.1 Mouse Models of SMA 
Unlike humans, mice possess only one Smn gene. Homozygous deletion of this gene 
results in embryonic lethality (Schrank et al., 1997; Monani et al., 2000). To 
overcome this, transgenic mice expressing human SMN2 have been created (Monani 
et al., 2000; Hseih-li et al., 2000; Le et al., 2005). 
1.2.1.1 Severe SMA Mouse Model  
In 2000 Monani et al., reported the generation of a mouse model of severe SMA. The 
resulting Smn
-/-
;SMN2 mice are hereafter referred to as Severe SMA mice. To 
generate these mice the human SMN2 gene was inserted into fertilised mouse 
oocytes. The adult mice were then bred with C57BL6JSmn
-/-
 mice to produce Smn
+/-
;SMN2 heterozygous carrier mice. These mice were then bred to produce Smn
-/-
;SMN2 Severe SMA mice.  
Severe SMA mice survive for 4 to 6 days. In the first 48 hours of life Severe SMA 
mice are indistinguishable from their unaffected littermates. This initial healthy 
period is followed by a rapid deterioration in which mice display decreased 
movement, a lack of suckling and laboured breathing. By 72-96 hours after birth 
Severe SMA mice display a marked phenotype with decreased weight, limb tremors, 
difficulty in righting and bell-shaped trunks similar to those observed in Type I 
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patients. At birth Severe SMA mice have a normal number of motor neuron cell 
bodies in the spinal cord but this number is drastically reduced by P5, when the mice 
die. This closely resembles the pattern of motor neuron loss seen in Type I SMA 
patients. Along with these motor and neuronal defects the most striking difference 
between Severe SMA mice and their unaffected littermates is their very small size. 
At the time of death Severe SMA mice are on average 68% smaller than their 
unaffected littermates, with affected mice being both smaller in overall size and less 
than half the weight of unaffected littermates (Monani et al., 2000). 
This model closely mimics the symptoms and disease progression seen in Type I 
SMA patients. A high SMN2 copy number generated alongside the single copy 
Severe SMA line shows that SMN2 has the same positive modified effects in 
transgenic mouse models as it has in patients. Smn
-/-
 mice with 8 copies of the human 
SMN2 transgene displayed no obvious SMA phenotype or impaired survival 
(Monani et al., 2000). The only apparent difference between high copy SMN2 Smn 
null mice and their Smn+/- littermates was a shortened, thickened tail. Increased 
SMN2 copy number in humans results in later symptom onset and an improved 
survival. A similar trend is observed in SMA model mice with an increased SMN2 
transgene number. 
1.2.1.2 Taiwanese SMA Mouse Model 




mice by introducing the human SMN2 
transgene to Smn
+/-
 mice on a variety of backgrounds. This generated 5 independent 
SMN2 transgenic founder lines that were crossed with Smn+/- mice to give a variety 
of Smn
-/-
;SMN2 mice which developed progressive motor neuron disease, the 
PhD The University of Edinburgh 2014 
  10 
severity of which depended on the number of SMN2 copies. In 2010 Riessland et al., 
adapted the breeding strategy of Hsieh-Li and co-workers to produce consistent SMA 
phenotype mice on a pure FVB/N background with no other contributing mouse 
strains.  
Riessland and co-workers initially bred mice carrying four copies of SMN2, two 





mice survived and bred normally without an 
obvious SMA phenotype, although the mice did display shortened and necrotic tails 
and ears. These founder mice were then crossbred with heterozygous Smn
+/-
 mice 










hereafter referred to as Taiwanese SMA mice. Taiwanese SMA mice survive on 
average for 11 days and develop a severe SMA phenotype displaying a reduced body 
weight, muscle wasting and motor neuron degeneration by P6-7.   
Survival is further extended in a third mouse model where in addition the SMN2 
transgene, the SMNΔ7 transgene has also been inserted. 
1.2.1.3 SMNΔ7 Mouse Model 
Alternative splicing of the SMN2 transgene results in the truncated SMNΔ7 
transcript which lacks exon 7. When the SMNΔ7 transgene was added to the Smn
-/-
;SMN2 genotype, survival was extended to 14 days (Le et al., 2005). 
To generate SMNΔ7 transgenic mice, SMN cDNA lacking exon 7, the SMNΔ7 
transcript, was inserted into fertilised FVB/N oocytes. The resulting SMNΔ7 
transgenic mice were then crossed with mice lacking endogenous murine Smn but 
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possessing the human SMN2 transgene. This created double transgenic 
SMNΔ7;SMN2;Smn
+/-
 mice on a pure FVB/N background. These founder mice were 
interbred to obtain Smn
-/-
;SMN2;SMNΔ7 mice, hereafter referred to as SMNΔ7 
SMA mice. 
SMNΔ7 SMA mice survive between 10 to 14 days. Differences in weight gain 
between SMNΔ7 SMA mice and control littermates are apparent by P5 and once 
established the reduced weight gain persists throughout the rest of life. At P5 motor 
defects are also apparent and SMNΔ7 SMA mice show difficulty righting. This 
weakness becomes progressively more pronounced over the following days and by 
P10 SMNΔ7 SMA mice have difficulty moving and display an abnormal gait and 
limb tremors when they do move. Alongside these motor deficits a reduction in 
motor neuron number in the lumbar spinal cord is also seen. While motor neuron loss 
is evident at earlier timepoints (P4) the loss is not significant. This suggests that the 
timeline of motor neuron loss is related to disease severity, with earlier motor neuron 
loss observed in mouse models which lack the SMNΔ7 transcript (Monani et al., 
2000; Monani et al., 2003).  
Mouse models are a useful tool in the study of SMA. The generation of transgenic 
mice allows for the close mirroring of the genetic basis of SMA and the resultant 
molecular phenotype where Smn protein is present in every cell albeit at markedly 
reduced levels. Manipulation of SMN2 copy number and additions of the SMNΔ7 
transcript have established a variety of mouse models of varying disease severity 
similar to that seen in human SMA patients. These models also mimic the molecular 
pathologies, symptoms and disease progression seen in SMA patients. While the 
work in this thesis will focus on mouse models of SMA, it should be noted that other 
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SMA model organisms are also available. These include Drosophila, zebrafish and 
the roundworm C.elegans. 
1.2.2 Other Animal Models of SMA 
In 2003 Chan and co-workers isolated a Drosophila Smn mutant, with similar point 
mutations to those seen in SMA patients. These mutants displayed abnormal motor 
behaviour showing a progressive loss of mobility and coordination before death. 
Physiological experiments revealed reduced post-synaptic currents and disorganised 
motor neuron boutons, indicative of neuromuscular junction (NMJ) defects. 
Drosophila models have proven to be a particularly useful tool for the identification 
of modifiers of Smn with a single study highlighting 27 genetic modifiers of Smn 
(Chang et al., 2008). Along with Drosophila models, zebrafish SMA models are also 
useful for the testing and analysis. 
Knockdown of Smn levels in zebrafish resulted in a drastic SMA-like motor axon 
degeneration (Winkler et al., 2005). Morpholino knockdown reduced Smn levels to 
16% of that seen in control animals. In these Smn knockdown animals motor axons 
were truncated and erroneously branched, indicative of axon outgrowth and 
pathfinding defects (Winkler et al., 2005). Zebrafish models benefit from their 
relative ease of genetic and protein manipulation and their transparent nature which 
allows for the real time study of motor axon development and growth (Winkler et al 
2005; McWhorter et al., 2005; Wishart et al., 2014). 
Finally, the orthologue of the human SMN1 gene, smn-1, has been identified in 
C.elegans. When knocked down with RNA interference techniques, reduced smn-1 
levels resulted in late larval arrest, reduced lifespan, sterility and impaired locomotor 
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and pharyngeal activity in c.elegans (Briese et al., 2009). The rapid lifecycle and 
ease of maintenance of C.elegans and Drosophila model SMA animals provide a 
useful starting tool for the identification of genetic modifiers and potential 
therapeutics. 
1.3 Tissue Pathology in SMA 
SMA displays the characteristic hallmarks of a motor neuron disease. SMA patients 
exhibit a loss of motor neurons in the spinal cord which is followed by an atrophy of 
skeletal muscles, leading to paralysis and eventually death. This has lead to the in 
depth investigation of the neuromuscular system in SMA. 
1.3.1 Neuromuscular Pathology in SMA 
The neuromuscular system is the connection between the nervous system and 
skeletal muscle which work in combination to permit movement. The neuromuscular 
system is composed of lower motor neurons and the muscles they innervate. The cell 
bodies of lower motor neurons are located in the ventral horn of the spinal cord. 
From here their projecting axons exit the spinal cord via the ventral spinal roots and 
travel, as peripheral nerves, to reach their target muscles. Within the muscle, axons 
branch multiple times to supply a number of muscle fibres. This collection of 
muscles and the motor axon innervating them is called a motor unit (Sanes & 
Lichtman, 1999). These axons make contact with the muscle at a specialised 
synapse: the neuromuscular junction (NMJ). This junction is composed of a skeletal 
muscle fibre, the motor nerve terminal, terminal Schwann cells and the capping 
kranocyte (Sanes & Lichtman, 1999; Court et al., 2008). In neuromuscular disorders, 
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such as SMA, the association between the nervous and muscular system is disrupted. 
In SMA, the NMJ is an early pathological target. 
Morphological, molecular and functional defects are observed at the NMJ in SMA 
model mice (Murray et al., 2008, Kong et al., 2009, Ruiz et al., 2010, Wyatt & 
Keusted et al., 2010; Dachs et al., 2001). These abnormalities are seen in both the pre 
and post-synaptic compartments of the NMJ.  A characteristic feature of the NMJ in 
SMA is the loss of presynaptic motor nerve terminals which results in the 
denervation of the underlying muscle fibre. Along with this loss, structural 
alterations of the motor nerve at the NMJ are also observed. These include 
accumulations of neurofilament and poor arborisation of the nerve terminal. Post-
synaptically defects in acetylcholine receptors (AChRs) are also seen. AChRs in 
SMA retain an immature plaque-like structure rather than developing into the mature 
pretzel-like structure seen in age matched control mice (Kariya et al., 2008). AChRs 
are also found to contain the embryonic γ-subunit which during normal development 
should be replaced by the adult ε-subunit. This suggests that the reduced levels of 
Smn found in SMA cause a delay in the development of AChRs. This resulted in 
intermittent transmission failures along with alterarations to quantal content and end-
plate potentials in SMA mice (Kariya et al., 2008).  Along with these physiological 
and morphological defects, molecular defects are also seen at the NMJ in SMA. 
Key proteins involved in the targeting of synaptic vesicles and the release of 
neurotransmitters are downregulated in the presynaptic terminal of NMJs in SMA 
(Dachs et al., 2011; Ruiz et al., 2010). Importantly these defects are observed prior to 
extensive denervation (Dachs et al., 2011; Ruiz et al., 2010). Similarly, many of the 
morphological defects at the NMJ are seen prior to the degeneration of axons and the 
PhD The University of Edinburgh 2014 
  15 
loss of motor neurons (Murray et al., 2008, Kong et al., 2009, Dachs et al., 2011). 
Loss of synaptic inputs and abnormal neurofilament accumulations are seen in early 
to mild symptomatic Severe SMA mice (Murray et al., 2008) and defects in terminal 
organisation are seen in Severe SMA mice without great spinal cord motor neuron 
loss (Dachs et al., 2011). In addition to these morphological and molecular defects, 
functional defects have also been reported at the NMJ in SMA, in particular the 
release of neurotransmitters (Kong et al., 2009, Ruiz et a., 2010). Overall synaptic 
vesicle density is reduced by almost 50% in Severe SMA mouse NMJs (Kong et al., 
2009) and when analysed the release of neurotransmitter at the NMJ was 
significantly reduced (Ruiz et al., 2010). 
These studies highlight the NMJ as an early pathological target in SMA mice. Recent 
investigations have confirmed similar defects in the NMJs of Type I SMA patients 
(Kariya et al., 2008; Martinez-Hernadez et al., 2013). 
Abnormal accumulations of neurofilaments and poorly developed motor endplates 
are seen in the diaphragm of Type I SMA patients (Kariya et al., 2008). Further 
investigation revealed defects in the foetal development of the diaphragm and limb 
muscles in SMA foetuses (Martinez-Hernadez et al., 2013). Detailed microscopic 
analysis of these muscles revealed alterations in AChR clustering, abnormal prenatal 
vesicle accumulations and aberrant nerve terminal structure (Martinez-Hernadez et 
al., 2013). 
These studies emphasise the nature of the NMJ as a pathological target in SMA. 
However, not all NMJs display pathology in SMA. NMJs from different muscles 
show a varied susceptibility to low Smn levels. Studies have been conducted to 
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identify the factors which contribute to synapse vulnerability in SMA (Murray et al., 
2008; Ling et al., 2012; Thomson et al., 2012). 
In general, axial muscles are more vulnerable to NMJ defects than limb muscles. 
However both proximal and distal limb regions contain a mix of vulnerable and 
resistant muscles (Ling et al., 2012). This suggests that muscle location cannot be 
used as a determinant of muscle vulnerability. 
In Amyotrophic Lateral Sclerosis (ALS), fibre type predisposes muscle vulnerability 
with fast-twitch muscle fibres innervated by fast fatiguing motor neurons being more 
vulnerable than slow twitch muscles (Hegedus et al., 2007). In SMA however no 
such correlation is observed between fibre type and NMJ vulnerability (Murray et al., 
2008; Ling et al., 2012). Similarly, no correlation is observed between NMJ 
vulnerability and motor unit size, total axonal arbour length, motor branching pattern 
and terminal Schwann cell number in Severe SMA mice (Thomson et al., 2012). 
These studies suggest that the vulnerability of NMJs in SMA is not likely due to a 
single factor but, instead, is the result of the cumulative effects of a variety of 
neuromuscular factors. Determination of these factors remains a major focus of SMA 
research. However, recent research in the field has begun to investigate the effects of 
reduced Smn levels in tissues beyond the neuromuscular system. 
1.3.2 Systemic Pathology in SMA 
While the neuromuscular system appears particularly sensitive to reduced Smn 
levels, the Smn protein is ubiquitously expressed. Recent studies have identified a 
wide range of body tissues which display vulnerability to low Smn levels.These 
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investigations have encouraged the view of SMA as a multi-system rather than 
purely motor neuron disorder. 
 
1.3.2.1 Muscle 
Mounting evidence suggests that muscle, independent of denervation, is a key site of 
pathogenesis in SMA (Fidizianska & Wado, 1990; Tens et al., 1996; Stahas et al., 
2008; Mutsaers et al., 2011). 
High levels of apoptosis are commonly recorded in SMA skeletal muscle 
(Fidizianska & Wado, 1990; Tens et al., 1996; Stahas et al., 2008). Biopsies of 
patient muscle also show evidence of delayed development and maturation 
(Fidizianska & Wado, 1990; Stahas et al., 2008). These impairments of muscle 
development are observed in muscles where no neuromuscular pathology is evident 
(Lee et al., 2011). Along with defects in growth and development, intrinsic molecular 
pathology is found in skeletal muscles which are resistant to motor neuron pathology 
and NMJ dysfunction (Mutsaers et al., 2011). These studies suggest that Smn is 
important in the development, growth and normal cellular function of skeletal 
muscle. 
1.3.2.2 Bone  
An increased incidence of congenital bone fractures has been reported in SMA 
patients (Kelly et al., 1997; Felderhoff-Mueser et al., 2002). Severe SMA model 
mice display an osteoporotic bone phenotype with decreased mineral content and 
density in bones, resulting in a thin, porous cortex (Shanmugarayan et al., 2009). 
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Severe SMA mice also display significant reductions in key osteoblast differentiation 
markers and an increased rate of osteoclast formation in bone marrow 
(Shanmugarayan et al., 2009). These studies suggest a role for Smn in bone 
remodelling and skeletal pathogenesis in SMA. 
1.3.2.3 Brain 
The reduced levels of Smn protein found in Severe SMA mice have been found to 
impair perinatal brain development (Wishart et al, 2010). Morphological changes are 
observed in the brain of Severe SMA mice, particularly in brain regions normally 
associated with high Smn expression. The hippocampal dentate gyrus of Severe 
SMA mice was found to be 50% smaller in area than control littermates. Along with 
this reduction in size, a reduced cell density and proliferation was also observed in 
this region. Proteomic analysis of Severe SMA mice revealed widespread changes in 
the expression of proteins required for cellular proliferation, migration and 
development (Wishart et al., 2010). This study suggests that high levels of Smn are 
required for normal brain development. 
1.3.2.4 Heart 
Cardiac defects, both structural and functional, are commonly reported in SMA 
patients (Rudnik-Schoneborn et al., 2008) and mouse models of the disease (Shababi 
et al., 2010; Heier et al., 2010; Bevan et al., 2010; Gogliotti et al., 2012). 
75% of Type I SMA patients carrying a single copy of SMN2 have atrial and septal 
defects (Rudnik-Schoneborn et al., 2008). These defects are sufficient to cause 
significant impairments of cardiac function (Rudnik-Schoneborn et al., 2008). The 
severity of these defects was associated with SMN2 copy number, with higher SMN2 
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copy number patients presenting less significant defects or none at all (Rudnik-
Schoneborn et al., 2008). Not only does this suggest a role for Smn in normal cardiac 
development but it also highlights an association between SMN2 copy number and 
defect severity, a link which is well established in the neuromuscular system 
(Feldkotter et al., 2002; Wirth et al., 2006). Similar congenital cardiac defects are 
also reported in mouse models of SMA (Shababi et al., 2010; Heier et al., 2010; 
Bevan et al., 2010; Gogliotti et al., 2012). 
During embryonic development, defects in interventricular septum width were 
observed in Severe SMA embryos. Along with this, the left ventricle, responsible for 
delivering blood to the body, was thin and branched in comparison to the thick and 
well-developed left ventricle seen in control embryos (Shababi et al., 2010). Similar 
septal defects were also observed in SMNΔ7 SMA pups along with a remodelling of 
the atrial walls and an increase in oxidative stress markers in the cardiac tissue 
(Shababi et al., 2010). Electrocardiogram (ECG) studies have revealed a significant 
bradycardia, slowing of the heart rate, in SMNΔ7 SMA pups in comparison to 
control littermates. This bradycardia is reported as early as P2 in SMNΔ7 SMA mice 
(Heier et al., 2010). This bradycardia is severe and eventually results in a progressive 
heart block and impaired ventricular depolarisation (Heier et al., 2010). Importantly 
these structural and functional defects have been observed prior to motor neuron 
degeneration (Shababi et al., 2010) and in the absence of motor neuron and muscle 
pathology (Gogliotti et al., 2012). This suggests that the defects in the heart occur 
independently of neuronal pathology and should be considered as an independent 
pathology in SMA. 
 
PhD The University of Edinburgh 2014 
  20 
 
1.3.2.5 Liver 
Targeted deletion of SMN exon 7 in the embryonic mouse liver results in a severe 
impairment of liver development more commonly associated with iron overload 
(Vitte et al., 2004). Severe atrophy of the liver is seen before late embryonic lethality 
(Vitte et al., 2004). This suggests an important role for Smn in the normal 
development of the liver. Defects are also seen in liver function in neonatal SMA 
mice (Hua et al., 2011). Decreased levels of circulating hepatic insulin-like growth 
factor 1 (IGF-1) are recorded in neonatal SMA model mice (Hua et al., 2011). IGF-1 
is a neurotrophic factor and is essential for normal post-natal growth and 
development. Disruption of hepatic IGF-1 production could contribute to the reduced 
weight seen in multiple SMA mouse modes (Monani et al., 2000; Hsieh-Li et al., 
2000; Le et al., 2005). 
1.3.2.6 Lung 
Several defects in the structure of the lungs have been noted in Taiwanese SMA mice 
(Schreml et al., 2013). On gross inspection, Taiwanese SMA lungs are discoloured 
with large red marks mottling the surface of the lungs in comparison to the uniform 
pale pink colouring of control littermate lungs (Schreml et al., 2013). Histological 
investigation revealed ruptured alveolar septas and enlarged alveolar spaces in SMA 
mice (Schreml et al., 2013). Varying degrees of emphysema were also in Taiwanese 
SMA mice (Schreml et al., 2013). Respiration in SMA mice is already compromised 
due to muscle weakness. These defects will exacerbate this respiratory distress and 
could contribute to mortality in the mice. 
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1.3.2.7 Intestine 
By P5 Taiwanese SMA mice display diarrhoea. Histological examination of the 
intestine revealed an empty, string-like structure to the organ and a reduced number 
of villi with the remaining villi appearing blunt and club like with large vacuoles. 
Severe oedema was also observed in the lamina propria of the villi (Schreml et al., 
2013). This gross disruption of the intestinal epithelium and structure could 
contribute to the severe digestive problems reported in SMA mice. 
1.3.2.8 Pancreas 
Abnormalities in the cellular organisation of the pancreas are seen in SMA model 
mice and Type I SMA patients (Bowerman et al., 2012). While SMA mice produce 
insulin, cell numbers in the pancreatic islands are imbalanced, with an increased 
number of glucagon-producing α cells at the expense of insulin-producing β cells 
This imbalance is also seen in Type 1 patients. (Bowerman et al., 2012). This 
imbalance is accompanied by defects in glucose metabolism including 
hyperglycemia, hyperglucaconemia and glucose intolerance in SMA mice and 
evidence of glucose intolerance in SMA patients (Bowerman et al., 2012). 
1.3.2.9 Metabolic Abnormalities 
Type I SMA patients show problems in fatty acid metabolism which are not a 
consequence of immobility, illness, muscle denervation or atrophy, suggesting 
intrinsic metabolic defects in SMA patients (Dahl et al., 1975; Crawford et al., 1998). 
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Along with these systemic organ and metabolic defects, alterations to the vasculature 
of SMA patients (Musch et al., 1975; Rudnik-Schoneborn et al., 2008; Araujo et al., 
2009) and mouse models (Naver et al., 2008; Bevan et al., 2010; Foust et al., 2010; 
Heir et al., 2010, Shababi et al., 2010; Gogliotti et al., 2012) is also commonly 
reported. 
1.4 The Vasculature 
The vascular network is formed by two distinct mechanisms: vasculogensis and 
angiogenesis (Poole et al., 1989).  
The original vascular network is formed embryonically by the process of 
vasculogenesis which describes the initial formation of vessels from angioblasts 
(Risau & Flamme, 1995). Further development, growth and remodelling of this 
primary network is brought about by angiogenesis in which new vessels form from a 
pre-existing network of vessels (Risau, 1997). This growth can occur by sprouting or 
non-sprouting angiogenesis (Risau, 1997). In sprouting angiogenesis the extracellular 
matrix surrounding endothelial cells is broken down allowing for the migration of 
proliferating endothelial cells. These endothelial sprouts are guided to their target by 
specialised endothelial tip cells (Risau, 1997). These tip cells then fuse together to 
form functional vessel loops (Risau, 1997). In non-sprouting angiogenesis pre-
existing vessels are split in two by pillars of extracellular matrix. This process is 
often termed intersusceptive angiogenesis (Risau, 1997). When combined these 
processes result in the formation of the mature, fully functional vascular network. 
Alterations in this vascular network have been observed in motor neuron diseases, 
including ALS and SMA. 
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1.4.1 Vascular Pathology in Motor Neuron Disease 
Vascular defects and their impact on disease progression have been reported in forms 
of motor neurone disease. In 2004 Palencia et al., reported a reduction in the number 
of capillaries to muscle fibres in equine motor neuron disease (EMND). EMND is 
very similar in nature to another form of motor neuron disease: sporadic ALS in 
humans. Reports of vascular alterations have previously been made in ALS 
(Garbuzova-Davis et al., 2007; Zhong et al., 2008; Nicaise et al., 2009; Garbuzova-
Davis et al., 2010; Miyazaki et al., 2011; Miyazaki et al., 2012). 
ALS is an adult onset form of motor neuron disease characterised by degeneration of 
motor neurons in both the brain and spinal cord which leads to muscle atrophy and 
paralysis, resulting in death within three to five years of a diagnosis (Haverkamp et al 
1995, Rowland and Schneider 2001). The majority of ALS cases arise sporadically 
with only 5-10% of cases being genetically linked, and 20% of these familial cases 
display miss-sense mutations in the Copper/Zinc superoxide dismutase-1 (SOD1) 
gene (Rosen et al., 1993).  
In SOD1 mice models of ALS a reduction in the levels of the tight junction proteins 
Zona Ocludin-1, Claudin-5 and Occludin were reported in endothelial cells (Zhong et 
al., 2008). This reduction caused disruption of the blood spinal cord barrier (BSCB), 
resulting in haemorrhaging, reduced circulation and poor perfusion in the spinal cord. 
Importantly these alterations were observed prior to any motor neuron degeneration 
reported in this model (Zhong et al., 2008). Similarly, disruption to the association 
between blood vessels and neurons, the neurovascular unit, has been observed 
occurring prior to motor neuron degeneration in SOD1 models and ALS patients 
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(Miyazaki et al., 2011). Here the endothelial cells of blood vessels and the foot 
process of astrocytes were seen to dissociate at presymptomatic stages (Miyazki et 
al., 2011). Recent work has shown that interventions to correct such defects can 
delay disease onset and improve lifespan (Winkler et al., 2013). In 2013 Winkler et 
al., showed that repairing the defects in the BSCB delayed the onset of motor neuron 
impairment and degeneration in SOD1 model ALS mice and also increases lifespan 
by 25%. Taken together these studies suggest a potential role for the vascular system 
in the initiation of motor neuron defects and loss in ALS. Modifications to the 
control rather than the structure of the vascular system has also been reported to have 
negative effects on motor neurons (Oosthyuse et al., 2001). 
Vascular Endothelial Growth Factor (VEGF) is a key angiogenic signal used for the 
growth and development of vascular networks (Ferrara et al., 2003). The promoter 
for VEGF possesses a hypoxia-response element, allowing for VEGF stimulated 
growth of vascular networks in response to hypoxic tissue conditions (Oosthyuse et 
al., 2001). When this hypoxia-response element is deleted VEGF can no longer 
stimulate vessel formation and growth in response to tissue hypoxia. In the spinal 
cord this resulted in adult-onset motor neuron degeneration similar to that found in 
ALS. Conversely, addition of exogenous VEGF to the spinal cord during hypoxia 
promoted motor neuron survival (Oosthyuse et al., 2001).  
These reports from both mouse models and patients suggest that an insufficiently 
formed and poorly functioning vascular system can lead to motor neuron 
degeneration in ALS. Vascular alterations have been noted in SMA patients and mice 
models but their impact on disease pathogenesis has yet to be established. 
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1.4.2 Vascular Pathology in SMA 
Defects in the vascular system have long been associated with SMA patients (Musch 
et al., 1975, Rudnik-Schoneborn et al., 2008, Araujo et al., 2009) and some defects 
have been reported in the vasculature of SMA mouse models (Naver et al., 2008, 
Bevan et al., 2010, Foust et al., 2010, Heir et al., 2010, Shababi et al., 2010, Gogliotti 
et al., 2012). 
Although there is no cure for SMA, severe Type I patient lives can be extended by 
invasive ventilation. In case studies of such patients, defects in the vasculature have 
been repeatedly reported, with the digits (fingers and toes) being particularly prone to 
damage (Araujo et al., 2009, Rudnik-Schoneborn et al., 2010).  These reports 
describe a progressive necrosis of the digits between four to six months of age where 
initially a single digit was observed to turn blue and then black. This discolouration 
then spread to all the digits of the foot and hand and then to more proximal body 
regions including the feet, knees and arms (Araujo et al., 2009). Skin biopsies of 
such discoloured tissue in a second case study revealed that the epidermis and upper 
regions of the dermis were necrotic and that the small blood vessels found within the 
tissue were occluded by multiple thromboses (Rudnik-Schoneborn et al., 2010), 
suggesting that impaired vessel perfusion may be involved in the tissue damage 
observed. As well as these functional impairments, alterations to the structure of 
small vessels in Type I SMA patients have also been reported (Musch et al., 1975). 
In a case study of a young Type 1 SMA patient, the basement membrane of skeletal 
muscle capillaries was noted to be significantly greater in width than the basement 
membrane of capillaries from normal skeletal muscle (Musch et al., 1975). The main 
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cellular component of capillaries, the endothelial cells, also appeared abnormal in the 
Type I patient, containing an excessive number of vacuoles. This suggests that the 
structure of fine blood vessels is affected in severe SMA patients. Similar vascular 
defects have also been reported in multiple mouse models of SMA. 
In the SMA mouse model developed by Hsieh-Li et al. in 2000, intermediate and 
mildly affected SMA mice developed chronic necrosis of the tail, which began at the 
tip and progressed retrogradely towards the base of the tail. Similar necrosis of the 
extremities (tail, digits and ears) has been observed in severe SMA mouse models, 
where the lifespan of SMA mice has been increased using therapeutic interventions 
(Narver et al., 2008, Foust et al., 2010). 
In 2008 Narver et al., reported extensive tissue necrosis in SMN2Δ7 mice treated 
with the HDAC inhibitor Trichostatin A. The normal life expectancy of SMA 
SMNΔ7 mice is 14-16 days (Sleigh et al 2012), but treatment with Trichostatin A, 
along with nutritional supplementation, increased the lifespan of these mice 
significantly. However, mice who survived beyond 27 days began to develop tissue 
necrosis. A blue to black discolouration was noted at the tail tip which spread 
towards the base, ultimately resulting in complete loss of the tail. In some mice this 
necrosis spread to the pelvis and colon. The digits of the hindlimb also became 
necrotic and again this progressed to loss of the foot and the whole hindlimb in 
extreme cases. Necrosis was also observed in more proximal regions, in particular 
the pinnae of the ear. When examined histopathologically, thromboses were found in 
the small vessels of tissue from these regions, as was observed in SMA patients 
(Rudnik-Schoneborn et al., 2010). In addition to the thrombi observed, the walls of 
the blood vessels themselves appeared necrotic (Narver et al., 2008). 
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These studies have identified vascular defects in SMA patients and mouse models of 
the disease. However, whether vascular defects directly affect the key sites of 
pathogenesis in SMA is yet to be established. 
1.5 SMA Therapeutics 
At present there is no cure for SMA. However, given that the genetic basis of the 
disease is well understood several approaches are being developed to restore SMN 
levels (Avila et al., 2007; Mattis et al., 2009; Passini et al., 2011; Ling et al., 2012) 
and to restore the SMN1 gene (Foust et al., 2010; Valori et al., 2010).  Given that 
motor neurons are the most established and characterised pathological target in 
SMA, therapies are also being developed to protect motor neurons (Haddad et al., 
2003; Lesbordes et al., 2003). However, the mounting evidence of systemic 
pathology in SMA suggests that any effective SMA therapies will need to treat 
system-wide symptoms and not only motor neurons. 
1.5.1 Antisense Oligonucleotides 
The major product of the SMN2 gene is a truncated, non-functional, unstable version 
of the Smn protein (Lorson & Androphy, 2000). This arises due to alternative 
splicing of the SMN2 gene caused by a single nucleotide exchange which 
erroneously activates splicing of exon 7 from the SMN2 transcript (Monani et al., 
1999; Lorson et al., 1999). Modulating this splicing activity is a direct approach to 
restore proper full length Smn protein production and expression. Antisense 
Oligonucleotides (ASOs) have been utilised to increase full length Smn expression 
(Hau et al., 2010; Osman et al., 2012; Passini et al., 2012). 
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ASOs specifically designed to bind to an intronic splicing silencer lead to the 
inclusion of exon 7 in the SMN2 transcript and increases the expression levels of full 
length Smn protein (Hau et al., 2010). Specific targeting of the ASO to this particular 
splicing silencer prevents unwanted off-target effects of the ASO. Infusion of the 
ASO into the lateral cerebral ventricle of adult mice expressing the human SMN2 
transgene resulted in a robust and persistent increase in exon 7 inclusion (Hau et al., 
2010) When injected neonatally, the ASO was found to reduce the tail and ear 
necrosis seen in Type III SMA mice (Hau et al., 2010). An ASO targeted against an 
intronic repressor downstream of exon 7 has also shown beneficial affects in 
neonatal SMA mice (Osman et al., 2012). 
Intronic splicing silencer N1 (ISS-N1) lies downstream of exon 7 and when targeted 
by a specific ASO, increased levels of full length Smn protein were observed in the 
brain and spinal cord of SMNΔ7 SMA mice. This increase in Smn resulted in weight 
gain and an increased lifespan in SMNΔ7 SMA mice. Along with this increase in 
survival, ASO treatment has also been reported to improve muscle physiology and 
motor neuron function (Passini et al., 2011). Alongside these beneficial effects, the 
variety of potential delivery routes of ASOs makes them an attractive therapeutic 
approach to investigate. Intrathecal infusion into cynomolgus monkeys was shown to 
deliver ASO to all spinal cord regions, presenting a potential practical delivery route 
in a clinical setting (Passini et al., 2011). 
1.5.2 Histone Deacetylase Inhibitors 
While the major product of the SMN2 gene is the non-functional SMNΔ7 transcript, 
approximately 10% of SMN2 transcripts are translated into full length Smn 
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(Lefebvre et al., 1995). Enhancing the transcription of SMN2 is an attractive 
approach to increase the levels of full length Smn protein it produces. The 
transcriptional activity of genes is regulated by the accessibility of DNA (Johnson & 
Dent, 2013). The accessibility of DNA is determined by the modification of the 
histone proteins which promote condensation of DNA into chromatin. Histone 
deacetylase (HDAC) enzymes repress transcriptional activity by allowing the close 
association of histone proteins and DNA. Conversely, inhibition of HDACs 
decreases this association, freeing the DNA and increasing transcription (Johnson & 
Dent, 2013). HDAC inhibitor drugs have been shown to increase Smn levels, 
improve survival, attenuate weight loss, increase muscle fibre size and improve 
cardiac defects in a variety of mouse models (Avila et al., 2007; Narver et al., 2007; 
Riessland et al., 2010). While the effects of HDAC inhibitors are not SMN2 specific, 
resulting in potential off-target effects (Ling et al., 2012), the systemic nature of 
HDAC inhibitor activation is an attractive method for treating the variety of systemic 
pathologies, not just neuromuscular symptoms, that are now associated with SMA. 
1.5.3 SMNΔ7 Transcript Stabilisation   
The SMNΔ7 transcript produced by the SMN2 gene is not only truncated but it is 
also highly unstable and degenerates rapidly (Lorson & Androphy, 2000). 
Stabilisation of this transcript is another potential therapeutic approach in SMA. 
Smn protein levels have been significantly increased by the administration of 
aminoglycosides (Mattis et al., 2009). Aminoglycosides induce transcriptional “read-
through”: continuation of translation beyond stop codons. Aminoglycoside treatment 
should inhibit the recognition of the translational stop codon in SMN2. Translation 
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would then read through the stop codon and continue on to include the normally 
excised exon 7 (Mattis et al., 2009). Direct daily delivery of the aminoglycoside 
TC007 into the CNS of SMNΔ7 SMA mice increased full length Smn levels in the 
brain and spinal cord. TC007 treatment has also been shown to increase full length 
Smn protein levels in induced pluripotent stem-cell derived SMA motor neuron 
cultures and patient fibroblasts (Mattis et al., 2009). 
1.5.4 Gene Therapy  
Depleted Smn levels have also been increased using viral gene therapy strategies to 
reintroduce the missing SMN1 gene into SMA cells and tissues (Azzous et al., 2004; 
Bevan et al., 2010; Foust et al., 2010, Valori et al., 2010, Dominguez et al., 2011). 
Viral SMN1 delivery has been shown to increase Smn levels in Type I SMA patient 
fibroblasts (Azzous et al., 2004; Bevan et al., 2010; Foust et al., 2010, Valori et al., 
2010, Dominguez et al., 2011) and similar studies in SMNΔ7 SMA mice have shown 
a restoration of motor neuron Smn levels, reduced motor neuron death and increased 
life span (Azzous et al., 2004). Investigations using self-complimentary adeno-
associated virus serus number 9 (scAAV9), which crosses the blood brain barrier 
(BBB), have reported rescue of motor neuron function, improved neuromuscular 
pathology and increased lifespan in SMA model mice (Foust et al., 2010; Valori et 
al., 2010; Dominguez et al., 2011). Improvements of structural and functional cardiac 
defects have also been reported following scAAV9 SMN1 delivery (Bevan et al., 
2010). While these results identify SMN1 replacement as a promising therapeutic, 
effective gene therapy in human patients has yet to be reported. 
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1.5.5 Neurotrophic and Neuroprotective Agents 
To develop properly, motor neurons require trophic support from their target skeletal 
muscle. Several factors are implicated in the trophic support of motor neurons, 
including Cardiotrophin-1 (CT-1) (Oppenheim et al., 2001). Secreted by embryonic 
myotubes, CT-1 is expressed in high levels in embryonic skeletal muscle and 
increases the survival of embryonic motor neurons (Oppenheim et al., 2001). 
Systemic adenoviral delivery of CT-1 has been shown to delay motor defects and 
improve survival in mutant mice which lack SMN exon 7 in their neurons (Lesbordes 
et al., 2003). CT-1 delivery was also noted to protect against motor axon loss and 
NMJ defects (Lesbordes et al., 2003). 
1.6 Aims 
From the above introduction covering the current literature available, is it clear that 
there is a rationale and requirement for studies on vascular pathology in SMA. This 
thesis will therefore aim to address the following questions; 
1) Is the vasculature altered in the primary pathological targets of SMA? 
2) What effect, if any, do these defects have on the tissue they are found in?  
3) Are these defects amenable to current SMA therapeutics? 
4) Are these defects the result of intrinsic defects in the main cell type of the 
vasculature? 
5) How should future studies seek to determine the mechanism underlying these 
defects? 
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In order to answer these questions, the incidence of vascular defects in the skeletal 
muscle and spinal cord will be investigated in a variety of established mouse models 
of SMA (Chapter 2, 3). The implication of these defects will be examined using an in 
vivo marker of tissue hypoxia (Chapter 3). The amenability of these defects to 
current SMA therapeutic strategies will be investigated using HDAC inhibitor 
treatment (Chapter 4). The viability of SMA endothelial cells will be investigated 
using cell culture techniques, to identify any potential cellular cause of the defects 
(Chapter 5). Finally, experimental approaches for the future investigation of the 
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Chapter 2: Skeletal muscle capillary defects in mouse models of SMA 
2.1 Introduction 
SMA displays the hallmark characteristics of a motor neurone disease with patients 
exhibiting a loss of motor neurons in the ventral horn of the spinal cord, followed by 
weakening and wasting of skeletal muscle which in turn leads to paralysis and death. 
However, given the ubiquitous expression of survival motor neuron (Smn) protein, 
the SMA gene product, it seems unlikely that the neuromuscular system alone is 
affected by the depleted levels of Smn found in SMA. Recent work has begun to 
emphasise the systemic nature of SMA, identifying a variety of tissues beyond the 
neuromuscular system which show alterations in SMA. These include the brain 
(Wishart et al 2010), the bone (Hseih-Li et al., 2000; Felderhoff-Mueser et al., 2002; 
Shanmugarajan et al., 2009), the liver (Ville et al., 2004; Hua et al., 2011), the 
intestine (Schreml et al, 2013), the lung (Schreml et al., 2013), the pancreas 
(Bowerman et al., 2012) the heart (Rudnik-Schoneborn et al., 2008; Bevan et al., 
2010; Heier et al., 2010; Shababi et al., 2010; Palladino et al., 2011; Gogliotti et al., 
2012) and the vasculature (Hsieh-Li et al., 2000; Narver et al., 2008; Araujo et al., 
2009; Foust et al., 2010; Rudnik-Schoneborn et al., 2010). 
Defects in the vascular system in particular have long been associated with SMA 
patients (Musch et al., 1975; Rudnik-Schoneborn et al., 2008; Araujo et al., 2009) 
and similar defects have been reported in the vasculature of SMA mouse models 
(Naver et al., 2008; Bevan et al., 2010; Foust et al., 2010; Heir et al., 2010; Shababi 
et al., 2010; Gogliotti et al., 2012). 
While there is no cure for SMA, the lifespan of Type I SMA patients can be extended 
by invasive ventilation.  In these longer surviving patients,defects in the structure and 
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function of the vasculature were aparent. The extremities of ventilated patients 
display a progressive necrosis, beginning at the digits and spreading to the arms and 
knees (Araujo et al., 2009). Biopsies of these necrotic tissues show alterations to the 
blood vessels including thromboses (Rudnick- Schoenebon et al., 2010) and 
thickened capillary basement membranes (Musch et al., 1975). These studies suggest 
that the perfusion of peripheral tissues is compromised in severe SMA patients and 
that this could be a result of alterations to fine vessel structure in SMA. Such defects 
are also commonly reported in mouse models of SMA. 
Intermediate and mildly affected SMA mice develop chronic, progressive necrosis of 
the tail (Hseih-li et al., 2000). Similar necrosis of the tail, ear and digits is seen to 
develop in more severe SMA mouse models where the lifespan of SMA mice has 
been extended as a result of therapeutic intervention. 
Extensive necrosis is seen in SMNΔ7 SMA mice which survived an additional 10-11 
days as a result of HDAC inhibitor treatment (Narver et al., 2008). This necrosis 
began at the tail and spread to the colon. As observed in patients, vessels form these 
necrotic regions housed multiple thromboses and even displayed necrosis of their 
own walls (Narver et al., 2008). How these vascular defects arise and their 
contribution to SMA pathogenesis has yet to be investigated. However, the 
involvement of vascular defects in other motor neuron diseases has been readily 
investigated. 
Capillary to muscle fibre ratios reduced in equine motor neuron disease (EMND) 
(Palencia et al., 2004) and a variety of vascular alterations are observed in ALS 
patients and animal models of the disease (Garbuzova-Davis et al., 2007; Zhong et 
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al., 20008; Nicaise et al., 2009; Garbuzova-Davis et al., 2010; Miyazaki et al., 2011; 
Miyazaki et al., 2012). In ALS, the blood spinal cord barrier (BSCB) is particularly 
affected. 
The expression of tight junctional proteins are reduced in ALS endothelial cells 
causing a disruption of the BSCB (Zhong et al., 2008). This BSCB disruption causes 
haemorrhaging and reduced circulation and perfusion in the spinal cord. Importantly, 
these defects are observed prior to motor neuron degeneration (Zhong et al., 2008). 
Further disruption to the neurovascular unit, including disassociation of endothelial 
cells and astrocytes, is seen before motor neuron degeneration in SOD 1 mutant mice 
and ALS pateints (Miyazaki et al., 2011). Importantly, correction of these vascular 
defects has been shown to delay disease onset and increase lifespan (Winkler et al., 
2013). While adult onset motor neuron degeneration, reminiscent of ALS, can be 
initiated by preventing proper formation of the spinal cord vasculature (Oosthyuse et 
al., 2001). 
These reports from both mouse models and patients suggest that an insufficiently 
formed and poorly functioning vascular system can lead to motor neuron 
degeneration in ALS. Vascular alterations have been noted in SMA patients and mice 
models but their impact on disease pathogenesis has yet to be established. A key site 
of pathogenesis in SMA is the skeletal muscle where intrinsic pathology has been 
reported in both SMA patient tissue (Fidzianska and Wado 1990; Tens et al., 1996; 
Stahas et al., 2008; Mutsaers et al., 2011) and mouse models of the disease (Mutsaers 
et al., 2011).  
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High levels of apoptosis in skeletal muscle (Fidzianska and Wado 1990; Tens et al., 
1996; Stahas 2008), is a well-characterised hallmark of SMA. Along with increased 
levels of cell death, the development and maturation of skeletal muscle has also been 
reported to be affected in SMA (Fidzianska and Wado, 1990). Muscle biopsies from 
an eight-month-old SMA patient displayed prenatal-like organisation of muscle 
fibres (Fidzianska and Wado, 1990). In another study postnatal muscle biopsies from 
SMA patients expressed high levels of fetal muscle protein markers (Stahas et al., 
2008). These findings suggest retardation in the development of SMA skeletal 
muscle. Similar impairments in muscle development have also been reported in 
muscles which do not show signs of neuromuscular pathology in SMA (Lee et al., 
2011).  
In the SMNΔ7 mouse model of SMA, impaired postnatal growth of skeletal muscle 
is observed in SMA mice where no evidence of motor neuron loss or altered 
neuromuscular transmission was observed (Lee et al., 2011). Intrinsic molecular 
pathology, including alterations in expression of proteins involved in muscle 
function, cell death pathways and morphological development, is found in skeletal 
muscle resistant to motor neuron pathology and neuromuscular junction dysfunction 
(Mutsaers et al., 2011). This suggests that Smn is important in the development and 
function of healthy skeletal muscle. This role of Smn in normal skeletal muscle is 
emphasised by work examining the effects of Smn knockdown in muscle cells 
(Shafey et al., 2005).   
Myoblast C2C12 lines with reduced levels of Smn protein have shown reduced cell 
proliferation and defective myoblast fusion resulting in malformed myotubes (Shafey 
et al., 2005). Importantly the severity of these defects in muscle cell development 
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was linked to the level of Smn protein present in the cells: the less Smn present, the 
more severe the defect (Shafey et al., 2005).  This work further suggests a key role 
for Smn in the normal development and function of skeletal muscle cells. While the 
presence of Smn in the sarcomere of both Drosophila and mice (Rajeda et al., 2007) 
along with the localisation of the Smn-complex to the sarcomere, in both cardiac and 
skeletal muscle (Walker et al., 2008), suggest that the function of Smn in muscle is 
conserved across species and muscle type.  
Given that reduced Smn levels result in defects in the molecular composition of 
skeletal muscle as well as its development and growth, it is possible that other 
systems within skeletal muscle are also affected by Smn depletion in SMA. The 
vasculature of skeletal muscle in particular provides an interesting topic of 
investigation. Not only has the vascular system been reported to show alteration in 
SMA patients (Araujo et al., 2009; Rudnik-Schoneborn et al., 2010) and mouse 
models (Narver et al., 2008; Foust et al., 2010), as previously described, it also 
particularly sensitive to alterations in other myopathies (Norton et al., 1968; 
Kobayashi et al., 1983; Visser et al., 1989; Estruch et al., 1992; Authier et al., 1996) 
and neuropathies (Malik et al., 1992; Borisov, 2000; Dedkov, 2002). 
Alteration to the form and composition of skeletal muscle capillaries has been 
reported in a variety of childhood myopathies (Norton et al., 1968; Kobayashi et al., 
1983; Visser et al., 1989; Estruch et al., 1992). Capillaries from patients with 
Duchene’s muscular dystrophy and mitochondrial myopathy have been reported to 
show an enlargement of the endothelial cells in the walls of vessels and consequently 
a narrowing of capillary lumens (Kobayashi et al., 1983). Similarly, alterations to 
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capillary structure are a commonly reported feature of inflammatory myopathies 
(Norton et al., 196; Visser et al., 1989; Authier et al., 1996). 
The basal lamina of capillaries is altered in SMA patients (Musch et al., 1975) and 
thickens in two inflammatory muscle disorders: scleroderma and systemic lupus 
erythematosis (SLE) (Norton et al., 1968). Together with changes in capillary width, 
a reduction in the number of capillaries in skeletal muscle has been reported in SLE 
(Norton et al., 1968). This loss of capillaries in skeletal muscle has also been 
reported in inflammatory myopathies such as dermatomyositis (Estruch et al., 1992) 
and in necrotising myopathies (Authier et al., 1996). In these myopathies the basal 
lamina was found to be duplicated, a feature often reported in SLE as well (Norton et 
al., 1968). Interestingly, similar alterations to capillary structure have been reported 
to occur prior to muscle fibre damage in dermatomyositis (Visser et al., 1989). 
Electron microscopy of skeletal muscle biopsies from early stage dermatomyositis 
patients showed alterations to the capillary bed of muscles. Patients who displayed 
mild muscle weakness showed no evidence of structural alteration to muscle samples 
but capillaries within the muscle showed numerous defects. The endothelial cells of 
capillary walls showed microtubule inclusions and macrovacuoles while a number of 
capillaries were found to be necrotic (Visser et al., 1989). Observing such structural 
changes in the capillaries of skeletal muscle while the muscle fibres themselves 
appear healthy suggests that damage to the vascular network in these muscles occurs 
prior to muscular pathology.  Vascular changes prior to muscle atrophy are also 
observed in denervated skeletal muscles (Borisov et al., 2000,). 
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In denervated rat extensor digitorum longus muscles, the number of capillaries to 
muscle fibres, the capillary-to-fibre ratio, was reduced by 88% in the months 
following denervation. The loss of capillaries was found to begin before any muscle 
fibre atrophy was observed (Borisov et al., 2000). This reduction in capillary number 
within the muscle resulted in an increase in diffusion distance between capillaries 
and muscle fibres of up to 400% and 18 months after the denervation was performed, 
40% of muscle cells were found to be avascular (Borisov et al., 2000).  As well as 
this profound reduction in extent, skeletal muscle capillary beds have been reported 
to respond to denervation in a more dynamic fashion (Chernukh and Alekseeva 
1975; Dedkov et al., 2002). 
A nine-fold reduction in the capillary-to-fibre ratio was reported in the hindlimb 
muscles of rats following denervation (Dedkov et al., 2002). While the number of 
capillaries within the muscle was reduced, the vessels themselves showed evidence 
of regenerative structures, in particular, an increase in the number of growing 
endothelial cells (Dedkov et al., 2002). This suggests that even though the capillary 
bed was reduced in density by denervation, the remaining vascular network retained 
its ability to generate new vessels. Similarly following a reduction in the total 
number of capillaries and a reduction in the number of functioning capillaries during 
denervation, an increase in capillary number was observed during reinervation of the 
gastrocnemius muscle in rats (Chernukh and Alekseeva 1975). These investigations 
of the skeletal muscle capillary bed suggest that capillaries within skeletal muscle are 
highly sensitive to alterations in muscle, be this change within the muscle tissue itself 
or damage to the nervous supply of the muscle. As both skeletal muscle and lower 
motor neurons innervating skeletal muscle show pathology in SMA it is possible that 
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the capillary bed in skeletal muscle is altered in response to one, either or both of 
these factors.  
Based on the evidence that the vasculature is altered in SMA and other forms of 
motor neuron disease and that the form and extent of the skeletal muscle capillary 
bed is altered in denervation and pathological myopathies, we hypothesised that the 
capillary bed of skeletal muscle could show similar alterations in SMA. To 
investigate this hypothesis a novel means of measuring capillary density in skeletal 
muscle is required. 
Skeletal muscle capillary density has historically been measured in muscles of the 
hindlimb. While these muscles are easy to locate and dissect from experimental 
animals, they present difficulties from an analytical perspective. Given their large 
bellied nature hindlimb muscles must be sectioned for immunological processing and 
analysis. This results in the quantification of two dimensional relationships between 
capillaries and muscle fibres, the most commonly used being the capillary-to-muscle 
fibre (CF) ratio. Recent stereoscopic analysis has discredited the use of the CF ratio 
as a means of measuring capillary density, reporting that the method underestimates 
capillary density in muscle by up to 75% (Cebasek et al., 2009). While 3D 
stereoscopic reconstruction techniques such as that described by Cebasek et al., 
provide a more accurate measure of capillary density in skeletal muscle, 
reconstruction of a single muscle fibre requires ten hours of microscopic work. This 
clearly emphasises the need for an accurate and efficient means of investigating and 
quantifying skeletal muscle capillary density. 
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Here a novel means of investigating capillary density in skeletal muscle was 
developed using a selection of thin, flat muscles from the cranial region and body 
wall. Capillary density in these muscles was quantified using immunohistochemical 
staining and fluorescent microscopy. Morphological aspects of the skeletal muscle 
capillary bed, such as the ramification of capillaries through skeletal muscle, as well 
as the calibre of capillaries were analysed using confocal and fluorescent 
microscopy. The capillary bed of SMA skeletal muscle was found to be dramatically 
altered at a late symptomatic time point in Severe SMA mice. Capillary density, 
when measured via immunofluorescence, was significantly decreased in SMA mice 
when compared to control littermates. The calibre of capillaries in SMA skeletal was 
significantly larger than that of control littermates while the ramification of 
capillaries through muscle was reduced in SMA mice. Timeline analysis of capillary 
density showed no difference in the extent of the capillary bed between SMA and 
control littermates at birth.  Similar levels of reduction in capillary density in SMA 
mice was also observed in the Taiwanese and SMN2Δ7 models of SMA at late 
symptomatic timepoints. Time line analysis of capillary density in the Taiwanese 
model showed a similar pattern of postnatal development of the capillary defect as 
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2.2 Methods 
2.2.1 Ethics Statement 
All animal experiments were approved by a University of Edinburgh internal ethics 
committee and were performed under license by the UK Home Office (Project 
License number 60/3891). 





 (Severe) mice (Jackson Labs strain no. 005024) on a congenic FVB 
background were maintained as heterozygous breeding pairs under standard SPF 
conditions in animal care facilities in Edinburgh.  All animal procedures and 
breeding were performed in accordance with Home Office and institutional 
guidelines. (SMN2)2Hung Smn1
tm1Hung
/J mice (Taiwanese) (originally received from 
Brunhilde Wirth in Koln) on a congenic FVB background were maintained as 
heterozygous breeding pairs under standard SPF conditions in animal care facilities 
in Edinburgh. All animal procedures and breeding were performed in accordance 
with Home Office and institutional guidelines. Retrospective genotyping for both 
strains was carried out using standard PCR protocols detailed below. Smn+/-
;SMN2;Δ7 (SMNΔ7) (Jackson labs strain no. 005025) breeding pairs were 
maintained in animal care facilities in Oxford. For this strain, basic dissection of the 
chest and abdominal wall were performed in Oxford by James Sleigh and shipped to 
Edinburgh. All genotyping of this colony was performed in Oxford by James Sleigh. 
Neonatal SMA mice and control littermates up to the age of P5 were sacrificed by 
immersion in ice/ water followed by decapitation. Pups above the age of P5 were 
sacrificed by an overdose of anaesthetic administered via intraperitoneal (IP) 
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injection of sodium pentabarbitol (Euthenal). Care was taken to ensure both methods 
of sacrifice were performed in such a manner as to protect the integrity of the 
muscles of interest: decapitations were performed inferior to cranial muscle 
attachments and IP injections were placed out with the boundaries of the transverses 
abdominus (TVA) muscle. 
2.2.3 Genotyping of Severe mice 
After death 10mm tails tips were collected from all mice for retrospective 
genotyping. The tips were digested overnight in tail tip lysis buffer plus 5µl 
proteinase K at 55ºC.  The following day the digested tail tips were vortexed, to 
ensure complete digestion, and centrifuged at 14000K for 15 mins. The supernatant 
was added to 500µl of iso-propanol and gently inverted to precipitate the DNA, as 
was evident by the formation of thin white strands. The samples were centrifuged at 
14000K for 10 minutes to pellet the DNA. The DNA pellet was washed twice with 
70% ethanol. After the second wash any remaining ethanol was allowed to evaporate 
before the pellet was resuspended in 200µl of autoclaved, filtered, de-ionised water. 
To genotype Severe mice two separate PCR reactions were needed: one to identify 
the presence of the endogenous mouse Smn gene and a second to identify the 
presence of the neomycin cassette used to insert the human SMN2 gene into the 
mouse genome. The presence, absence or combination of endogenous mouse Smn 
and the neomycin cassette determined the genotype of the mice. A sample where 
only endogenous mouse Smn was present indicated that the corresponding mouse 
was a wildtype. A sample where only the neomycin cassette was present indicated a 
knockout. Possessing both endogenous Smn and the cassette indicated a 
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heterozygous mouse. These heterozygous mice were phenotypically 
indistinguishable from their wildtype littermates and so, were considered control 
mice along with wildtypes. 
PCR reaction mixes were made using the following standards: 




MgCl2  1.6 
Forward Primer WT 
Reverse Primer WT 
0.1 
    0.1 
Forward Primer NEO 
Reverse Primer NEO 
dNTPs                                            
Taq 
0.2 
    0.2 
0.4
    0.1 
Table 1: Details of the standard PCR reagent volumes per sample. 
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Reverse NEO AGGTGAGATGACAGGAGATC 
Table 2: Details of the primer sequences for Severe model genotyping 
 
1µl of extracted DNA was added to each reaction mix. Positive and negative controls 
were ran with every experimental litter genotyped. For negative controls 1µl of auto-
claved, filtered water was added in the place of DNA. All reactions were ran with a 
previously identified heterozygous sample and a positive control. The reactions were 
conducted in a PCR machine using the following programme: 
Step Temperature (°C) Time (seconds) 
   
1 94 120 
2 94 30 
3   61   30 
4 72 (27 cycles) 45 
5 72 120 
6 4 Indefinite 
Table 3: Details of the PCR programme used for Severe model genotyping 
The PCR reaction products were separated by gel electrophoresis. Samples were run 
on a 1.5% agarose gel (1.5g Agarose, 100ml 0.1M TAE buffer and 10 µl Sybersafe 
DNA stain (Invitrogen)) at 100v for 30 minutes and visualised. Specific bands were 
identified by their molecular weight. 
2.2.4 Genotyping of Taiwanese mice   
The Taiwanese experimental mice are generated from the crossing of two separate 
parent lines. One parent strain possess two copies of murine Smn, one of which is 
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complete and produces full length Smn. The other contains a neomycin cassette 
which has been inserted into the Smn gene, interrupting it, producing a shorter, non-
functional Smn product. These heterozygous mice have no additional human SMN2. 
This parent strain is crossed with a second line of mice which possess multiple 
copies of human SMN2 but have no full length endogenous Smn. These homozygous 
mice have four copies of human SMN2 (2 copies on each allele) but only possess a 
copy of the interrupted Smn gene and not the full length endogenous murine Smn 
gene. When these two parent lines are bred the resulting experimental Taiwanese 
mice retain four copies of human SMN2 and a combination of endogenous full 
length and interrupted murine Smn genes. It is this combination that determines the 
genotype. A single PCR reaction is used to determine these genotypes. 
In the PCR reaction there are three primers; one forward and two reverse. These 
primers are used to identify the condition of the murine Smn. The forward primer 
and the first reverse primer identify full length murine Smn (1050bp), while the 
second reverse primer recognises the neomycin insert and so produces the shorter, 
interrupted Smn (950bp) product. Presence of both the full length and interrupted 
Smn product identifies a pup as heterozygous. These heterozygous mice are healthy, 
gain weight and develop normally with no sign of motor deficiencies. These mice are 
considered as control littermates in all experiments described. Presence of only the 
shortened interrupted Smn product identifies the pup as homozygous. These 
homozygous pups lag behind control mice in weight gain by 2-3 days after birth and 
are SMA symptomatic by P5. 
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To genotype the Taiwanese mice 10mm tails tips were collected from all mice after 
death for retrospective genotyping. Tail tip digestion and DNA extraction was 
performed as described for the Severe model mice.  
PCR reaction mixes were made up using the following standards; 




MgCl2  0.9 
Forward Primer 1.5 
Reverse Primer 1 







Table 4: Details of the standard PCR reagent volumes 
 





Reverse 2   
GTAGCCGTGATGCCATTGTCA 
AGCCTGAAGAAGATCAGC 
Table 5: Details of the primer sequences used for Taiwanese model genotyping 
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1µl of extracted DNA was added to each reaction mix. Positive and negative controls 
were ran with every experimental litter genotyped. For negative controls 1µl of auto-
claved, filtered water was added in the place of DNA. All reactions were ran with a 
previously identified heterozygous sample and a positive control. The reactions were 
conducted in a PCR machine using the following programme: 
Step Temperature (°C) Time (seconds) 
   
1 95 180 
2 94 30 
3   59   30 
4 68 (35 cycles) 60 
5 68 300 
6 4 Indefinite 
Table 6: Details of the PCR programme used for Taiwanese genotyping 
The PCR reaction products were separated by gel electrophoresis. Samples were run 
on a 1.5% agarose gel (1.5g Agarose, 100ml 0.1M TAE buffer and 10 µl Sybersafe 
DNA stain (Invitrogen) at 100v for 30 minutes. Gels were visualised and specific 
bands were identified by their molecular weight against a DNA ladder (Promega 
Express, g2101). 
2.2.5 Quantitative Fluorescent Western Blotting 
The aortas from P5 SMA and control littermates were collected and pooled into a 
single sample for each condition. Total protein was isolated from the aortas by 
homogenisation in RIPA buffer (Pierce, 89900). Proteinase inhibitor cocktail 
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(Thermo Scientific, 1861278) was added to the RIPA buffer at a concentration of 
5µg/ml. 30µl of RIPA buffer was added to each sample. Following homogenisation 
the samples were centrifuged at 14000rpm for 20 minutes. A BCA assay was then 
conducted to determine protein concentration in the samples, using a micro BCA 
Assay kit (Pierce, 23235). A master mix was made up using the following volumes 
per sample and standard; 500µl reagent A, 480µl reagent B and 20µl reagent C. 
Enough master mix was made to analyse each sample and standard in duplicate (1ml 
per sample). A protein standard curve was produced by adding increasing volumes of 
2mg/ml of BSA albumin protein standard (Pierce, 23209) to the master mix. 1ml of 
mix was transferred to appropriately labelled 1.5ml Eppendorf tubes to which 1µl of 
corresponding sample was added. The samples were briefly vortexed and then 
incubated at 60°C for one hour. Following incubation samples were transferred to 
cuvettes and their absorbance measured at 562nm on a Thermo Scientific 
spectrophotometer. The absorbance readings from the standard samples were used to 
produce a standard curve. Using the equation of the line y = mx + c the concentration 
of the experimental samples was calculated.  After doing so, 15mg of protein per 
lane was chosen as the optimum loading concentration for western blotting. Samples 
were diluted with the appropriate volume of autoclaved, deionised water to prepare 
10µl for loading. To aid loading 5µl of NuPAGE LDS Sample Buffer (Novex, 
NP0007) was added to each sample. The samples were then incubated at 98°C for 2 
minutes before loading into 4-12% precast NuPageBisTris gradient gels (Novex, 
NP0323BOX) along with 5µl of Sharp Pre-stained protein standard (Novex, 
LC5800). Samples were run at 80V for 5 minutes, to ensure even entry of the 
samples into the gel, and then at 170V for 45 minutes. The gels were then removed 
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from their precast casing and trimmed. The gels were then transferred to PVDF 
membranes (NuPAGE,) in transfer buffer (NuPAGE,) at 24Mv 16 hours. Following 
overnight transfer, the membranes were moved to 50ml falcon tubes and incubated 
with 5mls Odyssey blocking buffer (Licor, 402-467-0700) at room temperature, on a 
rolling platform for at 30 minutes. After this initial blocking, a fresh 5ml of blocking 
buffer was added to the membranes along with Tween-20 at a concentration of 
1:1000. Primary antibodies were added to the blocking buffer and tween solution, 
SMN (BD Biosciences, 610646) was added at a concentration of 1:1600.  Actin 
(Abcam, ab8226, 42 kDa) at a concentration of 1:1600 was added as a loading 
control. The membranes were then incubated overnight at 4°C on a rolling platform. 
Following incubation with the primary antibodies, the membranes were washed for 
6x5 minutes in 0.1M PBS.  Corresponding Odyssey secondary antibodies were then 
applied to the membranes along with fresh blocking buffer and Tween-20 for an 
incubation period of 90 minutes, at room temperature, on a rolling platform. Both 
Goat anti rabbit 680 (Odyssey) and Rabbit antimouse IRDye 800 (Odyssey) were 
used at a concentration of 1:1600. The membranes were washed again for 6x5 
minutes in 0.1M PBS before being dried and scanned at 600 and 800 nm on a Licor 
Odyssey scanner. Quantification of the blots was performed on single channel scans. 
Bands were identified according to their molecular weight and their arbitrary 
fluorescence intensity calculated by Odyssey software. 
2.2.6 Dissection 
All pre-fix dissections were performed in oxygenated mammalian physiological 
ringer (mM: NaCl 120, KCl 5, CaCL 2  2, MgCl2 1, NaH2PO4 0.4, NaHCO3 23.8, 
Glucose 5.6). All post-fix dissections were performed in 0.1M PBS. 
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2.2.6.1 Cranial Muscles 
The cranial muscles of the mouse are located on the posterior aspect of the neck, at 
the base of the skull. To remove these muscles intact, the whole muscle mass 
covering the skull, along with the skin and ears of the mouse was removed. The 
resulting preparation was pinned out flat, using insect pins, in a Sylgard lined petri 
dish. The preparation was orientated so that the skin and ears were flat on the 
Sylgard and the deepest muscle layer faced upwards towards the dissector. Excess 
muscle tissue and fat was carefully cleaned from the preparation until the cranial 
muscles and their midline raphe was visible. The preparation was then fixed in 4% 
paraformaldehyde (PFA) for 10 minutes, at room temperature, on a rocking platform. 
Following fixation the preparation was repeatedly rinsed in 0.1M PBS to remove 
excess fixative. At this point any remaining overlaying muscles, fat, connective 
tissue and skin covering the cranial muscles was removed. The cranial muscles were 
dissected individually, starting with the most superficial the interscutilaris (IS), 
followed by the abductor auris longus (AAL), the auricularus superior (AS) and 
finally the levator auris longus (LAL). The muscles were cut from their midline 
raphe before being reflected laterally towards their insertion at the pinnae of the ear 
and cut flush. Once removed from the preparation the individual muscles were gently 
cleaned of any remaining connective tissue by blunt dissection. 
2.2.6.2 Transversus Abdominus 
The skin on the front and back of the mouse was carefully removed to expose the 
intact underlying musculature and peritoneum. A horizontal, suprapubic incision was 
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made into the peritoneum and was extended bilaterally to reach the spine. Here the 
incision was extended proximally on the back of the mouse, by cutting through the 
ribs at their costovertebral attachment, freeing the ribcage from the spine. These 
ascending incisions were then extended medially on the front of the mouse, through 
the clavicle and sternum to free the ribcage from its superior attachment to the axial 
skeleton. The abdominal organs and diaphragm were gently removed from the 
preparation allowing the thoracic cage and the inferiorly attached abdominal 
musculature to be removed from the mouse. The preparation was then pinned flat in 
a Sylgard lined dish using insect pins. The superficial abdominal musculature was 
removed by cutting down the midline of the chest from the sternum to the cut edge of 
the abdominal wall. This midline incision was extended laterally to reach the ribs and 
then diagonally back towards the sternum, along the medial border of the ribcage, to 
remove a triangular flap of muscle, exposing the underlying TVA. The superior 
epigastric vessels, running the length of the midline, were gently dissected from the 
surface of the TVA. The preparation was then fixed in 4% PFA for 10 minutes, at 
room temperature, on a rocking platform. Following fixation the preparation was 
repeatedly rinsed in 0.1M PBS to remove excess fixative.  After washing, ribs 
attached to the TVA were gently removed one at a time. Overlying fibres of the 
oblique muscles, identified by their diagonal arrangement, were gently removed by 
blunt dissection. At this point the TVA was removed from the ribcage by repeating 
the triangular dissection pattern used to remove the superficial abdominal 
musculature. Any remaining connective tissue was removed by gentle blunt 
dissection. 
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2.2.7 Immunohistochemistry 
Two staining approaches were utilised to label the skeletal muscle capillary bed; one 
an antibody based protocol and a second more rapid labelling technique involving a 
fluorescently conjugated isolectin. 
2.2.7.1 Platelet cell adhesion molecule 1 (PECAM 1) capillary staining 
Intact muscles were blocked in immunoglobulin G protease-free standard blocking 
solution (0.2% bovine serum albumin (BSA), 0.5% Triton-X-100 (TX100) made up 
in 0.1M PBS) for 30 minutes, at room temperature on a rocking platform. Muscles 
were then incubated overnight, at 4°C, on a rocking platform with goat anti-mouse 
PECAM 1 primary antibody (R&D Systems, AF3628) at a concentration of 1:1000 
made up in blocking solution. The following day muscles were washed for 6x5 
minutes in 0.1M PBS at room temperature, on a rocking platform. After washing, the 
muscles were incubated with donkey anti-goat Cy 3 conjugated secondary antibody 
(Jackson ImmunoResearch Laboratories Inc) at a concentration of 1:250 made up in 
fresh that day standard blocking solution.  Muscles were incubated with the 
secondary antibody for 1 hour, at 4°C in the dark, on a rocking platform. From this 
point on the muscles were kept in the dark. Following the secondary incubation 
muscles were washed again for 6x5 minutes in 0.1M PBS at room temperature, on a 
rocking platform. Muscles were then exposed to 5µg/ml FITC conjugated α-
bungarotoxin (α-BTX) to label post-synaptic acetylcholine receptors. The muscles 
were washed for the final time for 3x5 minute washes in 0.1M PBS before being 
whole mounted on glass slides, with glass coverslips. Muscles were mounted in 
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Mowiol (10%Mowiol, Polyscience Inc., 20%Glycerol, 50%0.2M Tris buffer pH8.5, 
3%1,4-diazobicyclooctane made up in distilled water) with the diazobicylooctance 
(DABCO) acting as an anti-fade reagent. The resulting slides were left overnight, in 
the dark, at room temperature to set before visualisation and imaging the following 
day. 
2.2.7.2 Griffonia Simplicifolia Lectin -1 (GSL-1) capillary staining   
Whole muscles were incubated with Rhodamine conjugated Griffonia Simplicifolia 
Lectin-1 (GSL-1) (Vector Laboratories) at a concentration of 1:100 made up in 0.1M 
PBS for one hour, in the dark, at room temperature, on a rocking platform. From this 
point on muscles were kept in the dark. Following GSL-1 incubation the muscles 
were washed for 6x5 minutes in 0.1M PBS before being exposed to FITC conjugated 
α-BTX as standard to label post-synaptic acetylcholine receptors. Muscles were then 
washed for the final time for 3x5 minutes in 0.1M PBS before being mounted in 
Mowiol on glass slides, with glass coverslips. The resulting slides were left 
overnight, in the dark, at room temperature to set before visualisation and imaging 
the following day. 
2.2.8 Imaging 
Micrographs for the calculation of capillary density and calibre were captured using 
a standard inverted epifluorescence microscope (Olympus 1X71) combined with a 
chilled CCD camera (Hammamatsu C4742-95) and OpenLab (Improvision) image 
capture software. Cy3 and rhodamine labelled capillaries were imaged using 550nm 
excitation and 570nm emission optics. FITC post-synaptic acetylcholine receptors 
were imaged using 494nm excitation and 520nm emission optics. 
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Micrographs for the analysis of capillary ramification were captured using a Zeiss 
LSM 710 laser scanning confocal microscope (20 x objective/ 0.4 NA; 40 x 
objective/ 1.3 NA oil objective). 488nm and 543nm laser lines were used for 
excitation. Confocal z-series images were merged into stacks using Zen software. 
2.2.9 Quantification and Analysis 
Any muscles with poor quality staining or those that had been damaged during 
dissection were excluded from analysis. For capillary density calculations a 
minimum of 40 fields of view per muscle were taken with 40 x objective, 0.8 NA) 
Any fields of view where excessive overlying connective tissue interfered with 
imaging were excluded from further analysis. If excluded fields of view amounted to 
five or more in an individual muscle the entire muscle in question was discarded 
from further analysis.  The cranial muscles were systematically samples and images 
were captured in every field of view (40x objective, 0.8 NA) across the entire 
muscle. For the larger, segmentally innervated TVA images were captured in every 
third field of view across the entirety of the muscle. For initial analysis images from 
the regions of the muscles; medial, endplate and lateral, were quantified separately to 
determine any regional variation in skeletal muscle capillary density. These regions 
could be identified by following the well defined endplate banding pattern in the 
muscles along with the characteristic shape of the origin and insertions of each of the 
muscles.  
2.2.9.1 Quantifying capillary density 
Images were first enhanced in Adobe Photoshop (CS4) for contrast and brightness. 
This ensured that definite vessel borders were visible and also prevented any fine 
PhD The University of Edinburgh 2014 
  56 
capillary structures from being lost and discounted. Any out of focus images where 
capillaries appeared blurred or those where background was too high to completely 
isolate capillary structures were excluded from further analysis. Using Image J (NIH) 
the enhanced images were converted to binary. In the resulting binary images 
capillaries were assigned black and muscle background white, allowing for the ratio 
of black to total white pixels to be calculated. This produced a value for capillary 
area per field of view. By calculating the area of a x40 field of view, it was then 





2.2.9.2 Quantifying capillary calibre 
Measurements were taken from the same images used to quantify capillary density. 
A grid was overlain onto the images using Image J (NIH) and the diameter of 
capillaries found at the intersection of gridlines was measured. The shortest distance 
across each capillary was measured and measurements were not taken at capillary 
bifurcations.  To prevent repeated measurement of the same capillary across an 
image, any capillaries which crossed multiple gridline intersections were excluded 
from measurement. 
2.2.9.3 Analysis 
All data were collected using Microsoft Excel software and were graphed and 
analysed using GraphPad Prism software. Charts shown are mean ± s.e.m. In all 
analyses statistical significance was considered to be p < 0.05. Tests used are detailed 
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2.3 Results 
 
2.3.1 SMN protein is present in endothelial cells and is reduced in SMA mice 
Having identified the vascular system as a key area of interest in SMA we initially 
determined if the Smn protein, the reduction of which results in the SMA phenotype, 
was present in the cells of the vascular system. Western blots for the Smn protein in 
the aortas of P5 Severe
 
SMA mice and control littermates show abundant levels of 
Smn in control aortas and reduced levels in SMA mice. Adding this result to our 
knowledge of muscular pathology and vascular defects in both animal models of the 
capillary network supplying SMA skeletal muscle. In order to do this we developed a 
novel method to measure skeletal muscle capillary density using thin, flat muscles 
which can be viewed in a 2D planar manner. 
 
Figure 1- Smn protein is present in the cells of the vasculature. Western blot of 
Smn (~42kDa) and β Actin (~42kDa) of P5 Control and SMA aortas. A western blot 
was carried out to determine the presence of the Smn protein in cells of the 
vasculature. An antibody against Smn was used to probe protein samples extracted 
from P5 aortas. In the control sample a strong band was detected at approximately 
42kDa, the molecular weight of Smn protein. In the SMA sample a very faint band 
was present at 42kDa. β Actin was used as a loading control, with bands of similar 
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2.3.2 Novel Capillary density quantification technique 
2.3.2.1 Muscle selection, preparation and staining 
In order to examine the skeletal muscle capillary bed flat, thin muscles form the 
cranial region (Fig 2 Cranial muscles) and the abdominal wall (Fig 3 TVA) were 
selected. These muscles have the advantage of being only a few muscle fibres thick 
allowing for the examination of the entire capillary bed in a whole mount 
preparation, removing the need for sectioning. Classical capillary density 
quantification has relied upon the counting of capillary to muscle fibre ratios in 
sectioned muscle, which can underestimate capillary density by up to 75% (Cebasek 
et al., 2009). By analysing the intact capillary bed a more accurate measure of 
capillary density should be produced. The selected muscles also encompass a range 
of developmental phenotypes, fibre types, body position and susceptibility to 
pathology in SMA (Murray et al., 2008, Murray et al., 2010), allowing for the 
investigation of the nature of the capillary bed in a range of phenotypically distinct 
muscle.  For initial investigations the well characterised LAL muscle was chosen. In 
particular the caudal band of the LAL muscle (LALc), as it is known to be 
susceptible to neuromuscular pathology and is severely affected in SMA (Murray et 
al., 2008).  
The cranial muscles of the mouse are located on the posterior aspect of the neck, at 
the base of the skull. The muscles are responsible for independent movement of the 
ears. The most superficial of these muscles, the levator auris longus (LAL) muscle 
has been chosen muscle for this investigation. (A) To remove the entire muscle mass 
at the base of the skull a vertical incision was made through the skin between the 
eyes of the mouse. This incision was then extended caudally along the skull to the 
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midpoint between the scapulae of the mouse (Figure 2A).  This incision was 
extended bilaterally underneath the ears to reach the original incision between the 
eyes. To remove the skin, ears and attached muscles, the skin at the cut edge 
underneath the ear was lifted to expose the ear canal. Keeping the dissecting scissors 
flat to the roof of the skull the ear canal was cut away from the skull. Keeping the 
scissors flat to the skull this cut was extended medially towards the original midline 
incision. This was then repeated on the opposite side of the skull (Figure 2B). The 
resulting preparation contains the ears, skin and underlying muscle mass (Figure 2C).  
The preparation was then pinned out in a Sylgard lined petri dish using insect pins. 
The preparation was pinned so that the most superficial layer of muscles became the 
deepest layer (Figure 2D). The overlying large muscles were gently dissected until 
the cranial muscles and their midline raphe, highlighted with an arrow, were visible 
(Figure 2E). The preparation was now fixed for 10 minutes in 4% PFA, at room 
temperature on a rocking platform. Following fixation the superficial cranial muscles 
were dissected to reach the muscles of interest, the LAL, which forms the deepest 
layer of cranial muscle group when the preparation is pinned in this fashion. 
Individual cranial muscles were removed one at a time from the preparation by 
locating  and cutting through their individual sites of attachment at the pinae of the 
ears and reflecting the muscle medially towards the midline where they were cut 
flush. Once removed from the preparation the muscles were cleaned of any 
remaining fat or connective tissue by gentle blunt dissection. Here the muscles are 
shown in their order of removal starting with the most superficial IS, followed by the 
AS, the AAL and then the LAL. After being removed intact the LAL was then 
separated into its two distinct bands: the larger rostral band and the smaller caudal 
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band, highlighted with arrows and labelled (Figure 2F). Along with the distinct bands 
of the LAL, the TVA was also chosen for analysis (Figure 3). 
 
 
Figure 2 – Cranial muscle dissection. Step by step images depicting the cranial 
muscle dissection procedure. 
 
The TVA muscle forms the deepest layer of the abdominal musculature. To expose 
the abdominal musculature the skin on the front and back of the mouse was removed 
(Figure 3A).  A horizontal incision was then made in the body wall (Figure 3B). This 
incision was first extended bilaterally to reach the spine and then proximally by 
cutting through the ribs to remove the rib cage and attached abdominal musculature 
(Figure 3C). The preparation was thinned pinned out in a Sylgard lined petri dish 
using insect pins (Figure 3D). A triangular flap of overlying abdominal musculature 
was removed, along with the overlying blood vessel to expose the underlying TVA 
(Figure 3E). The preparation was then fixed in 4% PFA for 10 minutes, at room 
temperature, on a rocking platform. The overlying fibres of the oblique fibres, the 
PhD The University of Edinburgh 2014 
  61 
ribs and sternum were removed from the TVA allowing it to be freed from the rib 
cage. The muscle was then cleaned of any remaining fat or connective tissue in 
preparation for staining (Figure 3F). 
 
 
Figure 3 – Transversus Abdominus (TVA) dissection. Step by step images 
depicting the TVA dissection procedure.  
 
In these muscles the capillary bed was visualised by staining with an antibody 
against Platelet Cell Adhesion Molecule 1 (PECAM 1) (R&D Systems), the major 
component of endothelial cell-to-cell junctions (Newman 1997) (Figure 4). PECAM 
1 functions in the cell adhesion cascade which results in the extravasation of immune 
cells during inflammatory responses (Newman 1997).PECAM 1 has been used 
PhD The University of Edinburgh 2014 
  62 
extensively in other studies to reliable label muscle capillary beds. The motor 
endplates of muscles were visualised using FITC-conjugated α bungarotoxin. α 
bungarotoxin is a naturally occurring toxin, isolated from the venom of the Banded 
Krate. The toxin specifically binds to the α subunit of the nicotinic acetylcholine 
receptor (Figure 4). After staining images were captured using either a standard 
epifluorescent microscope or a laser scanning confocal microscope, depending on the 
type of analysis to be performed. Confocal microscopy was used to obtain Z-stacks 
for the analysis of capillary ramification. 
 
Figure 4 – Skeletal muscle capillary bed staining. The capillary bed was stained 
using immunohistochemistry to label capillaries and bungarotoxin staining to label 
motor endplates. (A) Capillaries were visualised using an antibody against Platelet 
Cell Adhesion Molecule 1 (PECAM 1) (R&D Systems) and a corresponding Cy 3 
secondary antibody (Jackson Research Laboratories Inc). (B) Motor endplates were 
visualised using an FITC-conjugated α bungarotoxin (Molecular Probes)which binds 
specifically to acetylcholine receptors (C) Merged images of the PECAM 1(A) and 
FITC-conjugated α bungarotoxin (B) staining. Images were captured at 20 x 
magnification. Scale bar equals 50µm. 
 
A second staining technique, involving a rhodamine conjugated lectin, was also 
utilised to stain the skeletal muscle capillary bed (Figure 5B). Lectins are naturally 
occurring sugar agglutinating molecules which are found in plants, seeds and 
legumes. Individual lectins have highly specific binding for a variety of sugar 
moieties in specific cell types and regions. In this investigation, GSL-1 was used. 
GSL-1 is derived from the seeds of the Griffonia Simplicifolia (Bandeiraea) plant. It 
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is a four-subunit 114kDa glycoprotein which has specific binding affinity for the 
galactose sugar group present in the glycoproteins of endothelial cells (Vector 
Laboratories). GSL-1 staining of the skeletal muscle capillary bed was found to be 
identical to the labelling of the capillary bed achieved by PECAM 1 antibody 
staining (Figure 5A). Given that GSL-1 labelled the capillary in an identical manner 
to PECAM 1 antibody staining it was preferentially chosen as the main means to 
label the skeletal muscle capillary bed. This was due to the many advantages of GSL-
1 labelling over antibody staining. 
As lectins are not antibodies they do not require many of the stages required in 
standard antibody staining protocols.  Given the high affinity of GSL-1 for its target 
glycoproteins, the muscles did not need to be incubated in blocking solution to 
prevent non-specific binding.  By using a fluorescently conjugated lectin, capillaries 
could be visualised in a single incubation without the need for additional 
fluorochrome incubation stages. This allowed the capillary bed to be reliably labelled 
more efficiently than conventional antibody staining. 
    
 
Figure 5 – Comparison of PECAM 1 antibody and GSL-1 lectin staining of the 
skeletal muscle capillary bed. (A) Capillaries were visualised using the standard 
PECAM 1 primary and Cy 3 secondary antibody protocol. (B) Capillaries were 
visualised using the rhodamine conjugated  Griffonia Simplicifolia Lectin-1 (GSL-1). 
PECAM 1 (A) and GSL-1 (B) label skeletal muscle capillaries in an identical fashion. 
Images were captured at 40 x magnification. Scale bar equals 50µm. 
A     B 
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2.3.2.2 Quantification of Capillary Density 
Once stained the capillary bed was imaged for analysis.  The thin, flat muscles 
selected for investigation can be viewed as whole mount preparations in plan-view.  
This presents a unique opportunity to view, image and assess the form and extent of 
the entire capillary bed of skeletal muscle in an intact and uninterrupted state.  The 
initial assessments performed examined the extent of the capillary bed in skeletal 
muscle of Severe SMA model mice and control littermates. To generate values for 
capillary density from the images of the capillary bed a novel system of area based 
measurements was used.  
40 x magnification images of the capillary bed were converted from their RGB 
colour format (Figure 6A) into binary using Image J (NIH) software. In doing so the 
capillaries were assigned black and the background of underlying skeletal muscle 
was assigned white (Figure 6B). The form and extent of capillaries within the image 
were not altered, merely their colouring.  It was now possible to measure the ratio of 
black pixels to white pixels using Image J (NIH). This generated a percentage value 
for the area of the image inhabited by black pixels and so gave a value for the 
percentage area of the image occupied by capillaries. This could then be presented as 
the percentage area of capillaries per 40 x magnification field of view of muscle. By 
calculating the area of a 40 x magnification field of view in mm
2
 it was possible to 
present the data as capillary area per mm
2 
of muscle. Using this method the capillary 
density for the selected muscles of interest was calculated.  
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Figure 6 – ImageJ binary conversion of labelled skeletal muscle capillaries. (A) 
Representative image of PECAM 1 labelled capillary bed. (B) The same 
representative image converted into binary using ImageJ software.  Image was 
captured at 40 x magnification. Scale bare equals 50µm. 
 
2.3.3 Alterations to skeletal muscle capillary bed of the LALc muscle in late 
symptomatic Severe SMA mice 
Initial inspection of capillary bed staining in the LALc muscle showed a dramatic 
difference in the architecture of the capillary bed in Severe SMA mice (Figure 7B) 
when compared to control littermates (Figure 7A). The arrangement, organisation 
and size of Severe SMA capillaries appeared altered but most striking alteration was 
the apparent reduction in muscle capillary density.  In control littermate LALc 
muscles, a densely packed, well organised capillary bed with evenly-spaced 
capillaries was observed (Figure 7A).  In contrast the capillary bed of the LALc in 
Severe SMA mice was sparse, with large spaces between adjacent capillaries, 
resulting in a loose open loop arrangement (Figure 7B).  As this apparent difference 
in capillary density was the most striking and dramatic alteration to the capillary bed 
of Severe SMA mice it was chosen as the principal feature to measure. 
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Figure 7 – Altered skeletal muscle capillary bed architecture in Severe SMA 
mice. Representative confocal micrographs of control (A) and SMA (B) LALc 
muscles visualised with PECAM 1. Images are 40 x magnification. Scale bar equals 
50µm.  
 
2.3.3.1 There is a significant, consistent reduction in capillary density across 
the entire LALc muscle in Severe SMA mice 
For analysis of capillary density, the LALc muscle was split into three regions, 
shown in schematic form in Figure 8A. Firstly, the lateral region of the muscle, 
closest to the muscles attachment at the pinae of the ear (Figure 1), where the main 
blood supply of the LALc enters the muscle. Secondly, the endplate region, which 
has been previously defined (Murray et al., 2008), houses the motor endplates of the 
muscles and traverses the majority of the belly of the muscle. Finally, the medial 
region of the muscle, which is furthest from the arteriolar entry point and closest to 
the attachment of the LALc to the midline raphe (Figure 1). Images were captured in 
each of three regions and the capillary density for each quantified.  
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In P5 control mice, no significant difference in capillary density was observed 
between the three muscle regions. The lateral region, closest to the arteriolar entry 
point, had a comparable capillary density to the medial region of muscle, which is 
furthest from the initial blood supply to the muscle.  A similar density of capillaries 
at either end of the muscle suggests that by P5, the capillary bed of the LALc has 
extended across the full length of the muscle. Interestingly, the density of capillaries 
in the endplate region was not significantly different from the regions of the muscle 
which lack motor endplates. It could have been expected that given the high energy 
status of motor endplates and neuromuscular transmission, capillary density in this 
region would be increased to meet greater oxygen and nutrient delivery demands. 
This data instead suggests that the skeletal muscle capillary density is uniform across 
the muscle, regardless of distance from primary blood supply or local specialisations 
of the tissue. A similar uniformity was observed in the capillary density of LALc 
muscles of SMA mice. 
A significant reduction was seen in the capillary density of the P5 Severe SMA 
LALc muscles when compared to their control littermates.  This reduction was seen 
in all three regions of the muscle. Again, as in the control LALc muscle, the capillary 
density in each of the three regions was comparable. This suggests that capillary 
density is not preferentially reduced in a specific region of the muscle. 
With no significant difference in capillary density between the muscle regions within 
the LALc muscle, the individual data sets were pooled giving one total muscle value 
for each condition. This allowed the relative capillary density of control and Severe 
SMA LALc muscles to be compared. The capillary density of Severe SMA LALc 
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muscles was significantly reduced (P<0.0001, unpaired two-tailed t-test) in 
comparison to control littermate muscles by 36%. 
 The uniform reduction in density observed across the LALc muscle suggests that the 
Severe SMA capillary bed, however altered, is capable of extending across the entire 
muscle. The presence of other noticeable defects in the structure of the capillary bed 
suggests that the capillary network in Severe SMA mice, while capable of expanding 
with a growing muscle, is not as fully developed as the capillary bed observed in 
control mice of the same age. 
Immature skeletal capillary networks have a polygonal arrangement which contracts 
and lengthens with the growing muscle fibres, to form a parallel ladder-like 
association between the capillaries and underlying muscle fibres (Wolffe et al. 
1975,). In the P5 control LALc muscles this arrangement is evident, while the P5 
Severe SMA muscles retain their large, extended, open, polygonal loops described in 
early stages of skeletal muscle vascular development (Wolffe et al., 1975). Along 
with this loose and disorganised structure on the surface of the muscle, the capillary 
bed of the Severe SMA LALc also appeared to differ in its penetration into the belly 
of the muscle. 
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Figure 8- Uniform reduction in capillary density across the LALc in Severe 
SMA mice. (A) Schematic representation of the LALc muscle indicating the entry 
site of the main muscle artery (red), the location of the motor endplate band (green 
dots) and the three muscle regions sampled (medial, endplate zone and lateral). (B) 
Representative micrographs of the capillary be visualised with GSL-1and motor 
endplates visualised with FITC-conjugated α bungarotoxin in control and Severe 
SMA LALc muscles from the three muscle regions sampled. Images are 40 x 
magnification. Scale bar equals 25µm. (C )Bar chart (mean ± s.e.m) quantifying 
capillary density in muscle regions of P5 control and Severe SMA mice. One Way 
ANOVA with Tukey post-hoc test, ns = no significance, P>0.05. Bar chart (mean ± 
s.e.m) quantifying pooled data from the three sampled regions. Unpaired, two-tailed 
t-test, *** P<0.0001. N≥3 mice and n≥6 muscles for each bar. 
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2.3.3.3 The ramification of capillaries through the skeletal muscle bed is 
altered in late symptomatic Severe SMA mice 
From the original confocal images it appeared that the capillary bed of the Severe 
SMA LALc lay in monolayer on the surface of the muscle (Figure 7). In comparison, 
the capillary bed in the control LALc muscle appeared to extend from the surface 
into the belly of the muscle. To assess the three dimensional relationship of the 
capillary bed in the muscle confocal Z-stack images were captured and extended 
orthogonal slices were taken through the stacks. When compared these slices through 
the full thickness of the LALc muscle belly revealed a difference in the ramification 
of the capillary bed between control and Severe SMA muscles. In control muscle 
(Figure 9A) multiple capillary loops could be seen extended throughout the full 
thickness of the muscle. In comparison the Severe SMA capillary bed appeared to 
form a monolayer which, rather than penetrating through the muscle, appeared to lie 
on its surface. This again suggests that the capillary bed in Severe SMA mice is 
capable of forming an initial simple network on the surface of the muscle, but the 
further development and growth required to extend this monolayer through the depth 
of the muscle is not occurring. This decreased ramification of capillaries through the 
muscle and the reduction in capillary density is further compounded by a structural 
alteration to the capillaries themselves observed in Severe SMA muscles. 
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Figure 9 – Altered ramification of capillaries in Severe SMA muscle. (A) 
Maximum intensity projections of confocal Z-stacks of LALc skeletal muscle capillary 
bed, visualised with GSL-1, from P5 control and Severe SMA mice. Yellow bars on 
these confocal micrographs indicate the position from where orthogonal slices were 
taken.(B) Extended, orthogonal slices of the capillary bed taken through Z-stacks. 
Images are 10 x magnification. Scale bar equals 25µm. 
 
2.3.3.4 Capillary calibre is increased in late symptomatic Severe SMA mice 
When first observing the capillary bed the most striking difference between control 
and Severe SMA LALc muscles, was the extent of capillaries covering the muscle. 
On closer inspection, subtle differences in the structure of the capillaries themselves, 
beyond their number and arrangement, seemed apparent, in particular, the calibre 
(diameter) of the capillaries themselves. To assess this, the calibre of capillaries from 
across all regions of the LALc muscle were measured in both control and Severe 
SMA mice. In comparison to control littermates, the calibre of Severe SMA 
capillaries was significantly increased (P<0.0001, unpaired, two-tailed students t-
test). On average control capillaries were approximately 4µm in diameter, while the 
average diameter of Severe SMA capillaries in the LALc muscle was approximately 
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6µm (Figure 10A). Representing an average 50% increase in capillary calibre in 
Severe SMA mice. When individual capillary calibres were presented in scatter plot 
format a far wider distribution of capillary calibres was seen in Severe SMA muscle. 
The tail of larger calibre capillaries was positively skewed, with 3.5% (62/1826) of 
capillaries lying in this tail (Figure 10B). In addition to a poorer ramification through 
the muscle the capillaries present in the Severe SMA capillary bed were much larger. 
 
 
Figure 10 – Increased capillary calibre in Severe SMA skeletal muscle. (A) Bar 
chart (mean ± s.e.m) quantification of capillary calibre in the LALc muscle of P5 
Severe SMA mice (black bar) and control littermates (white bar). Unpaired, two-
tailed t-test, *** = P<0.0001. N≥1650 profiles from ≥6 muscles from ≥3 mice for each 
bar. (B) Scatter plot of capillary calibres showing a wider distribution of diameters in 
Severe SMA mice with a positively skewed tail towards larger diameters.Black lines 
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2.3.4 Consistent loss of capillary density in skeletal muscle, regardless of 
muscle position, fibre type, developmental sub-type or susceptibility to 
neuromuscular pathology in SMA 
Having analysed the form and extent of the capillary bed in the LALc muscle in 
detail, the extent of the capillary bed in two other muscles was analysed. First the 
rostral band of the LAL (LALr) and then the abdominal Transversus Abdominus 
(TVA) muscle. 
Despite being closely related anatomically and sharing the same innervation the two 
bands of the LAL muscle show varying susceptibility to pathology in SMA (Murray 
et al., 2008). The LALc muscle is vulnerable to pathology and shows high levels of 
denervation at late symptomatic time points  with more than 95% of motor endplates 
denervated at P5 (Murray et al., 2008). The LALr however, is resistant and shows 
very little, to no pathology at P5 with less than 5% of motor endplates being 
denervated at this late symptomatic time point (Murray et al., 2008). The capillary 
density of the LALr muscle showed a 38% reduction in capillary density, closely 
mirroring the 36% reduction that was found in the LALc muscle (Figure 11). 
Observing a reduction in capillary density in skeletal muscle irrespective of the 
whether profound denervation of the muscles fibres is present or not is a key finding.  
The data suggests that the capillary phenotype we observed in Severe SMA skeletal 
muscle is not a result of muscle denervation. As well as their differing denervation 
status, the LALc and LALr are also of different developmental subtypes. 
 Muscles can be classed into differing developmental phenotypes on the basis of the 
rate at which mature neuromuscular junction (NMJ) formation occurs in the muscle 
(Pun et al., 2002). A mature NMJ will display clustered acetylcholine receptors to 
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which the presynaptic motor nerve and surrounding Schwann cells will be well 
aligned (Pun et al., 2002). In Fast Synapsing (FaSyn) muscles this process will take 
place over one day of embryonic development. In Delayed Synapsing (DeSyn) 
muscles this process can take up to five days of development (Pun et al., 2002). It has 
been suggested that this developmental phenotype could pre-determine muscle 
susceptibility to disease (Pun et al., 2002). The LALc muscle is of FaSyn while the 
LALr is of DeSyn developmental phenotype (Frey et al.,2000; Pun et al., 2002). 
Again, observing an almost identical reduction in capillary density in both the LALc 
and LALr suggests that developmental phenotype of a muscle does not affect the 
capillary defect. Another key difference between skeletal muscles, which could 
influence their capillary density, is their fibre type.  
Muscles can be classified on the basis of their fibre contraction responses (Close 
1964). Slow muscle fibres contract for long periods of time with little force, while 
fast fibres contract more rapidly and powerfully but fatigue more readily (Denny-
Brown, 1929; Eccles and Eccles et al., 1960; Close, 1964). After examining the 
bands of the LAL, both of which are of a fast fibre nature, the slow fibre, abdominal 
Transversus Abdominus (TVA) muscle was analysed.  
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Figure 11 – Consistent reduction in Severe SMA skeletal muscle regardless of 
muscle position, developmental or fibre type. Bar chart (mean ± s.e.m) 
quantification of capillary density in LALc, LALr and TVA muscles of Severe SMA 
mice (black bars) and control littermates (white bars). Unpaired, two-tailed t-test, *** 
=P<0.0001. N≥3 mice and n≥6 muscles for each bar. 
 
As well as being of a slow twitch fibre type the TVA is also susceptible to pathology 
in SMA (Murray et al., 2008). While analysing the two bands of the LAL muscle 
already allowed for the comparison of capillary density between pathologically 
vulnerable and resistant muscles, analysis of the TVA incorporates an important 
factor in the susceptibly of muscles to pathology in SMA: position in the body. 
In SMA, the upper and proximal muscles of the body are preferentially targeted, in 
particular the respiratory muscles and muscles of the upper limb (Lunn & Wang, 
2008). The TVA is located in the abdominal and thoracic regions of the body, much 
more caudally positioned than the LAL muscles in posterior aspect of the neck. Here 
the capillary density of Severe SMA TVA muscle showed a 40% reduction in 
comparison to control littermates, again in line with the reduction that was observed 
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in both LAL muscles (Figure 11). This suggests that capillary density is reduced in 
Severe SMA muscles, regardless of their position in the body. 
From the analysis of the LALc, LALr and TVA muscles, it can be suggested that 
capillary density is significantly reduced in Severe SMA skeletal muscle, regardless 
of muscle position in the body, muscle fibre type, developmental phenotype and of 
key interest, regardless of the level of denervation present in the muscle. The 
denervation which occurs in vulnerable muscles in the Severe SMA mouse model 
occurs postnatally (Monani et al., 2009; Murray et al., 2010). To address when this 
reduction in skeletal muscle capillary density occurred, the same selection of muscles 
were analysed in the same manner at two earlier time points; the early symptomatic 
P3 and pre-symptomatic P1 ages. 
 
2.3.5 Reduction in capillary density is a postnatal event which occurs in 
parallel with motor neuron loss 
The LAlc, LALr and TVA muscles were collected, stained, imaged and quantified in 
an identical manner to the previously described experiments, from neonatal P3 and 
P1 Severe SMA mice and their control littermates. In the Severe SMA model day of 
birth is considered to be P1. At the early symptomatic P3 time point, a reduction of 
30-33% was observed in all three of the Severe SMA skeletal muscles when 
compared to their control littermates (Fig 12). This reduction is in line with the 
reduction previously found at the late symptomatic P5 time point. However, at the 
earlier P1 (birth) pre-symptomatic time point a similar reduction was not observed. 
Here, instead, the capillary density of all three Severe SMA muscles did not differ 
from their control littermates (P>0.05, One Way ANOVA). With Severe SMA 
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muscles retaining 96-99% of the capillary density observed in control littermates. 
Seeing no difference in the capillary density of Severe SMA and control muscles 
suggests that the capillary bed of Severe SMA skeletal muscle is normal at birth. The 
capillary beds of control and Severe SMA mice are comparable when imaged (Fig 
12B) showing a similar structure and organisation. By P3 this similarity is lost, with 
control capillary beds already displaying a more compact and parallel network while 
Severe SMA capillaries retain the more loose, open looped arrangement. It is around 
this same time that the neuromuscular pathology found in the Severe SMA mice 
becomes apparent with SMA affected mice displaying NMJ defects in the TVA 
muscle (Sleigh et al., 2011). Observing the reduction in capillary density at this time, 
but not at birth, suggests that the defect is an early postnatal event which occurs in 
parallel with the neuromuscular pathology in this model, rather than as a 
consequence of it. 
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Figure 12 – Capillary density is reduced in P3 but P1 Severe SMA skeletal 
muscle. (A) Bar chart (mean ± s.e.m) quantification of capillary density in the LALc 
muscle from pre-symptomatic (P1), early symptomatic (P3) and late symptomatic 
(P5) Severe SMA mice and control littermates. (B) Representative micrographs of 
GSL-1 labelled capillary bed of the LALc muscle in P1, P3 and P5 Severe SMAmice 
and control littermates. (C) Bar chart (mean ± s.e.m) quantification of capillary 
density in the LALr muscle from pre-symptomatic (P1), early symptomatic (P3) and 
late symptomatic (P5) Severe SMAmice and control littermates. (D) Representative 
micrographs of GSL-1 labelled capillary bed of the LALr muscle in P1, P3 and P5 
Severe SMAmice and control littermates. (E) Bar chart (mean ± s.e.m) quantification 
of capillary density in the TVA muscle from pre-symptomatic (P1), early symptomatic 
(P3) and late symptomatic (P5) Severe SMAmice and control littermates. (F) 
Representative micrographs of GSL-1 labelled capillary bed of the TVA muscle in 
P1, P3 and P5 Severe SMAmice and control littermates. One Way ANOVA with 
Tukey post-hoc test, ns = no significance P>0.0, ***=P<0.0001. N≥3 mice and n≥6 
muscles for each bar. Images are 40 x objective. Scale bar equals 50µm. 
 
2.3.6 A similar reduction in capillary density is observed in other mouse 
models of SMA 
Having assessed the capillary defect in detail in the Severe SMA mouse model of 
SMA we sought to determine if a similar defect was present in other mouse models 
of SMA. In particular, the Taiwanese and 2Δ7 mouse models of SMA, both of which 
have an extended postnatal lifespan in comparison to the Severe SMA model.  
 
2.3.6.1A significant reduction in skeletal muscle capillary density is observed 
in Taiwanese SMA model mice 
The first model that was chosen to investigate was the Taiwanese. In comparison to 
the Severe SMA mice, Taiwanese SMA mice live for up to 11 days and develop an 
SMA phenotype at P6-7 when weight loss and motor deficits are apparent (Hsieh-li 
et al.,2000; Riessland et al 2010).  From these mice the TVA muscle was collected 
and the capillary bed stained, imaged and quantified in the same manner as previous 
experiments. Here again, at a late symptomatic time point (P11) there was a 
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significant (P<0.0001, One Way ANOVA with post hoc Tukey) 45% reduction in 
capillary density in SMA muscle when compared to control littermates (Figure 13A, 
13B). This confirmed the initial finding of the capillary defect in P5, late 
symptomatic Severe SMA mice in a second mouse model of SMA. As with the 
Severe SMA model a timeline analysis of capillary density was conducted.  
As was seen in the Severe SMA mice, at birth the capillary beds of Taiwanese SMA 
and control littermates were indistinguishable (Figure 13B) and, when quantified, the 
capillary density in both conditions was comparable (P>0.05, One Way ANOVA 
with post hoc Tukey). The similarity between control and capillary density was 
present at postnatal day 3, when Taiwanese SMA mice are described as pre-
symptomatic (Hsieh-li et al., 2000, Riessland et al., 2010). Again no significant 
difference was fond between the capillary density of control and Taiwanese SMA 
mice (P>0.05, One Way ANOVA with post hoc Tukey). When TVAs from P5 
animals were analysed, a visible difference was present in the form and extent of the 
capillary beds (Figure 13B) of control and Taiwanese muscle. Capillary density of P5 
Taiwanese SMA TVA muscle was reduced by 30 %, in comparison to control 
littermates. At this time Taiwanese SMA mice begin to display a distinguishable 
phenotype, lagging behind their control littermates in weight gain, suffering 
diarrhoea and displaying neuromuscular junction (NMJ) defects (Hsieh-Li et 
al.,2000; Riessland et al., 2010; Schreml et al.,2013). Here, as was seen in the Severe 
SMA model, defects in the capillary bed are not present at birth but develop 
postnatally. 
As the timeline progressed, a more pronounced difference between the organisation 
of capillary beds was evident and by late symptomatic P8 and P11 time points the 
PhD The University of Edinburgh 2014 
  81 
difference in the form and extent of the capillary bed between Taiwanese and control 
littermates was drastic (Figure 13B). A 39% reduction in capillary density at P8 and 
45% at P11 was seen between Taiwanese SMA and control skeletal muscle (Figure 
13A). Which is similar to the 36% late symptomatic reduction observed in the 
shorter lived Severe mouse model. This not only confirms the initial finding of a 
significant reduction in capillary density in SMA skeletal muscle in a second mouse 
model of the disease, but also confirms the postnatal time line development of the 
capillary defect in a second model of the disease. Another commonly used mouse 
model of SMA is the 2Δ7 model, which has an increased lifespan in comparison to 
the Taiwanese model. 
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Figure 13 – Reduction in capillary density is evident by P5 in Taiwanese SMA 
skeletal muscle. (A) Bar chart (mean ± .e.m) quantification of capillary density in 
the TVA muscle of pre symptomatic (P0, P3), early symptomatic (P5) and late 
symptomatic (P8,P11) Taiwanese SMA mice (black bars) and control littermates 
(white bars).  One Way ANOVA with Tukey post-hoc test, ns = no significance 
P>0.0, **=P<0.001, ***=P<0.0001. N≥3 mice and n≥6 muscles for each bar. (B) 
Representative micrographs of GSL-1 labelled capillary beds of TVA muscle from 
P0,P3,P5,P8 and P11 Taiwanese SMA mice and control littermates. Images are 10x 
objective. Scale bar equals 50µm. 
 
2.3.6.2 A significant reduction in skeletal muscle capillary density is observed 
in SMNΔ7 SMA mice 
SMNΔ7 SMA mice survive on average 14 days and develop an SMA phenotype by 
P6-7 (Kerr et al., 2000). These mice differ from the Severe and Taiwanese SMA 
models in that while possessing a copy of the incorrectly spliced human SMN2 the 
SMNΔ7 mice also carry a copy of the missing exon 7 transcript (Kerr et al., 2000). 
Again the TVA muscle was collected and the capillary bed stained for imaging and 
analysis. 
The capillary bed of late symptomatic P14 SMNΔ7 SMA mice displayed a 
significant 37% reduction in capillary density in comparison to control littermates 
(P<0.001, One Way ANOVA with post hoc Tukey) (Figure 14B). This confirmed the 
initial finding of a reduced capillary density in SMA skeletal muscle when compared 
to control tissue in a third mouse model of the disease. When an earlier, pre-
symptomatic time point (P6) was analysed (Figure 14B), a similar significant 31% 
reduction in SMA skeletal muscle capillary density was also observed (P<0.001, One 
Way ANOVA) (Figure 14A). This again confirming the development of the capillary 
defect is a postnatal phenomenon, in a third mouse model of the disease. 
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Figure 14 – Significant reductions in P6 and P14 SMNΔ7 capillary density. (A) 
Bar chart (mean ±s.e.m) quantification of capillary density in the TVA muscle of 
early (P6) and late symptomatic (P14) SMNΔ7 mice (black bars) and control 
littermates (white bars).  One Way ANOVA with Tukey post-hoc test, **=P<0.001, 
***=P<0.0001. N≥3 mice and n≥6 muscles for each bar. (B) Representative 
micrographs of GSL-1 labelled capillary beds of TVA muscle from P6 and P14 
SMNΔ7 SMA and control littermates.  Images are 10 x objective. Scale bar equals 
50µm.  
 
2.3.7 Post natal appearance and progression of the capillary defect 
In the three mouse models of SMA examined, the capillary defect arises postnatally 
(Figure 12, Figure 13) and is first observed in line with the appearance of NMJ 
pathology reported in each model (Figure 15). As the disease progresses in each 
model, the reduction in capillary density becomes more pronounced (Figure 12, 
Figure 13). By examining tissue from three models of varying lifespan this 
progression of the capillary defect can be followed in comparison to normal skeletal 
muscle capillary bed development.  
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Figure 15 – A schematic showing the appearance of neuromuscular pathology and 
skeletal muscle capillary defects in the Severe-SMA, Taiwanese-SMA and SMNΔ7 
mouse models of SMA. 
 
When examined there are subtle morphological differences between the capillary 
beds of control skeletal muscles from the three models. The older P11 Taiwanese 
(Figure 16B) and P14 SMNΔ7 (Figure 16C) display a more compact and parallel 
capillary bed than the younger P5 control Severe model TVA muscle (Figure 16A). 
This follows the normal pattern of capillary development in skeletal muscle, where 
capillaries are seen to lengthen with the muscle and become rectangular in 
arrangement and parallel to the underlying muscle fibres (Wolffe et al., 1975). This 
pattern is still observed, but to a lesser extent, in the corresponding SMA TVA 
muscles. 
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When compared to the P5 Severe model muscle (Figure 16D), the capillary beds of 
the longer surviving P11 Taiwanese (Figure 16E) and P14 SMNΔ7 (Figure 16F) 
muscles show a more mature organisation. While the younger P5 Severe SMA 
muscle displays an open, loosely looped capillary network structure (Figure 16E), the 
P14 SMNΔ7 SMA skeletal muscle in particular displays a more parallel, rectangular 
arrangement of capillaries (Figure 16F). While the organisation of the capillary bed 
is somewhat improved in the longer surviving SMA muscle, capillary density is not 
(Figure12, Figure 13, Figure 14). This suggests that while an increased lifespan 
allows the SMA muscle to enhance the initial primary structure of the capillary bed 
the further angiogenesis required to develop the mature capillary bed does not occur. 
 
Figure 16 – Comparative capillary network maturity in the three mouse models 
examined. Representative GSL-1 labelled skeletal muscle capillary beds from the 
TVA muscle at a late symptomatic time point in the Severe, Taiwanese and SMNΔ7 
mouse models of SMA show almost identical late-stage pathology. Images are 10x 
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2.4 Discussion 
In this chapter a novel means of assessing the skeletal muscle capillary bed is 
presented. This simple and efficient method takes advantage of the almost two-
dimensional capillary bed found in the small, thin, flat cranial and TVA muscles, 
which allows these muscles to be visualised and analysed in plan-view. The findings 
of this chapter show that the measurements obtained from this plan-view analysis 
were robust and repeatable across all regions of muscle, between phenotypically and 
regionally distinct muscles from the same animal and between muscles from 
different animals. Examining muscle in plan-view also allowed for the analysis of 
vessel structure, in particular, capillary calibre (diameter), a key component in 
determining the surface area of vessels. These finding suggest the method presented 
is a reliable means of assessing the form and extent of skeletal muscle capillary beds. 
It should be noted that the values presented in this study are relative and not absolute 
capillary density.  
The findings of this chapter show that the capillary bed of skeletal muscle is altered 
in SMA mice. Initially the results of this chapter show that the form and extent of the 
skeletal muscle capillary bed is altered in late symptomatic (P5) Severe SMA Severe 
model SMA mice. These alterations in SMA muscle include a reduction in capillary 
density, an increase in capillary calibre and a decrease in the penetration of vessels 
through the muscle belly, when compared to control littermates.   
Second, these findings show that the most striking alteration to the capillary bed, the 
reduction in its density was observed in a selection of phenotypically distinct 
muscles. Significant levels of capillary density reduction were observed in the 
cranially located fast twitch FaSyn LALc and DeSyn LALr and the abdominal slow 
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twitch TVA muscle. This suggests that the occurrence of the capillary defect is 
unaffected by the developmental phenotype, fibre twitch type and body position of 
the skeletal muscle examined.  
Thirdly this work showed an almost identical reduction in capillary density in the 
LALr muscle which is resistant to neuromuscular pathology in the Severe model and 
the LALc muscle which is particularly susceptible to pathology in this model, 
displaying denervation of >95% of motor endplates (Murray et al., 2008). The 
finding that the capillary bed is altered irrespective of the level of denervation 
present in the muscle suggests that the capillary defect is the result of intrinsic 
defects in the skeletal muscle rather than neuronal pathology. 
Fourthly this investigation revealed that while dramatically reduced at a late 
symptomatic (P5) timepoint, the capillary density of Severe SMA  muscle was not 
significantly different from control littermates at birth (P>0.5, One WayANOVA, 
with post hoc Tukey ). At birth Severe SMA mice are pre-symptomatic and show no 
neuromuscular pathology (Murray et al., 010). By P3 Severe SMA mice show 
neuromuscular pathology and are regarded as early symptomatic. At this early 
symptomatic stage the capillary beds of control and SMA skeletal muscle were 
observed to be significantly different (P>0.5, One Way ANOVA, with post hoc 
Tukey). These findings suggest that the capillary defect observed in SMA skeletal 
muscle is a postnatal phenomenon which occurs in line with the appearance of 
neuromuscular pathology.  
Lastly it was observed that the capillary defect seen in the Severe model was also 
present in a second and third mouse model of SMA. Full time line analysis in the 
Taiwanese mouse model revealed a similar developmental pattern of the capillary 
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defect as was observed in the Severe model. At birth and pre-symptomatic time 
points no significant difference was observed between control and SMA capillary 
density (P>0.5, One Wan ANOVA, with post hoc Tueky). Again the capillary defect 
was first observed at an early symptomatic (P5) time point when neuromuscular 
pathology is first observed in this model (Schreml et al., 2013). This again suggests 
that the development of the capillary defect parallels that of neuromuscular 
pathology rather than occurring as a consequence of it. Analysis of a late (P14) and 
early symptomatic (P6) time point in the SMNΔ7 model confirms the presence of 
significant reductions in skeletal muscle capillary density at these stages of disease 
progression in a third mouse model of SMA 
 
2.4.2 Effects of denervation on skeletal muscle capillaries 
These results suggest that the decrease in capillary density observed in SMA skeletal 
muscle is a postnatal phenomenon which occurs in parallel with the neuronal 
pathology observed in the mouse models examined and not as a consequence of the 
denervation which occurs during disease progression. 
An almost identical reduction in capillary density was observed in the LALr muscle, 
which is spared from neuronal pathology, as was seen in the LALc muscle which 
shows dramatic denervation and neuronal pathology in the Severe SMA mouse 
model of SMA (Murray et al., 2008). Both the LALr and LALc are fast twitch fibre 
type muscles (Erzen et al., 2000). While multiple studies have reported a reduction in 
capillary to muscle fibre ratio in response to denervation (Chernukh and Alekseeva, 
1975, Borisov et al., 2000; Dedkov et al., 2002; Cebasek et al., 2006), experimental 
denervation of the Extensor Digitorum Longus (EDL), a fast twitch fibre type 
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muscle, did not result in capillary loss (Cebasek et al., 2006). As well as maintaining 
capillary number following denervation, the organisation and arrangement of 
capillaries within the EDL was also retained, with capillaries seen to be running 
parallel to muscle fibres before and after denervation (Cebasek et al., 2006). While 
the slow twitch fibre Soleus muscle showed a significant reduction in capillary 
number and perturbations of vessel organisation when subjected to denervation 
(Cebasek et al., 2006). This suggests that the capillary bed of fast twitch fibre 
muscles are unaffected by denervation.  In contrast to this, the findings within this 
chapter report a dramatic alteration in the form and extent of the denervated fast 
twitch fibre type LALc muscle and also in the innervated fast twitch fibre type LALr. 
Observing such alterations in both muscles suggests that the capillary defect is not a 
consequence of denervation but that it occurs independently as a result of changes in 
the vascular system or the muscle, both of which have been described as being 
affected in SMA (Fidzianska and Wado, 1990; Tens et al., 1996; Stahas et al., 2008; 
Araujo et al., 2009; Rudnik-Schoneborn et al., 2010; Mutsaers et al., 2011) or as a 
failure of the capillary bed to develop properly. 
 
2.4.3 Development of skeletal muscle capillaries 
The initial vascular network is formed by the process of vasculogenesis, which 
describes the formation of vessels from angioblasts (Risau and Flamme, 1995). This 
primitive network is further developed by angiogenesis, the process by which new 
vessels form from a pre-existing network (Risau, 1997). The formation of capillaries 
in tissue is described by the classical studies of Clark who investigated 
vasculogenesis and angiogenesis in the tadpole tail (Clark, 1918; Clark, 1939). 
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Clark reported that following a period of primary differentiation the vascular system 
of the tadpole developed by sending out endothelial sprouts which were seen to 
anastomose with other nearby sprouts to form a putative capillary network (Clark, 
1918). Growth of new capillaries in adult tissue was found to occur in the same 
manner, with sprouts anastomosing to form capillary loops (Clark, 1939). Later 
studies by Wolff et al describe the further development of the primary capillary 
network in skeletal muscle. 
In their investigation Wolff et al injected India Ink into the hearts of rats ranging in 
age from embryonic to adult. Circulation of the dye allowed for the visualisation of 
the vascular network throughout the body, with the limb muscles in particular being 
examined in detail. In E17 skeletal muscles, a wide mesh of terminal vessels 
arranged in a polygon-shaped plexus reaching across the entire surface of the 
muscles were observed. As the animal age increased these meshes were seen to 
lengthen with the muscle, becoming rectangular in shape and parallel to muscle fibre 
direction (Wolff et al., 1975). 
As was observed in the work of Wolff et al., the present study shows that the 
vascular network of both control and SMA Severe and Taiwanese mice is well 
established by birth, with the capillary network covering the entire muscle. 
Observing that the capillary bed of control and SMA skeletal muscle is 
indistinguishable at birth suggests that the initial development of the vascular 
network (vasculogenesis) is not impaired in SMA skeletal muscle. As the age of 
animals increased, capillaries in control skeletal muscle followed the pattern of 
development described by Wolff becoming more rectangular and parallel in 
arrangement (Figure 12, Figure 13) while capillaries in SMA tissue retained a more 
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loose open loop arrangement similar to that seen at birth (Figure12, Figure 13). 
Maintaining a more immature capillary bed suggests that while the vascular network 
is able to form in SMA skeletal muscle, the ability to develop beyond the primary 
capillary network is impaired. Formation of a mature vascular network is the result 
of complex angiogenic signalling involving multiple pathways and molecules 
(Rissau 1997). Given the knowledge that intrinsic molecular pathology is present in 
SMA skeletal muscle, which is found independently of denervation (Mutsaers et al., 
2011), it is possible that angiogenic signalling pathways are also affected in SMA, 
resulting in the defective capillary bed observed in this chapter.  
 
2.4.4 The Neurovascular Link 
The patterning of blood vessels and nerves in peripheral tissues is shared 
(Mukouyama et al., 2002). In the skin arterioles and nerves are aligned as a result of 
nerve derived vascular endothelial growth factor (VEGF) directing the path of 
arteriolar growth (Mukouyama et al., 2002). In other tissues it is the nerves that rely 
upon vessels for development and differentiation (Shen et al., 2004). In the central 
nervous system neural stem cell neurogenesis is stimulated in regions where high 
levels of endothelial cell-derived growth factors are found (Shen et al., 2004). Not 
only is the development of the neural and vascular system closely related, the 
systems share regulatory and guidance signals (Eichman et al., 2005). 
Neuronal axons are guided to their target by the growth cone, the highly motile distal 
tip of the axon (Tessier-Lavigne and Goodman, 1996; Dickson, 2002). Similarly, the 
distal region of capillaries display highly motile tip cells which function in a similar 
manner to growth cones, guiding capillaries. These tip cells are guided by VEGF 
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(Ruhrberg et al., 2002, Stalmans et al., 2002) but also by many signals used by the 
neural system to guide axons. 
Neuropilin receptors along with semaphoring signals are known to function in 
repulsive axon guidance (Kolodhin et al., 1997; He and Tessier-Lavigne, 1997). The 
neuropilin 1 receptor is expressed in endothelial cells and neuropilin 1 mutant mice 
show multiple vascular defects, including impaired angiogenesis and insufficient 
vascular network development (Kawaksi et al., 1999). The neuropilin receptors have 
also been reported to be involved in vessel guidance (Herzog et al., 2001; Moyon et 
al., 2001; Yuan et al., 2002). Other notable pathways including PlexinD1 -
Semaphorin (Gitler et al., 2004; Torrez-Vazquez et al., 2004;  Gu et al., 2004) and 
netrin (Dickson and Keleman, 2004; Lu et al., 2004) signalling have been shown to 
have roles in guiding vessels.  
These studies suggest a conservation of molecular mechanisms between the neural 
and vascular networks. In such shared systems perturbation of one network could 
highlight a potential area of defect in the other. Axon growth and guidance has been 
reported to be disturbed in SMA. A reduction in axon outgrowth is observed in SMA 
motor neurons in culture (Rossoll et al., 2003). This impaired growth was attributed 
to a reduction in β-actin mRNA in the growth cones of developing motor neurons 
(Rossoll et al.,2003) suggesting defects in the machinery required for axon growth in 
SMA. Along with this impairment in growth, defects in axon path finding have been 
reported in SMA (McWhorter et al., 2003). Knock-down of Smn in zebra fish 
resulted in axon pathfinding defects (McWhorter at al., 2003). If the growth and 
pathfinding ability of axons is affected by low levels of Smn, it is reasonable to 
suggest that the growth and organisation of blood vessels, which share angio-
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neurogenic signals and guidance cues, could also be negatively impacted by the Smn 
reduction found in SMA. Such disturbances of the neurovascular link have been 
reported in neurodegenerative diseases such as Alzheimers Disease (Zlokovic, 2005; 
Zlokovic, 2008; Ruiz de Almodovar, 2009) and importantly, another form of motor 
neuron disease: ALS (Azzouz et al., 2004; Storkebaum et al., 2005; Zacchinga et al., 
2008; Ruiz de Almodovar 2009; Hwang et al 2009).  
 
2.4.5 Weaknesses of Study 
Although every attempt was made to ensure that this study was as robust as possible, 
there is an area of weakness that should be noted: the lack of clinically relevant 
muscles selected for analysis, such as the proximal limb muscles.  
Upper limb muscles show significant atrophy in SMA patients. While the vasculature 
of such large bellied muscles has been routinely analysed in previous studies of 
skeletal muscle, the measurements of capillarity obtained rely on the quantification 
of the capillary-to-muscle fibre ratio, which has been shown to underestimate 
capillary density by up to 75% (Cebasek et al 2010). In order to obtain a more 
accurate and reliable measurement of skeletal muscle capillary density the decision 
was made to analyse the capillary bed of the thin, flat LALc and LALr cranial 
muscles and the TVA of the abdomen.  While the LAL muscles, which are 
responsible for independent ear movement in the mouse, have no corresponding 
human analogue they are a useful preparation to investigate skeletal muscle 
vasculature in SMA. As well as being a more anatomically appropriate preparation 
for the visualisation and analysis of the capillary bed, the pathology of the cranial 
muscles in SMA is well characterised and understood (Murray et al., 2008, Murray et 
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al., 2010). The decision was made to include the TVA muscle in this investigation to 
complement the LAL muscles as while also being a thin, flat muscle it is present in 
humans and is affected in SMA. However, work conducted by an honours project 
student under my supervision has revealed a similar reduction in proximal limbs 
muscles as that seen in the LAL and TVA muscles. 
In brief, proximal limb muscles from P8 symptomatic Taiwanese SMA and control 
littermate mice were examined. A 63% reduction in capillary density was seen in 
Taiwanese SMA mice when compared to control littermates, along with a 57% 
reduction in the number of intramuscular arterioles in SMA muscle. These findings 
suggest that a similar level of capillary reduction occurs in both the thin, flat muscles 
used in this investigation and the clinically relevant proximal limb muscles. 
 
4.4.4 Conclusion 
From these results we can conclude that the form and extent of the skeletal muscle 
capillary bed is dramatically altered in mouse models of SMA.  A substantial 
reduction in the density of the capillary bed was observed in all muscles examined, at 
early and late symptomatic time points, in three genetically distinct models of SMA. 
This reduction in capillary density is a postnatal phenomenon which occurs 
independently of denervation. The organisation of the capillary network within SMA 
skeletal muscle is also impaired, including an increase in capillary calibre and a 
reduction in the ramification of capillaries into muscle.  
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Chapter 3: Spinal cord capillary defects in mouse models of SMA 
3.1 Introduction 
In the previous chapter a significant vascular defect was identified and characterised 
in skeletal muscle, a key site of pathogenesis in SMA. The other principal pathogenic 
target being the spinal cord. Both of these tissues house key elements of the motor 
neuron: motor nerve terminals are found in skeletal muscle while motor neuronal cell 
bodies are located in the spinal cord. If capillary defects are present in skeletal 
muscle, the nerve terminal field of the motor neuron, could similar defects be found 
in the spinal cord where motor neurons originate? Alterations to the vasculature in 
either or both of these regions could contribute to the motor neuron pathology seen in 
SMA.  
The term Motor Neuron Disease encompasses a variety of disorders which result 
from the degeneration of motor neurons and the atrophy of their associated muscles. 
Motor neuron diseases can be classified on the basis of the motor neuron populations 
affected in the disorder and these populations can be identified depending on their 
location within the nervous system. Upper motor neurons project from the motor 
cortex to the spinal cord, while lower motor neurons project from the spinal cord to 
skeletal muscle. In Primary Lateral Sclerosis (PLS) a progressive dysfunction of 
upper motor neurons is observed (Singer et al., 2006) while Amyotrophic Lateral 
Sclerosis (ALS) is characterised by progressive paralysis resulting from the death of 
upper and lower motor neurons (Cleveland & Rothstein, 2001). Spinal Muscular 
Atrophy (SMA) is characterised by the specific loss of lower motor neurons in the 
ventral horn of the spinal cord (Monani et al., 2005).  In contrast to the adult onset 
PLS and ALS, SMA is a childhood form of motor neuron disease with motor neuron 
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loss occurring prenatally in the severest forms of the disease (Soler-Botija et al., 
2002). Studies of control and Type I SMA foetuses have identified enhanced 
neuronal death from as early as 12 weeks of gestation, resulting in a progressive loss 
of motor neurons towards the neonatal period (Soler-Botija et al., 2002). This 
prenatal loss of motor neurons in the ventral horn identifies the spinal cord as a key 
site of pathogenesis in SMA. 
The scarcity of large motor neurons in the spinal cord has long been established as 
the primary neuropathology in SMA (Chou & Fakadej 1971; Robertson et al., 1978, 
Steiman et al. 1980; Araki et al., 2003). In 1971 Chou & Fakadej reported a marked 
loss of large motor neurons in the spinal cord and brainstem of a Type I SMA 
patient. In a later study by Robertson et al., this loss was quantified in more detail, 
with SMA patient cords exhibiting a 95% reduction in large motor neuron cell bodies 
when compared to age matched controls (Robertson et al., 1978). While the level of 
neuronal loss reported is high, some motor neurons do remain, even in the most 
severe form of the disease. However, of the few remaining motor neuron cell bodies 
the vast majority are found to be structurally compromised (Chou & Fakadej 1971; 
Lippa & Smith 1988; Murayama et al., 1990; Matsumoto et al., 1992; Araki 2003). 
Electron microscopy analysis of Type I patient spinal cord revealed the remaining 
SMA motor neuron cell bodies to be uncharacteristically rounded and distended with 
a swollen cytoplasm housing large numbers of mitochondria (Chou & Fakadej, 1971, 
Murayama et al., 1990). Further ultrastructural analysis highlighted the 
fragmentation of the rough endoplasmic reticulum and the accumulation of vesicles 
in the remaining cell bodies (Murayama et al., 1990). Immunohistochemical studies 
also revealed the accumulation of phosphorylated neurofilaments in the cell body 
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(Lippa & Smith, 1988; Murayama et al., 1990) along with granular ubiquitin 
deposits, while only occasional ubiquitin positive nuclei were observed in control 
cell bodies (Murayama et al., 1990; Matsumoto et al., 1992).  Along with these 
accumulations in the cell body, chromatolysis, the disintegration of Nissl bodies, is 
commonly reported in SMA motor neurons (Chou & Fakadej, 1971; Robertson et al., 
1978; Lippa & Smith 1988; Murayama et al., 1990; Araki et al., 2003). Importantly, 
when tissue from Type II patients was analysed the same severe motor neuron loss 
was observed but less structural perturbations were noted (Araki et al., 2003). Fewer 
swollen and chromalytic neurons were present, but no evidence of neurofilament 
accumulation (Araki et al., 2003), suggesting a link between neuronal defects and 
disease severity. Along with these changes to motor neuron number and structure, 
the glial population of the spinal cord was also affected in both patients (Chou & 
Fakadej 1971; Steiman, 1980; Brock et al., 1984; Araki et al., 2003; Garcia-Cabezas 
et al., 2004; Kuru et al., 2009) and SMA mouse models (Dahs et al., 2011; Caraballo-
Miralles et al., 2013).  
In histological analysis of Type I patient spinal cords intricate glial bundles were 
observed encasing motor neuron cell bodies and their atrophied terminal nerve 
endings (Chou & Fakadej, 1971). These glial bundles were seen to protrude into both 
the ventral and dorsal spinal roots in SMA patients (Chou and Fakadej, 1971) where 
aberrant expression of the astrocyte marker glial fibrillary acidic protein (GFAP) and 
its breakdown products were also reported (Brock et al., 1984). More recent studies 
have reported extensive gliosis in the ventral horn of Type I, II and III patient spinal 
cords (Araki et al., 2003, Garcia-Cabezas et al., 2004, Kuru et al., 2009) and in 
several mouse models of the disease (Dachs et al., 2011, Caraballo-Miralles et al., 
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2013). An increase in astroglial number in the ventral horn was reported in 
symptomatic P11 SMNΔ7 SMA mice when compared to control mice (Caraballo-
Miralles et al., 2013). A similar increase in astroglia number was found in newborn 
Severe SMA mice, but in the absence of high levels of motor neuron loss (Dachs et 
al., 2011). Taken together these findings suggest that cell populations in the spinal 
cord, beyond motor neurons alone, are affected in SMA. Similar spinal cord defects 
are noted in other pathologies including other forms of motor neuron disease, in 
particular Amyotrophic Lateral Sclerosis. 
 Loss of spinal motor neurons is reported in ALS patients (Boillee et al., 2006; Ravits 
et al., 2006) and mouse models of the disease (Gurney et al., 1994; Wong et al., 
1995; Bruijn et al., 1997; Wang et al., 2003; Jonsson et al., 2004). As is observed in 
SMA, the surviving motor neurons also display abnormalities, in particular the 
accumulation of neurofilaments, once again seen in ALS patients (Hirano et al., 
1984a; Hirano et al., 1984b) and mouse models (Gurney et al., 1994; Bruijn et al., 
1997; Dal Canto & Gurney 1994). These similar defects in both ALS and SMA, 
emphasises the importance of the spinal cord in the pathogenesis of motor neuron 
diseases.  
Having previously established alterations to the vasculature of SMA skeletal muscle, 
a key site of disease pathogenesis, we sought to examine the vasculature of the spinal 
cord, which is known to be altered in response to injury (Bartholdi,1997; Imperato, 
1997) and in ALS (Zhong et al., 2008; Zhong et al., 2009; Miyazaki et al., 2011). 
Before examining the vasculature of the cord in pathological circumstances it is 
imperative to understand the development and structure of the cord vasculature in 
both human and murine systems. 
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The vasculature of the spinal cord is complex, with a network of extrinsic and 
intrinsic vessels supplying the neural tissue of the cord. In humans, 31 pairs of 
segmental vessels grow from the dorsal aspect of the aorta early in gestation. 
Beginning cranially and working caudally down the length of the cord these paired 
vessels begin to fuse, forming the midline anterior spinal artery (Roth & 
Zonenshayn, 2003). Along the length of the anterior spinal artery approximately 200 
to 300 Central Arteries arise which enter the cord in the midline, to supply the 
anterior two thirds of the cord, including the ventral horns, with blood (Brockstein, 
1994). On the posterior aspect of the cord two posterior spinal arteries are formed 
which supply the posterior third of the cord (Brockstein, 1994). These two sets of 
arteries and their resulting capillaries remain functionally and anatomically distinct. 
There are no anastomoses between the capillaries of the anterior and posterior spinal 
cord (Roth & Zonenshayn, 2003). This anatomical distinction in also found in 
murine spinal cord vasculature (Sturrock, 1990). 
In humans the spinal cord is supplied by a single anterior and two posterior spinal 
arteries, while only a single posterior artery is observed in mice (Sturrock, 1990). 
The smaller number of posterior arteries is the major difference between human and 
murine cord vasculature. The murine vasculature develops prenatally as does its 
human counterpart. A dense network of vessels can be seen surrounding the cord by 
E10, with the anterior artery evident by E13 and a distribution of vessels throughout 
the cord tissue by E15 (Sturrock, 1990). Close examination of the murine cord 
revealed differences in the vessel density between the grey and white matter 
(Sturrock, 1990) a phenomenon also observed in the human cord (Brockstein, 1994). 
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The grey and white matter of the spinal cord receive their blood supply from distinct 
vessels. The end capillaries of the anterior and posterior spinal arteries supply the 
grey matter of the cord while the white matter is supplied by perforating branches of 
the pial plexus, an irregular network of vessels found within the pia mater 
(Brockstein,1994).  In both humans and mice the white matter has a less dense 
capillary network than the grey mater (Sturrock, 1990; Brockstein, 1994). This 
reflects the greater metabolic needs of the grey in comparison to the white matter. 
The blood supply to the grey matter itself is variable with regions of the cord with 
larger areas of grey matter (such as those supplying limb musculature) possessing 
larger diameter vessels than regions with smaller grey matter areas (such as those 
supplying trunk musculature) (Brockstein, 1994). Although these changes in supply 
reflect the high metabolic needs of neuronal tissue, the spinal cord itself has a 
relatively sparse blood supply (Dommusse, 1974). 
Classical studies describe the sparse nature of the spinal cord vasculature with 
Feeney &Watterson (1946) stating that “the nervous system is supplied with blood 
supply just enough for its minimum needs” and Woollam & Millen’s (1958) 
observation that “man has just as much nervous system as he can supply with oxygen 
and no more”. Taking the sparse nature of the spinal cord vasculature into 
consideration, any defect in the already limited supply could have dramatic 
consequences for the spinal cord. Such alterations to the cord vasculature are 
reported in variety of pathological conditions including multiple injury models and 
forms of motor neuron disease. 
The vasculature of the spinal cord shows a dynamic response to injury (Bartholdi, 
1997; Imperato, 1997). The initial response to compression of the cord is a reduction 
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in blood vessel number (Imperato, 1997). This is followed by an increase in vessel 
number at the site of injury. However, these new vessels often lack the astrocyte 
coating found surrounding central nervous system capillaries and these vessels soon 
disappear with the tissue debris as the site is cleared by macrophages.  Devoid of 
vessels the resulting space becomes a fluid filled cavern (Imperato, 1997). This 
suggests that though neovascularisation occurs after injury, the new vessels formed 
are unstable and when the other cell types required to stabilise the new capillary 
network do not regenerate, the vasculature will be lost. While these compression 
injury studies prompt neovascularisation, X-ray irradiation injury paradigms result in 
a reduction in vessel density (Barthaldi et al., 2006). The spinal cord of neonatal rats 
was subjected to a single bout of x-ray irradiation. In comparison to control rats, the 
spinal cords of x-rayed rats showed a reduction in vessel density. When the rats were 
examined at later timepoints the density of vessels in control rat spinal cords 
increased. In comparison the vessel density in the x-rayed rats remained at the same 
low level observed in the animals sacrificed at earlier timpoints (Barthaldi et al., 
2006). Not only was vessel number affected by x-ray, the structure of vessels 
themselves also altered. The vessels which remained in x-rayed spinal cords were 
found to be shorter and appeared swollen when compared to control vessels 
(Barthaldi et al., 2006). Impact injury to adult rat spine causes multiple alterations to 
endothelial cells which became swollen, with excessive ribosomes and Rough ER 
found in the cytoplasm (Barthaldi, 1997). Both the decrease in vessel density and 
alterations to the vessel cellular architecture had functional consequences. 
Reductions in grey and white matter perfusion were recorded 30 minutes after impact 
injury and perfusion continued to decline until severely low levels were recorded 8 
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hours post injury (Bartholdi, 1997). These investigations highlight how important 
vessel number and structure is for the normal functioning of the spinal cord 
vasculature.   
Reductions in vessel number, alterations in vessel structure and reduced blood flow 
in the spinal cord have all been reported in SOD1 mutant ALS mice (Zhong et al., 
2008, Zhong et al., 2009, Miyazaki et al., 2011). A 10-15% reduction in spinal cord 
total capillary length has been recorded in G93A SOD mutant mice (Zhong et al., 
2008). Importantly, this reduction in overall capillarity was found to occur before 
any loss of motor neurons. Functionally this decrease in capillarity resulted in a 30-
45% reduction in blood flow through the cord. Again this decrease in blood flow was 
recorded prior to motor neuron degeneration (Zhong et al., 2008). Observing such 
changes in the blood flow of the spinal cord before the onset of motor neuron 
degeneration suggests that impaired blood supply could be a contributing factor in 
motor neuron loss in the disease. 
A reduction in spinal cord capillary density in SOD1 mutant mice when compared to 
control mice was noted by Miyazaki et al., 2011. This reduction was observed 
presymptomatically and became more pronounced as the disease progressed. The 
diameter of capillaries in the mutant mice was also found to decrease with age. This 
suggests that the architecture of the capillary bed as a whole is significantly altered 
as the disease progresses. As well as gross changes in capillaries, the association 
between capillaries and neurons, the neurovascular unit, was also disrupted in mutant 
mice. The expression levels of key tight junction proteins responsible for maintaining 
the close association between astrocytes and capillaries was decreased while a key 
component of the endothelial cell basement membrane, Collagen IV, was increased 
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(Miyazaki et al., 2011). These alterations were found throughout the cord, including 
the ventral horn where large motor neurons are housed. Again these changes were 
recorded before the degeneration or loss of motor neurons in the cord and 
importantly, similar alterations in key components of the neurovascular unit were 
found in human ALS patients (Miyazaki et al., 2011). These findings identify the 
disruption of the neurovascular unit as a consistent phenotype in both patients and 
mouse models of ALS and suggest that the breakdown of the neurovascular unit may 
contribute to motor neuron degeneration and loss in ALS. Another key neurovascular 
association, the blood spinal cord barrier (BSCB), is also compromised in both ALS 
patients (Leonardi, 1984; Donnenfeld, 1984; Engelhardt,1993; Henkel, 2004; 
Garbuzoa-Davis et al., 2012; Winkler, 2013) and mouse models of the disease 
(Garbuzo-Daiz et al., 2007; Zhang et al., 2008; Nicaise et al., 2009; Zhang et al., 
2009; Garbuzova-Davis et al., 2011; Miyazaki et al., 2011). 
The BSCB along with the blood brain barrier (BBB) are vital to prevent the entry of 
erythrocytes and plasma molecules into the central nervous system (CNS). 
Breakdown in these barriers can lead to penetration of toxic substances into the CNS. 
Early investigations of cerebrospinal fluid (CSF) reported significantly higher levels 
of total protein in ALS patient CSF when compared to age matched controls 
(Leonardi et al., 1984), suggesting that unwanted proteins are able to leak through 
these barriers in ALS patients. Post-mortem analysis also revealed a build up of non 
CSF proteins in ALS patient spinal cords, in particular inflammatory and immune 
cell infiltration (Donnenfeld 1984, Engelhardt 1993, Henkel 2004). Build up of these 
proteins suggests impaired barrier permeability in ALS. Along with this 
accumulation of unwanted cells and proteins in the CNS of ALS patients, studies 
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have also reported a decrease in the expression of proteins key in maintaining CNS 
barrier integrity (Henkel et al., 2009). 
Quantitative-reverse transcriptase PCR analysis of ALS patient spinal cord samples 
showed a decrease in the mRNA expression of tight junctional proteins (Henkel et 
al., 2009). A similar reduction in tight junction marker expressions is also observed 
in mutant SOD ALS rats (Nicaise et al., 2009). These proteins including Zona-
Occludens 1, Occludin and Claudin-5, are essential to maintain the integrity of the 
CNS barriers. Reduction in the expression of these proteins suggests that the BBB 
and BSCB associations are compromised in ALS. This breakdown of the BBB and 
BSCB is a commonly reported feature of mutant SOD mice (Garbuzova-Davis et al., 
2007; Zhong et al., 2008; Zhong et al., 2009; Miyazaki et al., 2011).  
Electron microscopy studies of G93A SOD1 mutant ALS mouse spinal cord showed 
significant alterations to all components of the BBB and BSCB (Garbuzoa-Davis et 
al., 2007). Disorganised and degenerating mitochondria were seen in endothelial 
cells and the neuropill. Cells, including endothelial cells, astrocytes and their foot 
processes along with motor neurons, were swollen and a number of degenerating 
endothelial cells were also observed (Garbuzova-Davis et al., 2007). Importantly, 
these alterations were observed at early stages in the disease process as well as with 
disease progression. This suggests that impairment of the CNS barriers could 
contribute to disease progression. When analysed functionally the integrity of the 
BSCB was found to be compromised, with leakage from spinal cord microvessels 
observed from the earliest disease stages analysed (Garbuzova-Davis et al., 2007). 
Similar barrier leakage is also observed in mutant SOD1 ALS rats (Nicaise et al., 
2009). Again, highlighting the importance of CNS barrier integrity in motor neuron 
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health, many studies have the revealed the presence of BSCB defects prior to motor 
neuron degeneration (Zhong et al., 2008; Zhong et al., 2009; Miyazaki et al., 2011). 
In 2008 Zhong et al., reported micro-haemorrhaging, reductions in microcirculation 
and hypoperfusion in SOD 1 mutant mice before any motor neuron degeneration was 
observed. Disruptions to the endothelium, tight junction and basement membrane 
components of the neurovascular unit have been noted presymptomatically in the 
same mouse model of ALS (Miyazaki et al., 2011). This damage to the spinal cord 
vasculature was shown to be one of the earliest pathological events in SOD 1 mutant 
mice (Zhang et al., 2008), suggesting that alterations to the spinal cord vasculature 
could contribute to the degeneration of motor neurons in ALS.  
Based on our finding in skeletal muscle and the evidence that spinal cord vasculature 
is altered in other forms of motor neuron disease, we hypothesised that the capillary 
bed of spinal cord could be altered in SMA. We also hypothesised that any alteration 
to the spinal cord capillary bed would affect the ability of the network to supply 
oxygen to the cord tissue. To examine this, we looked for evidence of hypoxia in the 




Pimonidazole Hydrochloride (Hypoxyprobe 
TM-1
) in a nitroimidazole compound. 
Nitroimidazole compounds are derivatives of the organic, ring compound imidazole 
which contain a nitro functional group (-NO2) (Carreauet et al., 2011). 
Nitroimidazoles, including Pimonidazole Hydrochloride, are reductively activated in 
cells with a oxygen concentration less than 14 micromolar. This oxygen 
concentration is equivalent to an oxygen tension of 10mmHg at 37°C. Physiologic 
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oxygen tension differs depending on the body tissue and ranges between 35mmHg in 
the brain to 70mmHg in the kidney (Carreau et al., 2011). The activation of 
Pimonidazole Hydrochloride therefore only occurs in hypoxic cells. This activation 
allows Pimonidazole Hydrochloride to bind to thiol groups in proteins, peptides and 
amino acids. Primary antibodies targeted against these Pimonidazole Hydrochloride-
thiol adducts allows for the detection of tissue hypoxia by immunochemical means. 
By administrating Pimonidazole Hydrochloride to SMA mice and control littermates 
the presence or absence of hypoxia in key elements of the spinal cord was evaluated. 
Here the novel means of measuring capillary density described in Chapter 2 was 
modified and applied to sections of spinal cord. Capillary density in these sections 
was quantified using immunohistochemical staining and fluorescent microscopy. The 
integrity of the blood spinal cord barrier was also analysed using 
immunohistochemical staining and fluorescent microscopy. Capillary density, when 
measured via immunofluorescence, was significantly decreased in Taiwanese SMA 
mice when compared to control littermates. Timeline analysis of capillary density 
showed no difference in the extent of the capillary bed between SMA and control 
littermates at birth. A reduction in capillary density is also observed in the less severe 
SMN2Δ7 model of SMA at late symptomatic time point. Investigation of tissue 
hypoxia using Piminodizole Hydrochloride showed an increase in the number of 
hypoxic neurons in the ventral horn of Taiwanese SMA spinal cords when compared 
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3.2 Methods 
3.2.1 Ethics Statement 
All animal experiments were approved by a University of Edinburgh internal ethics 
committee and were performed under license by the UK Home Office (Project 
License number 60/3891). 
3.2.2 Animal Husbandry 
(SMN2)2Hung Smn1
tm1Hung
/J mice (originally received from Brunhilde Wirth in 
Koln) on a congenic FVB background were maintained as heterozygous breeding 
pairs under standard SPF conditions in animal care facilities in Edinburgh. All 
animal procedures and breeding were performed in accordance with Home Office 
and institutional guidelines. Retrospective genotyping this strain was carried out 
using standard PCR protocols detailed in previous chapters. Smn+/-;SMN2;Δ7 
(Jackson labs strain no. 005025) breeding pairs were maintained in animal care 
facilities in Oxford. For this strain dissection of the vertebral column was performed 
in Oxford by James Sleigh and shipped to Edinburgh. All genotyping of this colony 
was performed in Oxford by James Sleigh. 
SMA mice and control littermates were sacrificed by an overdose of anaesthetic 
administered via intraperitoneal (IP) injection of sodium pentabarbitol (Euthenal). 
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3.2.3 Genotyping 
Retrospective genotyping of Taiwanese SMA and control littermate mice was 
performed as per the Genotpying protocol described in earlier chapters (Chapter 2) 
3.2.4 Administration of Pimonidazole Hydrochloride 1  
Whole Taiwanese litters aged P5 were injected with the hypoxia marker 
Piminodizole HCL 1 (PIMO).  The P5 timepoint was selected as this is the earliest 
timpoint in the Taiwanese SMA mice that a reduction in blood vessel density is 
observed in the spinal cord. A single 60m g/kg dose of PIMO was administered via 
intraperitoneal (IP) injection. After injection mice were returned to their cage with 
their parents for an hour, during which time the mice were closely monitored. During 
this time PIMO was delivered to the body tissue via the bloodstream. In mice, PIMO 
has a plasma half of 25 minutes. This hour long period between injection and 
removal from the animal facility allows for the distribution of PIMO and its 
clearance from the plasma.  
3.2.5  Tissue Collection  
3.2.5.1 Pimonidazole Hydrochloride 1 injected mice  
90 minutes after injection with PIMO, Taiwanese SMA mice and control littermates 
were sacrificed by an overdose of anaesthetic administered via intraperitoneal (IP) 
injection of sodium pentabarbitol (Euthenal).  Mice were sacrificed in the order they 
were initally injected with PIMO. Each injection was timed to ensure that each 
animal was exposed to PIMO for the same amount of time and given the same time 
to clear residual unbound PIMO from the plasma. At the time of tissue collection 
PhD The University of Edinburgh 2014 
  109 
PIMO will already be bound to any hypoxic cells in the body tissues. During 
harvesting, tissue becomes anoxic. The very low levels of PIMO remaining in the 
plasma at the time of collection should prevent any PIMO binding as a result of 
dissection anoxia. To further ensure this, dissections were performed rapidly with 
tissues being collected and fixed in under five minutes. 
3.2.6 Dissection 
All pre-fix dissections were performed in oxygenated mammalian physiological 
ringer (mM: NaCl 120,  KCl 5, CaCL 2  2, MgCl2 1, NaH2PO4 0.4, NaHCO3 23.8, Glucose 
5.6). All post-fix dissections were performed in 0.1M PBS. 
3.2.6.1 Vertebral Column 
Following injection with anaesthetic, the mice were monitored closely. When no 
breathing was observed for a full minute and neither footpad or tail stimulation 
evoked a response, the mice were decapitated. Following decapitation the skin ws 
removed from the abdomen of the mice and the forelimbs were removed. The chest 
wall and abdominal musculature was then removed as if performing a TVA muscle 
dissection. The contents of the thoracic, abdominal and pelvic cavities were 
removed, leaving the intact vertebral column attached to the hindlimbs. Finally, the 
hindlimbs were removed leaving the full length of the vertebral column with the 
spinal cord intact within. This preparation was then transferred to a bijou tube 
containing approximately 5mls of 4% PFA and was left to fix overnight, at 4°C on a 
rocking platform. The following day the preparation was washed repeatedly in 0.1M 
PBS to remove excess fixative.   
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3.2.7 Tissue preparation 
3.2.7.1 Cryopreservation 
Before being sectioned with a cryostat the vertebral columns were cryoprotected. 
Columns were added to 15ml Falcon tubes filled with a 30% sucrose solution (made 
up in 0.1M PBS) and left until they had sunk to the bottom of the tubes. The columns 
were then embedded in a 50:50 solution of OCT (Cell Pathology) and 30% sucrose 
solution. The columns were transferred to tapered easy peel plastic embedding 
moulds filled with the OCT-sucrose solution and were left for one hour, at room 
temperature, on a rocking platform. After this acclimatisation period the columns and 
their surrounding embedding solution were frozen on dry ice. The resulting solid 
blocks were stored at -80°C until sectioning.  Columns from very young neonates 
(P0) were embedded whole with the cervical region (cranial end of the vertebral 
column) flat on the base of the mould – so it would be cut first. Columns from older 
mice (P5 and P11) were split into cervical, thoracic and lumbar regions and 
embedded in three individual moulds. In each case the superior cut edge of each 
vertebral/cord unit was embedded flat to the base of the mould. 
3.2.7.2 Tissue Processing for wax embedding 
Following fixation the P5 vertebral columns were dehydrated in the Centre for 
Integrative Physiology histology department tissue processor, using standard 
protocols. The columns were then cut in half at the mid point of the thoracic region 
and were embedded in paraffin wax. As above, the cervical region and most superior 
cut edge of the column were embedded flat to the base of the mould. The blocks 
were stored at 4°C until sectioning. 
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3.2.8  Cryostat Sectioning of Vertebral Column 
P0, P5 and P11 columns were sectioned at a thickness of 10µm on a Leica cryostat. 
Ten to twelve individual sections were collected onto each superfrost slide. Slides 
were stored at -20°C until staining. 
3.2.9  Microtome Sectioning of Vertebral Column 
P5 columns were sectioned at a thickness of 16µm on a Leica microtome. Adjacent 
sections from the beginning, middle and end of tissue ribbons were floated out in a 
water bath at 42°C and were mounted on superfrost slides. The resulting slides were 
stored at 4°C until staining. 
3.2.10 Immunohistochemistry of Frozen Sections 
3.2.10.1 PECAM 1 Capillary Staining 
Before staining slides were removed from -20°C storage and were left at room 
temperature to defrost.  Once defrosted the slides were blocked in immunoglobulin G 
protease-free standard blocking solution (0.2% BSA, 0.5% Triton-X 100 (TX100) in 
PBS, for 30 minutes at 4°C. To visualise the spinal cord capillary bed, slides were 
then incubated overnight with goat anti mouse PECAM-1 primary antibody (R&D 
Systems Cat. No. AF3628) at a concentration of 1:750 in standard blocking solution 
at 4°C. The following day slides were washed for 6x5 minutes in 0.1M PBS at room 
temperature on a rocking platform. After washing slides were incubated with donkey 
anti goat Cy3 conjugated secondary antibody (Jackson ImmunoResearch 
Laboratories Inc) made up in standard block at a concentration of 1:250, for 1 hour at 
4° C in the dark. Slides were washed for the final time for 6x5 minutes in 0.1M PBS, 
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at room temperature on a rocking platform. At all times slides were protected from 
exposure to light. Following this final washing series, slides were mounted with glass 
coverslips in Mowiol (10% mowiol, Polyscience Inc, 20% glycerol, 50% 0.2M Tris 
buffer pH 8.5, 3% 1,4-diazobicyclooctane made up in distilled water), the added 1,4-
diazobicyclooctane acting as an anti-fade reagent.  The mounted slides were left 
overnight in the dark, at room temperature to set before visualisation and imaging the 
following day. 
3.2.10.2 Blood Spinal Cord barrier Double Labelling Staining 
As with PECAM 1staining, frozen sections were defrosted and then blocked for 30 
minutes. To visualise key components of the blood spinal cord barrier, slides were 
then incubated overnight at 4°C with rabbit anti mouse Aquaporin 4 (Abcam 
ab125049), rabbit anti mouse Claudin 5 (Abcam ab59720 and rabbit antimouse 
Zona-Occludin 1 (Abcam ab53765) primary antibodies at a concentration of 1:100 in 
standard blocking solution. The following day slides were washed for 6x5 minutes in 
0.1M PBS at room temperature on a rocking platform. After washing slides were 
incubated with swine anti rabbit FITC conjugated secondary antibody (Dako) made 
up in standard block at a concentration of 1:40, for 1 hour at 4° C in the dark. Slides 
were then washed for 6 x 5 minutes in 0.1M PBS at room temperature, on a rocking 
platform. To visualise the spinal cord capillary bed, slides were then incubated with 
rhodamine conjugated Griffonia Simplicifolia Lectin 1 (GSL-1) at a concentration of 
1:100, made up in 0.1M PBS, for 1 hour at 4°C in the dark.  GSL-1 was selected as 
the means of visualising the capillary bed in double labelling experiments as it is not 
an antibody and could therefore not cross-react with the antibodies used to label the 
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blood spinal cord barrier. Slides were then washed and mounted as previously 
described.  
3.2.10.3  Capillary and Motor Neuron Double Labelling Staining 
The capillary bed was labelled with PECAM 1 as previously described. To visualise 
motor neurons in the spinal cord, slides were then incubated overnight in anti mouse 
SMI-32 primary antibody (a gift from Professor Siddharthan Chandran, University of 
Edinburgh) at a concentration of 1:500 in standard blocking solution at 4°C. The 
following day slides were washed for 6 x 5 minutes in 0.1M PBS at room 
temperature on a rocking platform. After washing slides were incubated with donkey 
anti mouse Alexalfuor 488 conjugated secondary antibody (Dako) made up in 
standard block at a concentration of 1:250, for 90 minutes at room temperature in the 
dark. Slides were then washed and mounted as previously described. 
3.2.10.4 Cresyl Fast Violet Staining 
Nissl staining, to identify the grey and white matter regions of the spinal cord, was 
performed using cressyl fast violet (CFV) staining. Again frozen sections slides were 
allowed to defrost and were rinsed in tap water before incubation in 0.2% CFV 
solution for 10 minutes. Slides were then rinsed in tap water and the intensity of 
staining checked under a Zeiss light microscope. Slides were further incubated with 
CFV if required, with staining checked at the end of every additional minute. When 
the distinction between grey and white matter was clearly evident slides were 
mounted in DPX, mounted and left overnight at room temperature in a fume hood to 
set. 
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3.2.11 Immunocytochemistry of Paraffin Sections 
Slides of sectioned spinal cord were deparaffinised in xylene for 20 minutes (two 
separate xylene solutions for 10 minutes each). After dewaxing the slides were 
rehydrated in a descending ethanol series (100% x2, 90%, 70% and 50%) for 5 
minutes in each ethanol percentage. Slides were then washed in 0.1% Tween in 
distilled water for 2 minutes followed by a further 2 minutes washing in 0.1% Tween 
in Tris-buffered saline (TBS), both washes performed on a rocking platform. Slides 
were then incubated for 5 minutes in 3% Hydrogen Peroxide solution to quench 
tissue peroxidise. Slides were washed again for 2 minutes in 0.1% Tween-TBS on a 
rocking platform. Antigen retrieval was performed by heating slides in sodium citrate 
buffer for 20 minutes in a water bath heated to 90°C. Following heating slides were 
removed from the water bath and left in the sodium citrate buffer for at least 20 
minutes to cool to room temperature. Slides were blocked in immunoglobulin G 
protease-free standard blocking solution (0.2% BSA, 0.5% Triton-X 100 (TX100) in 
PBS) for 10 minutes at room temperature. Slides were then incubated with FITC anti 
MAb1 primary antibody (Hypoxyprobe, Catalog Number: HP2-100Kit) at a 
concentration of 1:50 made up in standard blocking solution, for one hour at room 
temperature. Slides were washed 3 x 2 mins in 0.1% Tween-TBS on a rocking 
platform. After washing, slides were incubated with HRP linked rabbit anti-FITC 
secondary antibody (Hyproxyprobe, Catalog Number: HP2-100Kit) at a 
concentration of 1:50 made up in standard blocking solution, for 30 minutes at room 
temperature. Slides were washed 3 x 2 mins in 0.1% Tween-TBS on a rocking 
platform. Slides were then incubated with DAB (Vector Laboratories, SK-4100) for 
7 minutes before being flushed with distilled water to end the DAB reaction. Slides 
PhD The University of Edinburgh 2014 
  115 
were then stained with CFV as previously described. When the desired intensity of 
staining was achieved slides were dehydrated in an ascending ethanol series (50%, 
70%, 90%, 100% x2) for 5 minutes in each ethanol percentage. Slides were then 
briefly dipped in xylene before being mounted in DPX and left overnight, at room 
temperature, in a fume hood to set. 
3.2.12 Imaging 
Micrographs for the reconstruction of spinal cord sections, calculation of capillary 
density, for the analysis of blood spinal cord barrier integrity and of double labelled 
capillary bed and motor neurons were captured using a standard inverted 
epifluorescence microscope (Olympus 1X71) combined with a chilled CCD camera 
(Hammamatsu C4742-95) and OpenLab (Improvision) image capture software. Cy3 
and rhodamine labelled capillaries were imaged using 550nm excitation and 570nm 
emission optics. FITC labelled blood spinal cord barrier components were imaged 
using 494nm excitation and 520nm emission optics. Alexafluor 488 labelled motor 
neurons imaged using 494nm excitation and 520nm emission optics. Micrographs of 
CFV and DAB stained spinal cord sections were captured using a standard upright 
light microscope (Leica DM LB) combined with a Leica DFC480 camera and LAS 
AF Lite image capture software. 
3.2.13 Quantification and Analysis 
3.2.13.1 Quantifying capillary density 
Any section with poor quality staining, folding or those that had been damaged 
during sectioning were excluded from analysis. For capillary density calculations 
three sections per slide from a minimum of three slides for each mouse were imaged. 
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To calculate capillary density the spinal cord was divided into four regions; dorsal 
left, dorsal right, ventral left and ventral right. Within each quadrant three radial lines 
of 40x images, originating from the central canal and extending to the edge of the 
cord, were captured. Using adjacent CFV stained slides to distinguish between white 
and grey matter each of these lines could be divided into grey and white matter, 
resulting in images from the following regions; dorsal left grey and white, dorsal 
right grey and white, ventral left grey and white and ventral right grey and white. All 
images were analysed blind. Images from all spinal cord regions were first enhanced 
in Adobe Photoshop (CS6) for contrast and brightness. This ensured that definite 
vessel borders were visible and also prevented any fine capillary structures from 
being lost and discounted. Any out of focus images where capillaries appeared 
blurred or those where background was too high to completely isolate capillary 
structures were excluded from further analysis. Using Image J (NIH) the enhanced 
images were converted to binary. These binary images were produced solely for 
quantification. In the resulting binary images capillaries were assigned black and 
spinal cord background white, allowing for the ratio of black to total white pixels to 
be calculated. This produced a value for capillary area per field of view. Knowing 
the area of a 40x field of view the results could be presented per unit area of spinal 
cord. 
3.2.13.2 Spinal Cord Reconstructions 
Reconstructions of spinal cord sections in their entirety were created using Adobe 
Photoshop (CS6).  Overlapping 10x magnification images covering whole sections 
were captured and then enhanced in Adobe Photoshop for contrast and brightness. 
By reducing the opacity of the images common features between individual images 
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could be identified and matched. This allowed for individual images to be stitched 
together to create a montage of the whole section. To achieve a more uniform image 
the resulting montages were converted to black and white. In these montage images 
spinal cord background is black and capillaries are white. 
3.2.13.3. Quantification of Hypoxic Cells 
Any section with poor quality staining, folding or those that had been damaged 
during sectioning were excluded from analysis. Using CFV staining as a guide the 
spinal cord was divided into four regions; dorsal left, dorsal right, ventral left and 
ventral right. Within each quadrant a single x40 magnification image was captured at 
the boundary between grey and white matter. Three sections per slide from a 
minimum of three slides for each mouse were imaged. All images were analysed 
blind. The automated Image J (NIH) Huang setting was then used to threshold the 
images. Cells below the defined intensity were removed from the image, while cells 
above the set threshold remained. The remaining cells having been DAB labelled in 
the PIMO reaction. The number of these DAB and CFV Nissl labelled cells present 
after the threshold step was then counted using the cell counter plug-in in Image J 
(NIH).  
3.2.13.4 Analysis 
All data were collected using Microsoft Excel software and were graphed and 
analysed using GraphPad Prism software. Charts shown are mean ± s.e.m. In all 
analyses statistical significance was considered to be p < 0.05. Tests used are detailed 
in figure legends. 
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3.3 Results 
3.3.1 Quantification of Spinal Cord Capillary Density 
In the previous chapter a novel method of measuring capillary density was presented. 
This technique calculated the area of skeletal muscle covered by capillaries. In this 
chapter an adapted version of this capillary density measurement is applied to 
sections of spinal cord. 
When calculating capillary density in skeletal muscle the muscles were sampled 
systematically, with 40x magnification images captured in the medial, endplate and 
lateral regions of the muscle at a stipulated number of fields of view apart. The 
structure of the spinal cord is comparatively more complex than skeletal muscle, 
containing a variety of cell types, structures and regions. This means the cord can be 
segregated in a variety of ways either on the basis of body axis position (dorsal/ 
ventral) or cell type (grey/white matter). To ensure that capillary density was 
measured across entire spinal cord sections, the cord was divided into identifiable 
regions using CFV staining of Nissl bodies (Figure 1). 
Initially, the cord was divided into quadrants through the central canal, creating the 
following zones; dorsal right, dorsal left, ventral right and ventral left. Within these 
for zones radial lines of 40 x magnification images extending from the central canal 
to the edge of the edge of the cord were captured. Images were taken in every field of 
view available. To ensure each zone was sampled thoroughly, three equidistant, 
radial sets of images at approximately 25°, 45° and 65° from the origin in each 
segment were captured. CFV staining highlighted the boundary between grey and 
white matter in each radial set, allowing for the capillary density for grey and white 
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matter to be collected and analysed separately. This division is denoted by the dotted 
blue line in Figure 1. This resulted in eight separate zones from which images were 
captured; dorsal right grey, dorsal right white, dorsal left grey, dorsal left white, 
ventral right grey, ventral right white, ventral left grey and ventral left white. Upon 
analysis, no significant difference in capillary density was found between the right 
and left sides of the cord in P11 control mice (P>0.05 One Way ANOVA with post 
hoc test Tukey) (Figure 2) and P11 Taiwanese SMA mice (P>0.05 One Way 
ANOVA with post hoc test Tukey) (Figure 3).  Data from the right and left sides 
were therefore pooled to give the four final regions of the cord presented in all 
further analysis; Dorsal Grey, Dorsal White, Ventral Grey and Ventral White. This 
method of sampling was applied to every section of cord analysed. Having designed 
and tested the sampling technique, careful consideration was given to the region of 
cord selected for analysis. 
Historically, the lumbar region of the spinal cord has been the preferred cord region 
examined in SMA investigations. This is due to the greater number of motor neurons 
present in the ventral horn of the grey matter supplying the musculature of the lower 
limb. However, areas of the spinal cord with increased grey matter volumes have 
been shown to have the most variable capillary density and diameter (Brockstein, 
1993). In our initial investigation of the vasculature in SMA (Chapter 2 of this 
thesis), we reported alterations in both the density and diameter of capillaries in 
SMA skeletal muscle. To prevent any inherent differences in vessels masking 
potential alterations in the cord vasculature in SMA, the thoracic region of the cord 
was selected for analysis. All of the results presented in this chapter are from the 
thoracic region of the spinal cord. The thoracic spinal cord, lacking increased 
PhD The University of Edinburgh 2014 
  120 
projections for upper and lower limbs, contains the most consistent grey matter area 
in the cord and should therefore contain the most consistent vessel density and 
diameter. Examining the thoracic region of the cord increases our confidence that 
any potential alterations observed in the spinal cord vasculature are due to the disease 
mutation and not inherent differences caused by variation between different regions 
of the cord. 
 
                         
Figure 1 – Schematic representation of spinal cord sampling method. 
Representative micrograph of P11 control spinal cord visualised with cressyl fast 
violet. Horizontal and vertical lines through the central canal indicate the four initial 
regions into which the cord was divided; Dorsal Right, Dorsal Left, Ventral Right and 
Ventral Left. Diagonal lines represent the tracks along which 40 x magnification 
sample images were collected in each quadrant. Dotted blue line highlights the 
distinction between grey and white matter. 10x magnification. 
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Figure 2 – Comparison of capillary density in right and left regions of P11 
control Taiwanese mice. Bar chart (mean ± s.e.m) quantification of capillary 
density in the right (dark grey bars) and left (light grey bars) sides of the four regions 
of the spinal cord of P11 control mice.  Unpaired, two-tailed t-test, ns = no significant 
difference, P>0.05. N≥3 mice and n≥3 cords for each bar.  
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Figure 3 - Comparison of capillary density in right and left regions of P11 
Taiwanese SMA mice. Bar chart (mean ± s.e.m) quantification of capillary density 
in the right (dark grey bars) and left (light grey bars) sides of the four regions of the 
spinal cord of P11 Taiwanese SMA mice.  Unpaired, two-tailed t-test, ns = no 
significant difference, P>0.05. N≥3 mice and n≥3 cords for each bar.  
 
3.3.2 Significant reduction in spinal cord capillary density in late symptomatic 
Taiwanese SMA mice 
Along with the individual images captured for capillary density measurement, 
example cord sections were imaged in their entirety. Overlapping 10x magnification 
images were captured across whole sections and then stitched together using 
Photoshop to create low magnification montages of whole spinal cord sections. 
Initial inspection of these montage images revealed a dramatic reduction in the 
capillary density of late symptomatic P11 Taiwanese SMA spinal cords (Figure 5) 
when compared to control spinal cord montages (Figure 4). 
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Figure 4 – P11 Control Taiwanese spinal cord capillary bed. Representative montage 
micrographs of P11 control spinal cord visualised with PECAM 1. Individual images used to 
construct montage of entire section are 10 x magnification. Scale bar equals 200µm. 
         
Figure 5 – P11 Taiwanese SMA spinal cord capillary bed. Representative montage 
micrographs of late symptomatic P11 Taiwanese SMA cord visualised with PECAM 1. 
Individual images used to construct montage of entire section are 10 x magnification. Scale 
bar equals 200µm. 
 
From the montage images, capillary density in both P11 Taiwanese SMA and control 
spinal cords appeared to be greater in the more central grey matter regions than the 
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white matter cord periphery. When measured, the capillary density of P11 control 
spinal cord grey matter was found to be significantly greater than that of the white 
matter (unpaired, two-tailed, t-test) (Figure 6). A similar significant difference was 
also seen in P11 Taiwanese SMA cords, with capillary density in the grey matter 
again being significantly greater than the white matter (unpaired, two-tailed, t-test) 
(Figure 7).  These findings are consistent with studies of both human and mouse 
spinal cord vasculature which describe higher capillary numbers in the grey matter to 
cope with higher metabolic demands (Sturrock, 1980; Brockstein, 1993). Having 
confirmed the internal differences between grey and white matter within the cord, the 
vasculature of Taiwanese SMA and control spinal cords was compared in detail. 
                       
Figure 6 – Comparison of Grey and White matter capillary density in P11 
control Taiwanese mice. Bar chart (mean ± s.e.m) quantification of capillary 
density in P11 control mice in the grey matter (grey bar) and white matter (white bar) 
of the spinal cord.  Unpaired, two tailed t-test, ***= P<0.001. 
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Figure 7 - Comparison of Grey and White matter capillary density in P11 
Taiwanese SMA mice Bar chart (mean ± s.e.m) quantification of capillary density in 
P11 Taiwanese SMA  mice in the grey matter (grey bar) and white matter (white bar) 
of the spinal cord.  Unpaired, two tailed t-test, ****= P<0.0001. 
 
In control cords capillaries can be seen throughout the section, extending from the 
centre to the edges of the cord. While the distinction between grey and white matter 
cannot clearly be identified without CFV stained adjacent sections, capillaries do 
appear more dense in the central regions of the cord in comparison to the periphery 
(Figure 4). In comparison to skeletal muscle, the capillaries of the spinal cord do not 
appear in a particular pattern of organisation. The capillaries are not tightly packed 
into a neat arrangement but appear scattered throughout the cord. Although scattered, 
the capillaries appear to be equally distributed and separated from one another 
(Figure 4). In contrast, considerable portions of the Taiwanese SMA cord appear 
completely devoid of capillaries, with large gaps between neighbouring vessels 
(Figure 5). As was seen in the control cords, more capillaries are seen in the centre of 
the cord than the periphery, although far fewer capillaries are seen in each of these 
areas in P11 Taiwanese SMA cords than control cords (Figure 4, Figure 5) and 
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almost no capillaries can be seen around the periphery of P11 Taiwanese SMA cords 
(Figure 5). After examining the appearance of the overall cord vasculature the 
capillary density in the individual regions of the cord was measured. 
For analysis, the data from the four spinal cord regions detailed in Figure 1 were 
graphed and compared. In each of the four regions capillary density was significantly 
reduced in P11 Taiwanese SMA cords when compared to control littermates 
(P<0.0001,unpaired two-tailed, t-test) (Figure 8). Specifically, over the four regions 
capillary density was reduced by: Dorsal Grey 53%; Dorsal White 60%; Ventral 
Grey 62%; Ventral White 70 % (Figure 8).  This represents an overall average 
reduction in spinal cord capillary density of approximately 61% in P11 Taiwanese 
SMA mice when compared to control littermates (Figure 9). Observing a significant 
reduction in capillary density in the Ventral Grey region is particularly pertinent as 
this is the region of the cord where the lower motor neuron cell bodies affected in 
SMA are located. 
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Figure 8 – Reduced capillary density in all four spinal cord regions in P11 
Taiwanese SMA mice. Bar chart (mean ± s.e.m) quantification of capillary density 
in the four regions of the spinal cord of P11 Taiwanese SMA mice (black bars) and 
control littermates (white bars). Unpaired, two-tailed t-test,**P<0.01,**** =P<0.0001. 
N≥3 mice and n≥3 cords for each bar. Representative micrographs of PECAM 1 
stained capillaries (seen in white) in each cord region in Taiwanese SMA and control 
littermates. PECAM 1 staining was converted to binary to show vessels of the white 
matter clearly. 40 x magnification. Scale bar equals 50µm. 
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Figure 9 – A significant difference overall spinal cord capillary density in P11 
Taiwanese SMA mice and control littermates. Bar chart (mean ± s.e.m) 
quantification of overall spinal cord capillary density in P11 Taiwanese SMA mice 
(black bar) and control littermates (white bar). Unpaired, two tailed t-test, ***= 
P<0.001. 
 
3.3.3 Spinal cord capillary density defects occur postnatally in parallel with motor 
neuron loss  
Examination of P11 late symptomatic Taiwanese SMA spinal cord revealed a very 
similar degree of capillary reduction to that which was found in P11 Taiwanese SMA 
skeletal muscle (Chapter 2, Figure 13). Timeline analysis of Taiwanese skeletal 
muscle highlighted that this reduction in capillary density was a post natal 
phenomenon which occurred in parallel with the neuromuscular pathology present in 
the Taiwanese mouse model. To determine if a similar pattern occurs in the spinal 
cord two younger ages of mice were examined; the presymptomatic day of birth (P0) 
and the symptomatic P5 age. 
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As with the late symptomatic P11 time point, montage images of entire cross-
sections of Taiwanese SMA and control spinal cords were created. At the 
presymptomatic P0 timepoint Taiwanese SMA and control montages were 
indistinguishable from one another (Figure 10). Capillaries were present throughout 
cord sections consistent with previous studies of murine spinal cord vasculature, 
which show capillaries dispersed throughout the cord by E15 (Sturrock, 1980). While 
capillaries are present in both Taiwanese SMA and control cords there appear to be 
fewer vessels than were observed at the P11 time point. Again, this is consistent with 
previous studies of the cord which describe a rapid period of vascularisation 
occurring later in postnatal development at P5, (Sturrock, 1980). After these initial 
general observations the capillary density of each region of the cord was investigated 
in more detail. 
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Figure 10 – 
P0 spinal cord capillary bed. Representative montage micrographs of P0 spinal 
cord visualised with PECAM 1. Individual images used to construct montage of 
entire section are 10 x magnification. Scale bar equals 200µm. 
In each of the four spinal cord regions at P0, no significant difference was found 
between the capillary density of Taiwanese SMA mice and control littermates 
(P>0.05, un-paired, two-tailed, t-test) (Figure 11). When these regional 
measurements were combined to generate a value for overall cord capillary density, 
again, no significant difference was observed between Taiwanese SMA and control 
mice (P>0.05, up-paired, two-tailed, t-test) (Figure 12). Seeing no difference in 
capillary density between Taiwanese SMA and control mice suggests that the 
capillary bed of Taiwanese SMA spinal cord is normal in its extent at birth. By P11 
however the capillary density of Taiwanese SMA spinal cords is dramatically lower 
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than control littermates. To determine at which stage of the disease this disparity in 
density occurs, spinal cords from symptomatic P5 Taiwanese SMA and control 
littermates were analysed.  
 
Figure 11 - No significant difference in capillary density between control and 
Taiwanese SMA mice at birth. Bar chart (mean ± s.e.m) quantification of capillary 
density in the four regions of the spinal cord of P0 Taiwanese SMA mice (black 
bars) and control littermates (white bars). Unpaired, two-tailed t-test, ns= no 
significant difference, P>0.05. N≥3 mice and n≥3 cords for each bar. Representative 
micrographs of PECAM 1 stained capillaries in each cord region in Taiwanese SMA 
and control littermates. 40 x magnification. Scale bar equals 50µm. 
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Figure 12 -  No significant difference in overall spinal cord capillary density in 
P0 control and Taiwanese SMA mice. Bar chart (mean ± s.e.m) quantification of 
overall spinal cord capillary density in P0 Taiwanese SMA mice (black bar) and 
control littermates (white bar). Unpaired, two tailed t-test, ns= no significance, 
P>0.05. N≥3 mice and n≥3 cords for each bar. 
 
When the spinal cords of P5 Taiwanese SMA and control littermates were examined, 
a difference in capillary density was observed, but only reached significance in three 
out of the four defined regions; Dorsal Grey 27% (P<0.01) Dorsal White 75%  
(P<0.001), Ventral Grey 51% (P>0.05) and Ventral White 69%  (P<0.01). The 
accompanying P values were generated from individual unpaired, two-tailed, t-tests 
of each region (Figure 13). On average this amounts to an overall reduction in spinal 
cord capillary density of approximately 68% (Figure 14). Capillary density was 
decreased by 51 % in the Ventral Grey region of Taiwanese mice in comparison to 
controls, this was not found to be a significant reduction (P = 0.1508, unpaired, two-
tailed, t-test). However the Ventral Grey region does maintain the same trend as the 
three other regions of the cord, displaying fewer capillaries than the control 
counterpart region (Figure 13).  
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Figure 13 – Significant difference in capillary density in three of the four spinal 
cord regions in P5 Taiwanese SMA mice. Bar chart (mean ± s.e.m) quantification 
of capillary density in the four regions of the spinal cord of P5 Taiwanese SMA mice 
(black bars) and control littermates (white bars). Unpaired, two-tailed t-test, ns = no 
significance P>0.05, ** =P<0.01, ***P<0.001 N≥3 mice and n≥3 cords for each bar. 
Representative micrographs of PECAM 1 stained capillaries in each cord region in 
Taiwanese SMA and control littermates. 40 x magnification. Scale bar equals 50µm. 
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Figure 14 – Significant difference in overall spinal cord capillary density in P5 
control and Taiwanese SMA mice. Bar chart (mean ± s.e.m) quantification of 
overall spinal cord capillary density in P5 Taiwanese SMA mice (black bar) and 
control littermates (white bar). Unpaired, two tailed t-test, ***=P<0.001. N≥3 mice 
and n≥3 cords for each bar. 
These findings suggest that the reduction in capillary density observed in the 
Taiwanese SMA spinal cord follows similar post natal pattern of development to that 
seen in Taiwanese SMA skeletal muscle (Chapter 2, Figure 13). Here, as was seen in 
SMA skeletal muscle, the spinal cord capillary beds of presymptomatic (P0) mice are 
indistinguishable but by symptomatic (P5) stages a significant defect is observed, 
which is maintained to late symptomatic (P11) stages (Figure 15). When overall 
spinal cord capillary density values for the three ages analysed are presented 
together, control capillary density can be seen to increase steadily with age (Figure 
15). In Taiwanese SMA spinal cords a less regular pattern is observed (Figure 15). 
For a more detailed discussion of this please refer to the Weaknesses Of Study 
section within the Discussion portion of this chapter. Importantly, by the 
symptomatic stage capillary density of Taiwanese SMA spinal cords is markedly 
decreased in comparison to controls and the disparity in densities between the two 
conditions is never bridged (Figure 15). 
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Figure 15 – Difference in capillary density between control and Taiwanese 
SMA mice is evident by P5 and persists until late symptomatic P11 time point. 
(A) Bar chart (mean ± s.e.m) quantification of capillary density in the spinal cord  
from presymptomatic (P0),  symptomatic (P5) and late symptomatic (P5) Taiwanese 
SMA mice(black bars) and control littermates (white bars). One Way ANOVA with 
Tukey post-hoc test, ns = no significance P>0.05 ***=P<0.0001. N≥3 mice and n≥3 
cords for each bar. 
 
3.3.4 A significant reduction in spinal cord capillary density is observed in the 
SMNΔ7 mouse model of SMA 
Having assessed the spinal cord capillary defect in detail in the Taiwanese mouse 
model of SMA, we sought to determine if a similar defect was present in another 
mouse model of the disease, the SMNΔ7 model. SMNΔ7 mice survive on average 14 
days and develop an SMA phenotype by P6-7 (Kerr et al., 2000). Along with the 
incorrectly spliced human SMN2 gene found in the Taiwanese model, SMNΔ7 also 
carry a copy of the missing exon 7 transcript (Kerr et al., 2000). Here, spinal cords 
from P14 late symptomatic SMNΔ7 SMA mice and control littermates were 
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collected and the capillary bed stained and imaged for analysis. Analysis of P0 and 
an earlier disease timepoints was not possible as the SMNΔ7 colony became 
unavailable to us. 
Again for initial examination of general capillary bed architecture low magnification 
montage images of SMNΔ7 SMA (Figure 17) and control thoracic regions of spinal 
cords (Figure 16) were created.  In these older control mice the distinction between 
grey and white matter is clearly evident (Figure 16). This creates a more organised 
capillary bed appearance in these P14 mice than the younger P11 Taiwanese mice, 
where this boundary was not readily identifiable with PECAM 1 staining alone. In 
comparison to this relatively organised control capillary bed, SMNΔ7 spinal cords 
appeared markedly different, with a striking reduction in the number of observable 
capillaries within the cord (Figure 17). When capillary density was measured a 
significant reduction was found in each of the four spinal cord regions; Dorsal Grey 
61% (P<0.001), Dorsal White 55 % (P<0.01), Ventral Grey 37% (P<0.001) and 
Ventral White 43% (P<0.001) (Figure 18). The accompanying  P values were 
generated from individual unpaired, two-tailed, t-tests of each region (Figure 18). On 
average this amounts to an overall reduction in spinal cord capillary density of 
approximately 49% (Figure 19). This confirmed the initial finding of a reduced 
spinal cord capillary density in late symptomatic SMA mice in a second mouse 
model of the disease. 
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Figure 16 - P14 control SMNΔ7 spinal cord capillary bed. Representative 
montage micrograph of P14 SMNΔ7 SMA control spinal cord visualised with 
PECAM 1. Individual images used to construct montage of entire section are 10 x 
magnification. Scale bar equals 200µm. 
 
Figure 17 - P14 SMNΔ7 SMA spinal cord capillary bed Representative montage 
micrograph of P14 late symptomatic SMNΔ7 SMA spinal cord visualised with 
PECAM 1. Individual images used to construct montage of entire section are 10 x 
magnification. Scale bar equals 200µm. 
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Figure 18 – Significant reductions in capillary density in all four spinal cord 
regions in P14 SMNΔ7 SMA mice. Bar chart (mean ± s.e.m) quantification of 
capillary density in the four regions of the spinal cord of P14 SMNΔ7 SMA mice 
(black bars) and control littermates (white bars). Unpaired, two-tailed t-
test,**=P<0.01, ***=P<0.001. N≥3 mice and n≥3 cords for each bar. Representative 
micrographs of PECAM 1 stained capillaries in each cord region in SMNΔ7 SMA 
and control littermates. 40 x magnification. Scale bar equals 50µm. 
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Figure 19 – Overall spinal cord capillary density in P14 SMNΔ7 mice. Bar chart 
(mean ± s.e.m) quantification of overall spinal cord capillary density in 14 SMNΔ7 
SMA mice (black bar) and control littermates (white bar). Unpaired, two tailed t-test, 
***=P<0.001. N≥3 mice and n≥3 cords for each bar. 
 
3.3.5  Disrupted Claudin 5 expression in late symptomatic Taiwanese SMA 
mice 
Capillaries in the spinal cord have a specialised barrier function and form the blood 
spinal cord barrier (BSCB). The BSCB is the term applied to the close association 
between neighbouring astrocytes and capillaries which controls the access of 
immune cells and plasma proteins to the spinal cord. The BSCB is composed of 
endothelial cells, their basement membranes, pericytes and the end feet processes of 
astrocytes (Bartanusz et al., 2011).  In order to form this barrier properly, spinal cord 
capillaries must express key tight junction and adherens proteins. Tight junctional 
proteins such as Zona-Occludens 1 (ZO-1) and Claudin-5 (CL-5) found in capillary 
endothelial cells and are the key vascular components of the barrier while the water 
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transporter Aquaporin-4 (AQ-4) in astrocytes is essential for the maintenance of the 
physiological function of the BSCB.  Any alterations to the normal expression and 
presence of these proteins can lead to disruption of the BSCB a defect commonly 
reported in ALS (Garbuzo-Daiz, 2007; Zhang et al., 2008; Nicaise et al., 2009; 
Zhang et al., 2009; Garbuzova-Davis et al., 2012 Miyazaki et al., 2011). Having 
identified a significant reduction in the capillary density of SMA spinal cords in two 
different mouse models of the disease we briefly examined the presence of three key 
BSCB proteins in late symptomatic P11 Taiwanese SMA mice.  
 Here, sections of P11 late symptomatic Taiwanese SMA and control littermate 
spinal cord have been double labelled with the isolectin GSL-1 staining the capillary 
bed and with each of the BSCB proteins of interest (Figure 20). 
In control spinal cords complete co-localisation between capillaries and all three 
BSCB proteins is observed (Figure 20). In Taiwanese SMA cords GSL-1, AQ-4 and 
ZO-1 labelling co-localises (Figure 20) but not every GSL-1 labelled capillary is co-
labelled with Cl-5 (Figure 20). GSL-1 and Cl-5 co-labelling is present in large but 
not in small capillaries in the sections (Figure 20). This suggests that while elements 
of the BSCB are present in late symptomatic P11 Taiwanese SMA mice, the barrier 
is not fully formed.  
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Figure 20 – Claudin 5 expression is disrupted in late symptomatic Taiwanese 
SMA mice while Aquaporin 4 and Zona Occludens 1 appear normal. 
Representative micrographs of P11Taiwanese SMA and control spinal cord 
visualised in red with GSL-1 and in green with Aquaporin 4, Claudin 5 and Zona 
Occludens 1. 20 x magnification. Scale bar equals 50µm. 
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Having established a reduction in capillary density in both Taiwanese and SMN Δ7 
SMA spinal cords, we next sought to investigate the effects of this capillary defect on 
the tissue of the spinal cord itself. 
Along with nutrients and metabolites, blood vessels deliver oxygen to the body 
tissues. This oxygen reaches the cells of organs and tissues by diffusing through the 
thin walls of the capillary beds within the tissue. Oxygen diffuses from capillaries in 
such a way that cells nearer vessels are more oxygenated than those further away 
from vessels. Any alteration in the number of vessels supplying a tissue or the 
distance of a cell from supplying vessels will affect the level of oxygen which will 
reach that tissue or cell.  The findings of this chapter show an overall reduction of 
61% in spinal cord capillary density in P11 Taiwanese SMA mice when compared to 
control littermates (Figure 9).  When examined regionally, a 62% reduction in 
capillary density was seen in the ventral grey region of P11 Taiwanese SMA mice 
when compared to the same region in control littermates (Figure 8). This reduction is 
particularly interesting, given that the ventral grey region houses the cell bodies of 
the lower motor neurons which degenerate and are eventually lost in SMA. To 
determine how the relationship between capillaries and motor neurons is affected by 
this reduction, sections of P11 Taiwanese SMA and control littermate spinal cords 
were double labelled with the capillary marker PCAM1 and the motor neuron marker 
SM1-32 (Figure 21). These double labelled sections were from adjacent slides to 
those used for the calculation of capillary density in P11 Taiwanese SMA and control 
littermate spinal cords. 
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3.3.6 Reduction in the number of capillaries surrounding motor neurons in 
late symptomatic P11 Taiwanese SMA mice 
When control and Taiwanese SMA spinal cords were double stained with PECAM 1 
and SM1-32, differences in the relationships between capillaries and motor neuron 
cell bodies were immediately apparent (Figure 21). In control spinal cords may 
capillary profiles were observed surrounding motor neuron cell bodies. In this 
representative image no fewer than 12 capillaries are seen in the field of view 
surrounding a cell body (Figure 21). In contrast, far fewer capillary profiles were 
observed in the field of view surrounding the remaining Taiwanese SMA motor 
neurons. In this representative image only 6 capillary profiles can be clearly 
identified (Figure 21). This reduction is in line with the 60% reduction in capillary 
density that has already been measured in this region of these P11 Taiwanese SMA 
spinal cords (Figure 21). In control spinal cords capillary profiles were observed in 
close proximity to cell bodies (Figure 21). However, in Taiwanese SMA spinal 
sections few, if any capillaries were seen in close relation to cell bodies (Figure 21). 
This is consistent with the pattern of vessels seen in the P11 Taiwanese SMA 
montage images where large sections of the cord appear devoid of capillaries (Figure 
5). These example images are by no means conclusive, but serve illustrate the point 
that the association between capillaries and motor neurons is significantly altered in 
P11 Taiwanese SMA mice. To determine the physiological implications of such 
alterations on the motor neurons, the presence or absence of tissue hypoxia in the 
spinal cord (neurones and glia) was investigated using Pimonidazole Hydrochloride, 
an injectable marker of tissue hypoxia. 
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Figure 21 – The number of capillaries surrounding motor neurons is reduced 
in late symptomatic Taiwanese SMA mice. Representative micrographs of 
motor neurons visualised with SM1-32 (green) and the capillary bed 
visualised with PECAM 1 (red) in late symptomatic P11 Taiwanese SMA and 
control spinal cords. Images are 20 x magnification. Scale bar equals 50µm. 
 
P11 late symptomatic Taiwanese SMA mice have a severe disease phenotype 
displaying drastic weight loss and muscle wasting along with pronounced motor 
deficits. At this state of disease progression, invasive procedures, such as the 
injection required to administer PIMO, are not ethically approved. To ensure 
minimal discomfort to the animals, a younger age and less severe disease status was 
required. The previous findings of this chapter have identified a significant reduction 
in capillary density in Taiwanese SMA spinal cords at P5 (Figure 14). This reduction 
is in line with that seen at the late symptomatic P11 timepoint (Figure 9). At P5 mice 
display a significant capillary defect in the spinal cord but their overall disease 
phenotype is mild enough to gain approval for injection experiments. P5 was 
therefore chosen as the optimal age for administration of PIMO to Taiwanese SMA 
and control littermates. 
PhD The University of Edinburgh 2014 
  145 
3.3.7 Increase in the number of hypoxic cell bodies in the ventral horn of 
SMA spinal cords 
Pimonidazole Hydorchloride (PIMO) binds to the thiol groups of proteins in hypoxic 
cells. These hypoxic cells can then be identified by a primary antibody which targets 
the PIMO-thiol adducts and a peroxidise conjugated secondary antibody which 
visualises the hypoxic cells via the DAB reaction. To ensure the reliability of this 
procedure a series of controls were conducted alongside every staining experiment. 
Spinal cords sections, from Taiwanese SMA and control littermates that had been 
dosed with PIMO, were treated with secondary antibody and DAB but not primary 
antibody. A second set of sections, from the same mice, were treated with DAB only 
but not primary or secondary antibody. Both groups of sections were then 
counterstained with Cressyl Fast Violet (Figure 22). In both control groups no DAB 
staining was observed in any region of the spinal cord or surrounding vertebrae and 
muscle (Figure 22). This was still the case when the length of DAB incubation was 
tripled. These control experiments suggest that any DAB staining observed is a result 
of proper PIMO action and not as a result of inappropriate secondary binding or 
endogenous peroxidise activity in the cells. 
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Figure 22 – No erroneous DAB staining in control staining procedure. 
Representative micrographs of secondary antibody only and DAB only control 
sections from P5 symptomatic Taiwanese SMA mice and control litter mates 
injected with the hypoxia marker PIMO. Spinal cords are counterstained with 
Cressyl Fast Violet. Images are 10x magnification. Scale bar equals 200 µm.  
 
When examined by eye, very few DAB positive cells were observed in the spinal 
cord of control PIMO dosed mice. In contrast, numerous DAB positive cells were 
clearly seen in the spinal cord of Taiwanese SMA mice (Figure 23). Given that the 
ventral horn of the spinal cord houses motor neuron cell bodies and the importance 
of these cells in SMA, we focused on this region in particular (Figure 23). Here a 
clear difference in the number of DAB positive cells can be seen between the control 
and Taiwanese SMA sections (Figure 23). To quantify this observation, the number 
of DAB positive cells in the ventral horn of the spinal cord in both Taiwanese SMA 
and control littermates was counted using Image J (NIH) software.  
PhD The University of Edinburgh 2014 
  147 
 
 
Figure 23 – Increase number of DAB positive cells in the ventral region of P5 
Taiwanese spinal cord. Representative micrographs of DAB visualisation of PIMO 
labelled hypoxic cells in ventral horn of P5 symptomatic Taiwanese SMA mice and 
control littermates. Spinal cords counterstained with Cressyl Fast Violet. Images are 
40x magnification. Scale bar equals 50µ. 
 
The ventral horn of the spinal cord was identified by CFV Nissl staining. In this 
region the number of Nissl and DAB co-labelled cells were counted. In Taiwanese 
SMA mice the number of Nissl and DAB co-labelled cells was significantly 
increased in comparison to control spinal cords (P<0.001, unpaired, two-tailed, t test) 
(Figure 25). The average number of cells which were Nissl and DAB positive, in 
control spinal cords being 2.2 and 7.4 in Taiwanese SMA mice, amounting to a 3.3 
fold increase in Nissl+DAB positive cells in Taiwanese SMA mice when compared 
to control littermates (Figure 25). This suggests that there is an increase in the 
number of hypoxic cells in the ventral horn of Taiwanese SMA spinal cords.  
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Figure 24 - Significantly increased number of hypoxic cells in the ventral 
region of P5 Taiwanese spinal cord. Bar chart (mean ± s.e.m) quantification 
hypoxic cells in ventral horn of symptomatic P5 Taiwanese SMA mice (black bar) 
and control littermates (white bar). Unpaired, two-tailed, t-test. *** = P<0.001 N≥3 
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3.4 Discussion 
In this chapter the capillary bed of the spinal cord in two mouse models of SMA was 
investigated. The findings of this chapter show that the capillary bed of the spinal 
cord is significantly altered in SMA mice. 
The results of this chapter show first, that the vasculature of both Taiwanese SMA 
and control spinal cord mice conforms to the grey-white matter balance previously 
described in human and murine spinal cord vasculature (Sturrock, 1980; Brockstein, 
1993). 
Second, these findings show that the capillary density of the spinal cord is 
dramatically reduced by 61% in Taiwanese SMA mice when compared to control 
littermates at a late symptomatic time point (P11). This reduction in density was 
observed throughout the cord, in both the grey and white matter and in both the 
dorsal and ventral horns. The dorsal and ventral cord regions are supplied by 
anatomically and functionally discrete capillaries, which do not anastomose with one 
another (Sturrock, 1980; Brockstein, 1993). Observing a reduction in capillary 
density in each of these regions suggests a widespread defect in spinal cord 
vasculature in Taiwanese SMA mice.  
Third, this work revealed that while dramatically reduced at a late symptomatic (P11) 
timepoint the capillary density of the Taiwanese SMA spinal cord was not 
significantly different from control littermates at birth (P>0.5, One way ANOVA, 
with post hoc Tukey). At birth, Taiwanese SMA mice are presymptomatic and show 
no neuromuscular pathology (Hseih-li et al., 2001; Reissland et al., 2010). By P6-7 
Taiwanese SMA mice are regarded as symptomatic displaying a phenotype of 
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reduced body weight, organ pathology, diarrhoea, muscle wasting and motor neuron 
degeneration (Hseih-li et al., 2000; Reissland et al., 2010; Schreml et al., 2013). At 
P5 the capillary beds of control and SMA spinal cords were observed to be 
significantly different (P<0.001, One way ANOVA, with post hoc Tukey). These 
findings suggest that the capillary defect observed in SMA skeletal spinal cord is a 
postnatal phenomenon which occurs in line with the appearance of motor neuron 
pathology. 
Fourth, this investigation confirmed the presence of the spinal cord capillary defect 
seen in a second mouse model of SMA at a late symptomatic timepoint.  Capillary 
density in P11 Taiwanese SMA and P14 SMNΔ7 SMA mice is comparable. P11 
Taiwanese SMA mice retain 47% of control littermate density and SMNΔ7 SMA 
mice retain 51% of control littermate density. This suggests that the spinal cord 
capillary defects observed are not an epiphenomenon of mouse genetics but a 
consistent SMA disease phenotype.  
Fifth, preliminary investigations of the blood spinal cord barrier revealed defects in 
the expression of the key BSCB tight junction protein Claudin 5 in P11 late 
symptomatic Taiwanese SMA mice. While Claudin 5 was present in large capillaries, 
it was not detected in smaller capillaries in SMA mice. This may suggest a defect in 
the BSCB related to the expression and accumulation of Claudin 5 in Taiwanese 
SMA mice. 
Finally, the findings of this chapter show an increase in the number of hypoxic cells 
in the ventral horn of Taiwanese SMA spinal cords when compared to control 
littermates. Given their location, it is likely that many of these hypoxic cells are 
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neurones and that many of these neurones are motor neurones. This increase in 
hypoxic cells is observed at an early stage in disease progression. Taiwanese SMA 
mice display reduced body weight, muscle wasting and motor neuron degeneration at 
P6-P7. An increase in hypoxia in the spinal cord could contribute to these 
pathological changes, in particular the degeneration of motor neurons, the defining 
pathology of SMA. 
3.4.2 Vascular contribution to motor neuron degeneration 
The findings of this chapter describe a reduced capillary density in the spinal cords 
of SMA mice. Importantly this reduced density is seen at an early timepoint in the 
progression of the disease. It is possible that this reduction in vessel number could 
contribute to the pathogenesis of SMA, particularly the degeneration of motor 
neurons. A 10-15% reduction in the total length and number of spinal cord capillaries 
results in a 30-45% reduction in spinal cord blood flow (Zhang et al., 2008). A 
similar decreased perfusion of the cord occurs in response to spinal cord injury. This 
is a rapid response with reduced perfusion seen with 30 minutes of injury (Means et 
al., 1978). Such reductions in spinal cord perfusion have been shown to lead to the 
degeneration of motor neurons (Oosthuyse et al., 2001). 
Vascular Endothelial Growth Factor (VEGF) is essential for angiogenesis, the 
process by which new blood vessels are formed (Carmeliet, 2000). VEGF is 
particularly sensitive to oxygen levels in tissue and is upregulated by more than ten 
times by very slight decreases in tissue oxygen level (Dor & Kesket, 1997; Semenza 
2000). This response is mediated by hypoxia inducible factors which bind to the 
hypoxia response element of the VEGF promoter (Semeza, 2000). When this 
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hypoxia response element was deleted in mice, the hypoxia induced expression of 
VEGF was blunted, particularly in neural tissue such as peripheral nerve and the 
spinal cord (Oosthuyse et al., 2001). While the density and structure of capillaries in 
the spinal cord of these mice appeared normal, vascular perfusion in the spinal cord 
was halved (Oosthuyse et al., 2001). As a result, motor neurons in the ventral horn of 
the spinal cord degenerated, with 30% of ventral horn motor neurons being lost 
entirely. This loss of motor neurons lead to severe muscle weakness in the mice 
which presented with a phenotype very similar to that of ALS with hindlimb 
clasping, muscle weakness and progressive immobility (Oosthuyse et al., 2001). This 
study suggests that motor neuron degeneration and subsequent motor neuron disease 
symptoms can be caused by inadequate blood supply to motor neurons. This presents 
a potential mechanism by which capillary defects in the spinal cord may contribute to 
motor neuron loss in SMA. 
3.4.3 Effects of Hypoxia on blood barrier composition 
In this chapter defects in the expression of the tight junctional protein Claudin -5 
were observed. Although not entirely absent, the expression pattern of Claudin-5 was 
altered. A similar alteration of Claudin-5 expression is reported in the vasculature of 
mice exposed to hypoxic conditions (Koto et al., 2007). 
Under normal conditions Claudin-5 is observed in the plasma membrane of retinal 
microvascular endothelial cells. To observe the effects of hypoxia on this expression, 
neonatal mice were housed in hypoxic chambers for the first 7 days of life and their 
retinas collected. Reduced Claudin-5 immunostaining was observed in the retinal 
vasculature. This reduction was further confirmed by a 41% decrease in Claudin-5 
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protein expression, as measured by western blotting, in the retinas from hypoxic 
conditions when compared to normoxic conditions (Koto et al., 2007). As the retina 
is part of the central nervous system, the retinal vasculature displays similar barrier 
qualities to that of the brain and spinal cord.  To determine the effects of this 
reduction in a key tight junctional protein on the barrier functions of the retinal 
vasculature, tracer experiments were conducted. The small nuclear label Hoechst and 
the larger fluorescently conjugated lysine-flexible dextran were injected into the left 
ventricle of heavily anesthetised hypoxic and normal oxygen conditioned mice. The 
larger dextran was seen in the vascular lumen with little to no observable leakage 
into the surroundings in the vasculature of both the normal and hypoxia condition 
retinas. In contrast, enhanced extravasation of the Hoescht was seen in the hypoxic 
retinal vasculature, as identified by nuclear staining of retinal glial and neural cells 
by the Hoescht (Koto et al., 2007). These findings suggest that the expression of 
Claudin-5 is altered in response to hypoxia and that this affects the permeability of 
the retina vasculature to small molecules. 
In this chapter an increase in the number of hypoxic cells was observed in the spinal 
cord of P5 Taiwanese SMA mice. When examined, the expression pattern of 
Claudin-5 in the spinal cord vasculature was also altered in Taiwanese SMA mice 
when compared to control littermates. These alterations were observed at the later 
P11 timepoint.  It is possible that increased levels of hypoxia in the Taiwanese SMA 
spinal cord has contributed to these alterations in Claudin-5 expression. The 
particular sensitivity of Claudin-5 to hypoxia could explain why it appears to be the 
only blood spinal cord barrier component affected in the Taiwanese SMA mice. This 
could in turn be a factor in motor neuron damage resulting via a leaky BSCB. 
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3.4.4 Weaknesses of Study 
Although every attempt was made to ensure that this study was as robust as possible, 
there are areas of weakness that should be noted: the delivery route of the hypoxia 
marker PIMO to the body tissues and a potential phenotype drift in the Taiwanese 
colony. 
Once administered the hypoxia marker PIMO is distributed to the body tissues via 
the vasculature. Given that we observe defects in the vasculature of SMA mice it 
could be suggested that this may not be the ideal route to administer an investigative 
label. However, while we see a reduction in the number of blood vessels in SMA 
spinal cords, vessels are still present within the tissue in sufficient number for the 
animals to live. This suggests that while the vascular system may be deficient in 
SMA mice, it still functions well enough to be compatible with life. This combined 
with other benefits of the PIMO method identify it as an appropriate methodological 
approach to identify the presence of hypoxia in SMA tissues. 
PIMO is a stable, safe and non-toxic marker of tissue hypoxia. Doses of 200mg/kg, 
over three times the dosage used in these experiments, have been safely delivered to 
P3 neonatal mice without any adverse side effects (Freeburg and Abraham 2004). 
Given the defects observed in multiple body systems the Taiwanese SMA mice,  
including the lungs and digestive tract (Schreml et al., 2013), PIMO is an ideal tool 
to administer without exacerbating the disease. Along with these animal health 
benefits, PIMO allows for the identification of hypoxia in identifiable cellular 
structures within a tissue. 
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Unlike measurements of hypoxia using probes, the imuunoperoxidase methodology 
of PIMO allows for the specific identification of hypoxic cells in a structure, not just 
an overall tissue reading of oxygen levels. By using Cressyl Fast Violet Nissl 
staining alongside the DAB PIMO labelling, the exact cellular location of hypoxia in 
the Taiwanese SMA spinal cords was identified. 
Shortly after completion of this project it became apparent that Taiwanese SMA 
mice were not surviving to P11. When the colony was initially established Taiwanese 
SMA mice survived on average for 11 to 12 days. In the weeks following this 
investigation this average survival had decreased to 8 to 9 days. These shorter lived 
mice showed similar motor impairments, in particular a difficulty in righting ability, 
at P6-7 as the original, longer lived mice. However, these mice displayed more 
severe diarrhoea which was apparent earlier than that seen in the P11 surviving mice. 
This suggested an increase in the severity of systemic defects in the mice. Upon 
examination multiple abnormalities were seen in Taiwanese SMA organs including 
an accumulation of white fluid in the abdomen and discolouration of the liver and 
lungs. Many organs, including the heart, liver and spleen were also found to be 
disproportionately small in the Taiwanese SMA mice. While similar defects were 
observed in the longer surviving P11 mice, they were more pronounced in the 
reduced survival mice. This increase in systemic pathology could explain why 
Taiwanese SMA mice began to die earlier and could also be the underlying reason 
for the apparently more severe vascular defect observed at the P5 timepoint, which 
was the last timepoint to be collected in this study. This suggests that the severity of 
the capillary defect is linked to disease severity. This is a common pattern in many 
phenotypical and clinical aspects of SMA, with the severest Type I patients 
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displaying the most pronounced motor defects (Lung & Wang 2008) and 
abnormalities in multiple body systems including cardiovascular (Rudnik-
Schoneborn, 2008) and metabolic systems (Bowerman et al., 2012). Milder forms of 
the disease show less motor impairment, with most Type III patients meeting all 
major motor milestones (Lung & Wang, 2008). Fewer systemic perturbations are 
reported in the less severe forms of the disease.  
3.4.5 Conclusion 
From these results we can conclude that the extent of capillary bed is altered in SMA 
mouse model spinal cord. The density of capillaries in SMA spinal cord is reduced in 
comparison to control cord. This reduction in capillary density was found to be post 
natal phenomenon which occurred throughout the cord, in both the grey and white 
matter as well as the dorsal and the ventral horns. A significant increase in the 
number of hypoxic cell bodies was also observed in the ventral horn of SMA mouse 
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Chapter 4: Treatment with the HDAC inhibitor SAHA ameliorates skeletal 
muscle capillary defects in a mouse model of SMA 
4.1 Introduction 
At present there is not cure for Spinal Muscular Atrophy. After a diagnosis of the 
most severe Type I form of the disease, palliative care is currently the only clinical 
option. However, given its monogenetic basis (Lefebrve, 1995), SMA is a suitable 
target for genetic intervention. These interventions focus on replacing the lost SMN1 
gene or enhancing the level of full length SMN protein produced by the SMN2 gene. 
Viral gene therapy strategies aim to reintroduce the SMN1 gene into SMA cells and 
tissues, with the hope of restoring depleted SMN levels. Studies using viral SMN1 
delivery have reported an increase in SMN levels in both isolated human cells 
(Azzouz et al., 2004) and mouse model (Azzouz et al., 2004) cells and tissues. 
Lentivector SMN1 delivery restored SMN levels in Type 1 patient fibroblasts 
(Azzouz et al., 2004; Bevan et al., 2010; Foust et al., 2010; Valori et al., 2010; 
Dominguez et al., 2011). Intramuscular injections of the same vector in the SMNΔ7 
mouse model of SMA resulted in restoration of SMN levels in motor neurons, 
reduction in motor neuron death and an increase in life expectancy (Azzouz et al., 
2004). Although effective in peripheral tissues, lentivector packaging prevents 
delivery of the SMN1 gene across the blood brain barrier to the central nervous 
system. In 2009 Foust et al., reported the bypassing of the blood brain barrier by the 
self-complimentary adeno-associated virus serous number 9 (scAAV9). Delivery of 
the SMN1 gene by scAAV9 viral means has been used by multiple groups with 
reported rescue of motor neuron function, improved neuromuscular physiology and 
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increased life span (Foust et al., 2010; Valori et al., 2010; Dominguez et al., 2011). 
Importantly, improvement of non-neuromuscular tissues has been reported post 
scAAV9 SMN1 delivery. In 2010 Bevan et al., described improvements in 
ventricular remodelling and a resolution of cardiac arrhythmia in SMNΔ7 mice 
treated with scAAV9 SMN1. 
While replacement of SMN1 shows promise as a treatment for SMA in animal 
models, effective gene therapy in patients has yet to be reported.  However, another 
potential treatment approach, involving the amplification of full length Smn 
production by the remaining SMN2 gene, has been shown to improve the SMA 
phenotype in both SMA mouse models and patients.  
In comparison to the SMN1 gene, SMN2 only produces 10% full length, fully 
functioning Smn protein (Burghes & Beattie 2009).  When SMN1 is lost in SMA, the 
comparatively low levels of full length Smn produced by the remaining SMN2 gene 
cannot fully compensate for the loss of SMN1. It is this drastic reduction in Smn 
protein levels that results in the SMA phenotype. A significant correlation between 
the level of Smn and SMA disease severity has long been established.  Early studies 
of the SMN genes reported a putative link between SMN protein levels and SMA 
disease severity, detailing a more marked reduction in SMN protein levels in the 
liver and spinal cord of more severe Type I patients, when compared to milder Type 
III patients (Lefebvre et al., 1997). More in depth studies involving patients of all 
SMA types have elucidated a significant correlation between SMN2 copy number 
and SMA severity (Feldkotter et al., 2002). 
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80% of Type I patients possessed one or more copies of SMN2, while 82% of Type 
II patients carried three SMN2 copies and 96% of Type III patients were found to 
possess three or four SMN2 genes (Feldkotter et al., 2002). Patients with even 
greater SMN2 copy numbers, up to five and six copies display even milder SMA 
phenotypes (Wirth el al., 2006). This correlation is also observed in animal models of 
the disease (Hsieh et al., 2000; Monani et al., 2000). 
The severity of pathology evident in mice models correlates with the amount of full 
length Smn protein present (Hsieh et al., 2000), with higher levels of Smn resulting 
in milder SMA phenotypes. It has also been reported that mice lacking endogenous 
Smn but carrying eight human SMN2 copies show no SMA phenotype (Monani et 
al., 2000). Taken together this human and animal evidence highlights the importance 
of SMN2 as a modifier of the disease. The particular suggestion that the phenotypic 
severity of SMA can be modulated by the amount of Smn produced by SMN2 makes 
it an attractive target for SMA therapeutics. Levels of Smn can be amplified by 
genetically increasing SMN2 copy number (Monani et al., 2000) or by enhancing the 
transcription of the SMN2 gene present. One such transcription enhancement method 
is the use of Histone Deacetlyase (HDAC) inhibitors which act on the machinery 
responsible for condensing DNA. 
Almost the entire genomic DNA is packaged into the nuclesome, the basic unit of 
chromatin, by histone proteins (Bradbury, 1992), highlighting the fundamental 
importance of histone proteins and their interactions in the regulation of gene 
expression. Nucleosomes are an octomeric structure which contain two molecules of 
each of the four histone proteins; H2A, H2B, H3 and H4 (Grunstein 1997). DNA is 
wound tightly around this histone core and this tight association prevents the DNA 
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from being freely available for transcription (Grunstein 1997). However, 
modification of the exposed terminal amino acids of the histone core loosens the 
association between it and the DNA permitting access to the DNA and initiating 
transcription (Grunstein, 1997). These terminal amino acids are freely available for 
modification by acetlylation, methylation and phosphorylation. Of these 
modifications, acetylation is most well understood. 
Acetylation of histones occurs at the highly conserved lysine residues of the histone 
N-termini (de Ruijter, 2003). This acetylation is a dynamic process and is a key 
component of the regulation of gene expression. While acetylation of histones 
promotes DNA transcription (Alfrey et al., 1964, Hebbs et al., 1988, Lee et al., 
1993), deacetylation has been shown to have repressive transcriptional activity. 
Efficient and effective transcription relies on the balance between acetylation and 
deacetylation of histones. Reduction in acetylation silences genes (Durrin et al., 
1991), while hyperacetylation impairs the ability of histones to regulate nuclesome 
structure (Bauer etal., 1994, Garcia-Ramirez 1995) and also increases the access of 
transcription factors to DNA (Lee et al., 1993). The level of histone acetylation 
occurring in the nucleus is key to controlling transcription. This level of acetylation 
is determined by the balance of histone acetyltransferases and deacetlylases 
(Grunstein 19997). By altering the balance in favour of one or the other, chromatin 
structure and therefore transcription can be reversibly modulated. A key player in 
maintaining this balance is the Histone Deacetylase (HDAC) family. 
HDACs are multi-subunit enzyme complexes within the nucleus that are responsible 
for the targeted deacetylation of histones (de Ruijter, 2003). The Classical HDAC 
family is composed of Class I and the Class II HDAC enzymes. While these enzymes 
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share approximately 82% sequence identity their expression profiles differ. Class I 
HDACs are expressed in the majority of tissues, while the expression of Class II 
HDACs is more restricted (de Ruijter 2003). Independent of class, the HDAC 
enzymes function in the same manner: by removing acetyl groups from the histones 
of the nucleosome. This tightens the association between the nucleosome and DNA, 
restricting transcription factor access to the DNA and so repressing transcription 
(Strahl & Allis, 2000; Wade, 2001; Yoshida et al., 2001). The action of HDAC 
enzymes can be inhibited by a class of compounds and molecules known as HDAC 
inhibitors, which act by blocking the enzyme’s active site. These include, amongst 
others, short chain fatty acids such as butyrate, phenylbutyrate and valproic acid (de 
Ruijter, 2003). Given their ability to enhance transcription, HDAC inhibitors provide 
an attractive means by which the levels of full length Smn protein produced by the 
SMN2 gene could be increased. Multiple studies have taken advantage of HDAC 
inhibitor activity in an attempt to find possible SMA therapeutics. 
Work involving HDAC inhibitor treatment in SMA has reported positive effects in 
mouse models and in patient cells. Application of sodium butyrate to isolated SMA 
lymphoid cells resulted in an increase in the level of full length Smn in vitro. While 
dosing of SMA mice increased Smn expression in spinal cord motor neurons in vivo 
and improved SMA symptoms (Chang et al., 2001). Application of the chemically 
similar Phenylbutyrate to patient fibroblasts also resulted in increased SMN 
expression in SMA cells (Andressai et al., 2004). Benzamide treatment of SMA 
patient fibroblasts resulted in a seven fold increase in SMN2 protein expression 
(Riessland et al., 2006). Other studies using SMA patient fibroblasts have shown a 
similar increase in SMN2 protein product when treated with Valproic acid (Sumner 
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et al., 2003, Brichta et al., 2004). Valproic acid has been the subject of many clinical 
trials, with varying degrees of success. 
In 2006 Weihl et al., reported improved muscle strength in SMA adults who had 
been treated with Valproate for 8 months. However, another trial focusing on non-
ambulatory children who were treated with L-Carnitine and Valproic acid showed no 
improvement in muscle strength or function (Kissel et al., 2011). It is worth noting 
that severity of SMA differed significantly between these two trial groups which 
could explain the marked difference in results between the trials. HDAC inhibitors 
other than Valproic acid have shown promise as possible SMA therapeutics, 
including Trichostatin A, which has been reported to have positive effects at both the 
protein and phenotype (Avila et al., 2007; Narver et al., 2007) level.  
Daily dosing SMNΔ7 SMA mice with Trichostatin A increased SMN2 transcript and 
protein levels in neural and muscle tissue, while also improving survival duration, 
attenuating weight loss and improving motor function (Avila et al., 2007). When 
combined with nutritional support Trichostatin A improved survival of SMNΔ7 mice 
by 170% (Narver et al., 2007). More recent work has focused on the FDA approved 
HDAC inhibitor suberolynalidehydroxamic acid (SAHA). 
In 2006 Hahnen et al., reported the ability of SAHA to increase SMN transcript 
levels at very low micromolar concentrations and emphasised its low toxicity when 
administered daily. Since then SAHA has been shown to improve the SMA 





 mice with SAHA was able to rescue the embryonic 
lethality of SMN loss, producing SMA offspring. While 25mg/kg daily dosing of 
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Tawainese SMA mice increased Smn RNA and protein levels in multiple tissues, 
increased life span by 30% and improved motor ability as well as neuromuscular 
pathology (Riessland et al., 2010). SAHA treatment also ameriolates the muscular 
pathology observed in Taiwanese SMA mice (Mutsaers et al., 2011). These 
beneficial effects of SAHA treatment in SMA mice and tissues along with its FDA 
approved status make SAHA a very attractive possible therapeutic in SMA.  
JNJ is a hydroxamic derivative which is chemically related to the potent HDAC 
inhibitor LBH589. LBH589 has previously been shown to increase SMN protein 
levels ten fold in SMA patient fibroblasts (Garbes et al., 2009), Importantly, LBH589 
was able to promote SMN production in cells which were unresponsive to other 
HDAC treatment (Garbes et al., 2009).  While JNJ retains a similar potency to 
LHB589 (Deleu et al., 2009; Schreml et al., 2013), it has an improved 
pharmacological profile and increased half life (Deleu et al., 2009). These improved 
pharmacological features make JNJ an appealing HDAC inhibitor to investigate as a 
potential therapeutic in SMA. In this chapter we investigate the effect of SAHA 
treatment on the capillary defect we observe in SMA skeletal muscle. Along with 
this well established HDAC, we also investigate the effects of the novel HDAC JNJ-
2648158 (JNJ) on the capillary defect. 
Based on the evidence that HDAC inhibitors can increase Smn protein levels and that 
the SMA phenotype in turn is improved by this increase, we hypothesised that 
ubiquitously increasing Smn levels via treatment with HDAC inhibitors would 
ameliorate the capillary defect we observe in SMA skeletal muscle.  
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Here a selection of hindlimb and body wall muscles from mice treated with the 
HDAC inhibitors SAHA and JNJ were analysed to assess the effect of postnatal 
increase of Smn levels on the skeletal muscle capillary defect. Capillary density in 
these muscles was quantified using immunohistochemical staining and fluorescent 
microscopy of the capillary bed along with quantitative fluorescent western blot 
measurements of a key endothelial marker. Morphological aspects of the skeletal 
muscle capillary bed, such as the alignment between capillaries and their underlying 
muscle fibres, as well as the calibre of capillaries were analysed using fluorescent 
microscopy. Treatment with the HDAC inhibitor SAHA was found to ameliorate the 
capillary defect observed in late symptomatic Taiwanese SMA mice. Capillary 
density, when measured via immunohistochemical staining of the capillary bed and 
via quantitative fluorescent western blotting of the endothelial marker PECAM 1, 
was significantly increased in SMA mice treated with SAHA when compared to 
untreated SMA mice. Capillary alignment and calibre was also improved in SAHA 
treated mice. Treatment with JNJ was found to produce a small but not significant 
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4.2 Methods 
4.2.1 Ethics statement 
All breeding and animal experiments were carried out in Cologne and approved by 
the local animal protection committee and conducted in accordance with guidelines 
established by the Landesamt fur Natur, Umwelt and Verbraucherschutz NRW in 
Germany. In vivo experiments involving JNJ-26481585 were performed under the 
reference number 9.93.2.10.31.07.292.   
4.2.2 Animal husbandry 
Taiwanese FVB.Cg-Tg(SMN2)2Hung Smn1
tm1Hung
/J  were bred and maintained in 
micro-isolation chambers in  the mouse facility of the Institute of Genetics, Cologne 
according to guidelines established by the Landesamt fur Natur, Umwelt and 
Verbraucherschutz NRW in Germany. 
4.2.3 Drug Administration 
4.2.3.1 Suberoylanilidehydroxamic Acid (SAHA) 
Litters of Taiwanese SMA mice, including both SMA mice and control littermates, 
were treated orally via a feeding needle with the HDAC inhibitor 
suberolynalidehydroxamic acid (SAHA). Mice were dosed twice daily from day of 
birth (P0) with 2.5mg/kg of SAHA dissolved in DMSO or the equivalent volume of 
DMSO alone as a control. 
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4.2.3.2 JNJ-26481585 (JNJ) 
Litters of Taiwanese SMA mice, including both SMA affected and control 
littermates, were treated orally via a feeding needle with the HDAC inhibitor JNJ-
2648158 (JNJ). Mice were dosed every other day from day of birth (P0) with 2.5µg 
of JNJ until P2 (P0 and P2 timepoints). At P4 the JNJ dose was increased to 5 µg. 
4.2.4 Tissue Collection 
All mice were humanely sacrificed via euthanasia in accordance with protocols 
established by the Landesamt fur Natur, Umwelt and Verbraucherschutz NRW in 
Germany. Initial tissue collection and dissection was performed in Germany by Julia 
Schreml. 
4.2.4.1 SAHA treated mice 
Mice treated with SAHA were sacrificed at P10. Quadriceps and gastrocnemius 
muscles from the hindlimb were dissected from the mice. The quadriceps muscles 
were immediately frozen on dry ice and stored individually at -80C until shipment 
on dry ice to Edinburgh for analysis. The gastrocnemius muscles were removed 
intact and fixed in 4% paraformaldehyde, washed and embedded in paraffin wax for 
storage before shipment to Edinburgh. 
4.2.4.2 JNJ treated mice  
Mice treated with JNJ were sacrificed at P5. Initial pre-fix dissection of the 
transverses abdominus (TVA) muscle was conducted in Germany. In brief, the skin 
from the trunk of the mouse was carefully removed leaving the underlying 
abdominal wall intact. The rib cage and attached abdominal musculature was 
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dissected out and fixed in 4% paraformaldehyde for 20 minutes. The fixed 
preparations were stored in 1xPBS for shipment to Edinburgh.  
4.2.5 Genotyping 
Retrospective genotyping of the mice was performed in Germany by Julia Schreml 
as per the Taiwanese genotyping protocol described in detail in earlier chapters 
(Chapter 2). 
4.2.6 Quantitative Fluorescent Western Blotting 
Total protein was isolated from the quadriceps muscles by homogenisation in RIPA 
buffer (Pierce, 89900). Proteinase inhibitor cocktail (Thermoscientific, 1861278) was 
added to the RIPA buffer at a concentration of 5µg/ml. 30µl of RIPA buffer was 
added to each muscle sample. Following homogenisation the samples were 
centrifuged at 14,000rpm for 20 minutes. A BCA assay was then conducted to 
determine protein concentration in the samples, using a micro BCA Assay kit 
(Pierce, 23235). A master mix was made up using the following volumes per sample 
and standard; 500µl reagent A, 480µl reagent B and 20µl reagent C. Enough master 
mix was made to analyse each sample and standard in duplicate (1ml per sample). A 
protein standard curve was produced by adding increasing volumes of 2mg/ml of 
BSA albumin protein standard (Pierce, 23209) to the master mix. 1ml of mix was 
transferred to appropriately labelled 1.5ml Eppendorf tubes to which 1µl of 
corresponding sample was added. The samples were briefly vortexed and then 
incubated at 60°C for one hour. Following incubation, samples were transferred to 
cuvettes and their absorbance measured at 562nm on a Thermo Scientific 
spectrophotometer. The absorbance readings from the standard samples were used to 
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produce a standard curve. Using the equation of the line y = mx + c the concentration 
of the experimental samples was calculated.  After doing so, 15mg of protein per 
lane was chosen as the optimum loading concentration for western blotting. Samples 
were diluted with the appropriate volume of autoclaved, deionised water to prepare 
10µl for loading. To aid loading 5µl of NuPAGE LDS Sample Buffer (Novex, 
NP0007) was added to each sample. The samples were then incubated at 98°C for 2 
minutes before loading into 4-12% precast NuPageBisTris gradient gels (Novex, 
NP0323BOX) along with 5µl of Sharp Pre-stained protein standard (Novex, 
LC5800). Samples were run at 80V for 5 minutes, to ensure even entry of the 
samples into the gel, and then at 170V for 45 minutes. The gels were then removed 
from their precast casing and trimmed. The gels were then transferred to PVDF 
membranes (NuPAGE,) in transfer buffer (NuPAGE,) at 24Mv 16 hours. Following 
overnight transfer, the membranes were moved to 50ml falcon tubes and incubated 
with 5mls Odyssey blocking buffer (Licor, 402-467-0700) at room temperature, on a 
rolling platform for at 30 minutes. After this initial blocking, a fresh 5ml of blocking 
buffer was added to the membranes along with Tween-20 at a concentration of 
1:1000. Primary antibodies were added to the blocking buffer and tween solution, 
platelet cell adhesion molecule 1 (PECAM 1: R&D Systems, AF3628, 130kDa) was 
added at a concentration of 1:1600.  Actin (Abcam, ab8226, 42 kDa) at a 
concentration of 1:1600 was added as a loading control. The membranes were then 
incubated overnight at 4°C on a rolling platform. Following incubation with the 
primary antibodies the membranes were washed for 6x5 minutes in 0.1M PBS.  
Corresponding Odyssey secondary antibodies were then applied to the membranes 
along with fresh blocking buffer and Tween-20 for an incubation period of 90 
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minutes, at room temperature, on a rolling platform. Both in Donkey antigoat IRDye 
680 (Odyssey) and Rabbit antimouse IRDye 800 (Odyssey) were used at a 
concentration of 1:1600. The membranes were washed again for 6x5 minutes in 
0.1M PBS before being dried and scanned at 600 and 800nm on a Licor Odyssey 
scanner. Quantification of the blots was performed on single channel scans. Bands 
were identified according to their molecular weight and their arbitrary fluorescence 
intensity calculated by odyssey software. 
4.2.7. Sectioning of Gastrocnemius muscles 
Gastrocnemius muscles were processed and embedded in paraffin wax in Germany 
prior to dispatch. The embedded muscles were section at 10µm on a Leica 
microtome. Adjacent sections from the beginning, middle and end of tissue ribbons 
were floated out in a water bath at 42°C and mounted on charged slides, creating a 
series of sections from throughout the whole muscle. 
4.2.8 Dissection 
Upon arrival the initial transverses abdominus (TVA) preparations were dissected 
and prepared for immunohistochemistry as described in detail in earlier chapters 
(Chapter 2).  
4.2.9 Immunohistochemistry 
4.2.9.1 Sectioned SAHA treated Gastrocnemius muscles 
Slides of sectioned gastrocnemius muscle were deparaffinised in xylene for 20 
minutes (two separate xylene solutions for 10 minutes each). After dewaxing the 
slides were rehydrated in a descending ethanol series (100% x2, 90%, 70% and 50%) 
PhD The University of Edinburgh 2014 
  170 
for 5 minutes in each ethanol percentage. Slides were then washed for 5 minutes in 
0.1M PBS on a rocking platform before antigen retrieval was performed using 
sodium citrate buffer (pH6). Initially slides were washed in the buffer for 10 minutes 
at room temperature on a rocking platform. After this low temperature incubation the 
slides were boiled in citrate buffer for 20 minutes in a microwave. After this heat 
treatment the slides were left in the buffer for 20 minutes to cool to room 
temperature. Following cooling the slides were washed for 2x5 minutes in 0.1% 
Triton-PBS. Slides were blocked in immunoglobulin G protease-free standard 
blocking solution (0.2% BSA, 0.5% Triton-X 100 (TX100) in PBS) for 1 hour at 4° 
C before overnight incubation with goat anti mouse PECAM-1 primary antibody 
(R&D Systems Cat. No. AF3628) at a concentration of 1:750 in standard blocking 
solution at 4°C. The following day slides were washed for 6x5 minutes in 0.1M PBS 
at room temperature on a rocking platform. After washing slides were incubated with 
donkey anti goat Cy3 conjugated secondary antibody (Jackson ImmunoResearch 
Laboratores Inc) made up in standard block at a concentration of 1:250, for 1 hour at 
4° C in the dark. Slides were washed for the final time for 6x5 minutes in 0.1M PBS, 
at room temperature on a rocking platform. At all times slides were protected from 
exposure to light. Following this final washing series slides were mounted with glass 
coverslips in Mowiol (10% Mowiol, Polyscience Inc, 20% glycerol, 50% 0.2M Tris 
buffer pH 8.5, 3% 1,4-diazobicyclooctane made up in distilled water). The 1,4-
diazobicyclooctane acts as an anti-fade reagent.  The mounted slides were left 
overnight in the dark, at room temperature to set before visualisation and imaging the 
following day. 
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4.2.9.2 Whole mount JNJ treated TVA muscles 
To label the skeletal muscle capillary bed, intact TVA muscles were labelled with the 
rhodamine-conjugated lectin Griffoniasimplicifolia-1 (GSL-1). As described in 
earlier chapters, GSL-1 is not an antibody and does not require many of the staining 
procedures used in antibody based immunohistological protocols. Muscles were 
exposed to 5µg/ml αBTX conjugated to FITC (made up in 0.1M PBS) for 10 minutes 
to label post-synaptic acetylcholine receptors. Muscles were then washed 2x5 
minutes in 0.1M PBS. To label the skeletal muscle capillary bed, muscles were 
incubated with Rhodamine conjugated Griffonia Simplicifolia Lectin 1 (GSL-1) at a 
concentration of 1:100, made up in 0.1M PBS, for one hour, at room temperature, on 
a rocking platform. Following this incubation muscles were washed for 6x5 minutes 
in 0.1M PBS before being mounted in Mowiol on glass slides, with glass coverslips. 
The resulting slides were left to set overnight in the dark at room temperature before 
visualisation and imaging the following day. 
4.2.10 Imaging 
Micrographs for the calculation of capillary density were captured using a standard 
inverted epifluorescence microscope (Olympus 1X71) combined with a chilled CCD 
camera (Hammamatsu C4742-95) and OpenLab (Improvision) image capture 
software. Cy3 and rhodamine labelled capillaries were imaged using 570 emission 
optics. FITC labelled capillaries and post-synaptic acetylcholine receptors were 
imaged using 520 emission optics. 
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 4.2.11 Quantification and Analysis 
4.2.11.1 Sectioned Gastrocnemius muscles 
Any sections with poor staining or those that had been damaged during the 
sectioning or staining procedure were excluded from analysis. For capillary density 
calculations a minimum of 10 fields of view per muscle section were taken with a 
x20 objective, 0.4 NA. Care was taken to ensure that images were obtained from 
areas where the muscle was cut in the longitudinal plane by viewing muscle fibre 
orientation in phase contrast. 
4.2.11.2 Whole mount TVAs 
Any muscles with poor quality staining or those that had been damaged during 
dissection were excluded from analysis. For capillary density calculations a 
minimum of 40 fields of view per muscle were taken with a x40 objective, 0.8 NA. 
Any fields of view where excessive overlying connective tissue interfered with 
imaging were excluded from further analysis. If excluded fields of view amounted to 
five or more in an individual muscle the entire muscle in question was discarded 
from further analysis. Images were captured in every third field of view across the 
entirety of the muscle. 
4.2.11.3 Quantifying capillary density 
Images from both sectioned and whole mount muscles were first enhanced in Adobe 
Photoshop (CS4) for contrast and brightness. This ensured that definite vessel 
borders were visible and also prevented any fine capillary structures from being lost 
and discounted. Any out of focus images where capillaries appeared blurred or those 
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where background was too high to completely isolate capillary structures were 
excluded from further analysis. Using Image J (NIH) the enhanced images were 
converted to binary. In the resulting binary images capillaries were assigned black 
and muscle background white, allowing for the ratio of black to total white pixels to 
be calculated. This produced a value for capillary area per field of view. By 
calculating the area of a x40 field of view, it was then possible to calculate the area 





4.2.11.4 Quantifying capillary calibre 
Muscle capillary calibre (diameter) was measured in the PECAM 1 stained sections 
of the gastrocnemius muscle. Measurements were taken from the same images used 
to quantify capillary density. A measuring grid was overlain onto the images using 
Image J (NIH) and every capillary found at the intersection of gridlines was 
measured. The shortest distance across the capillary was measured. Measurements 
were not taken at capillary bifurcations. If the same capillary crossed multiple 
gridlines it was measured only once, at the first gridline encountered. 
4.2.11.5 Analysis 
All data were collected using Microsoft Excel software and were graphed and 
analysed using GraphPad Prism software. Charts shown are mean ± s.e.m. In all 
analyses statistical significance was considered to be p < 0.05. Tests used are detailed 
in figure legends. 
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4.3 Results 
Having established the presence of a capillary defect in flat muscles of the body wall 
and described it in detail, we sought to investigate the capillary bed of another group 
of muscles. Limb muscles are known to be affected in SMA patients (Monani, 2005; 
Tsirikos and Baker, 2006; Wirth et al., 2006; Russman 2007; Farrar et al., 2009) and 
show motor defects in a variety of mouse models of the disease (Monani et al., 2000; 
Hsieh Li et al., 2000). Here we examine the vasculature of the hindlimb 
gastrocnemius muscle, which is known to display alterations in molecular 
mechanisms in Taiwanese SMA mice (Mutsaers et al., 2011). In comparison to the 
thin, flat, relatively two dimensional muscles of the body wall, the gastrocnemius 
muscle is much thicker, comprising multiple muscle fibres in a large muscle belly. In 
order to apply our novel method of capillary density quantification (Chapter 2) the 
gastrocnemius muscle was embedded in paraffin wax and sectioned on a Leica 
microtome. The capillary bed in the resulting sections of muscle was visualised using 
the endothelial marker PECAM 1. 
4.3.1 Hindlimb muscles of late symptomatic Taiwanese SMA mice show 
similar capillary bed defects as flat muscles form the body wall 
On initial inspection it was evident that the capillary bed of the Taiwanese SMA 
gastrocnemius muscle was altered in comparison to control littermates (Figure 
1A,B). The number of capillaries present in sections from SMA muscle (Figure 1B) 
appeared to be less than that of control muscles (Figure 1A). Further, the 
arrangement of capillaries within the muscle appeared to differ. When compared to 
images from control and SMA P11 late symptomatic Taiwanese TVA muscles 
(Figure 1C,D), the alterations observed in the gastrocnemius muscle sections 
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appeared similar, with both displaying an obvious reduction in capillary density and 
more subtle impairments in capillary organisation and arrangement. As it is the most 
striking difference between the two conditions, the apparent reduction in capillary 
density seen in the SMA gastrocnemius muscle was chosen for initial analysis. 
 
Figure 1-Alterations to gastonemius capillary bed are comparable to those 
seen in the TVA. Representative micrographs of PECAM 1 labelled capillary bed in 
gastrocnemius (A,B) and TVA (C,D) muscles in control and SMA littermates. Images 
are 20x magnification. Scale bar equals 50µm. 
 
4.3.1.1Capillary density of gastrocnemius muscle is significantly reduced in 
late symptomatic Taiwanese SMA mice 
Capillary density in the gastrocnemius muscle sections was measured using the novel 
method described in detail in Chapter 2. In brief, PECAM 1 labelled images of the 
capillary bed were captured at 20x magnification and their contrast enhanced in 
Adobe Photoshop to ensure no loss of fine capillary structure. The resulting images 
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were converted to binary using Image J software and the ratio of total black to white 
pixels calculated. This provided a value for total capillary area per field of view, 
which was then converted to capillary area per mm
2
 of muscle. When the resulting 
values for control and Taiwanese SMA gastrocnemius muscle capillary density were 
compared a significant (P<0.0001, unpaired two-tailed students t-test) and dramatic 
difference between the two conditions was observed (Figure 2A). In comparison to 
control littermates, the capillary density of P11 late symptomatic gastrocnemius 
Taiwanese SMA muscle was reduced by 81% (Figure 2A). Having confirmed that 
the capillary density is drastically reduced in P11 Taiwanese SMA gastrocnemius 
muscle, the other notable defects in the capillary bed were then investigated and in 
particular, the arrangement of the capillaries within the muscle itself. 
 
Figure 2 – Capillary density is significantly reduced in late symptomatic SMA 
gastrocnemius muscle. (A) Bar char (mean±s.e.m) quantifying capillary density in 
gastrocnemius muscle of P11 control and SMA mice. Unpaired, two-tailed t-test, 
****P<0.00001. N≥3 mice for each bar and n≥6 muscles for each group. 
Representative micrographs of PECAM 1 labelled capillary bed of P11 control (B) 
and SMA (C) gastrocnemius muscle. Images are 20x magnification. Scale bar 
equals 50µm.  
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4.3.1.2 Impaired organisation of the skeletal muscle capillary bed   
When initially examined the arrangement of capillaries within the gastrocnemius 
muscle sections appeared altered between control and Taiwanese SMA mice (Figure 
1A,B). With control capillaries displaying a more linear, parallel arrangement 
(Figure 1A) than their SMA counterparts. To investigate the arrangement of the 
capillaries within the muscle further phase contrast images of the muscle fibres 
underlying capillaries were captured and compared (Figure 3A,3B). Here it can be 
seen that the overlying capillaries form a parallel arrangement with their underlying 
muscle fibres and can be seen to run the length of the muscles fibres (Figure 3A, 3C). 
In comparison, capillaries in the Taiwanese SMA gastrocnemius muscle only rarely 
display a close, parallel association with their underlying muscle fibres (Figure 
3B,D) and instead appear as shortened, isolated vessels lacking the regular 
arrangement expected in the tissue (Figure 3D). The phase contrast images captured 
(Figure 3A,B) confirm that the capillaries compared from both the control and 
Taiwanese SMA mice are from regions of the muscle where fibres are sectioned in a 
longitudinal plane. This ensures that the differences observed between the control 
and Taiwanese SMA capillary beds are not due to comparison between muscle 
regions of different fibre orientation. 
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Figure 3 – Alignment of capillaries with underlying muscle fibres is altered in 
late symptomatic Taiwanese SMA mice. Representative phase contrast images of 
muscle fibres from P11 control (A) and SMA (B) gastrocnemius muscles and 
PECAM 1 labelled capillaries directly overlying the corresponding phase captured 
muscle fibres (C, D). Images are 20x magnification. Scale bar equals 50µm.  
 
4.3.1.3 Increase in capillary calibre in late symptomatic Taiwanese SMA mice  
When examining the structure of the capillary bed of TVA muscles in more detail the 
calibre of capillaries in SMA muscle was found to be increased in comparison to 
control littermates. As the capillary bed of the gastrocnemius muscle had been found 
to possess similar decreases in density and alterations in arrangement as the TVA 
muscle, capillary calibre in the sectioned gastrocnemius muscle was measured. 
Capillary calibre was measured in longitudinal portions of the gastrocnemius muscle. 
The orientation of muscle fibres was confirmed by viewing the muscle under phase 
contrast before capturing the PECAM 1 labelled fluorescent images of the capillary 
bed. When quantified the calibre of capillaries in Taiwanese SMA gastrocnemius 
muscle was significantly greater in comparison to control littermates (P<0.05, 
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unpaired, two-tailed, students t-test). On average control capillaries were 
approximately 1.4µm in diameter, while Taiwanese SMA capillaries were 
approximately 1.6µm (Figure 4A), representing a significant average 14% increase in 
capillary calibre in Taiwanese SMA mice (P<0.05, unpaired, two-tailed, t test). 
When individual capillary calibres were presented in scatter plot format a slightly 
wider distribution of calibres was evident in the Taiwanese SMA muscle when 
compared to controls. This suggests a greater degree of variation in the diameter of 
SMA capillaries than control vessels. While this spread is not as great as was 
observed in the LALc muscle (Figure, Chapter 2), it shows a similar trend with 
Taiwanese SMA capillaries skewed towards larger diameters. In comparison to the 
large number of capillaries measured in the LALc muscle, 1650 profiles from ≥6 
muscles, far fewer capillaries were available for measurement in the gastrocnemius 
muscle. This is due to the use of sectioned tissue rather than whole mount muscle. 
 
Figure 4 – Increased capillary calibre in P11 Taiwanese SMA gastrocnemius 
muscle. (A) Bar chart (mean ±s.e.m) quantification of capillary calibre in the 
gastrocnemius  muscle of P11 SMA Taiwanese mice (black bar) and control 
littermates (white bar). Unpaired, two-tailed t-test, * = P<0.05. N≥181 profiles from 
≥6 muscles from ≥3 mice for each bar. (B) Scatter plot of capillary calibres showing 
distribution of calibres for each condition. 
PhD The University of Edinburgh 2014 
  180 
4.3.2 Treatment with SAHA ameriolates the capillary bed defects observed in 
late symptomatic SMA mice 
Identifying and characterising the same defects in the capillary bed of P11 late 
symptomatic Taiwanese SMA gastrocnemius muscle as we previously described in 
the cranial and TVA muscles, presented the opportunity to investigate the impact of 
SMA therapeutics on the capillary defect. In comparison to the cranial and TVA  
muscles, the muscles of the hindlimb are easy to identify and dissect intact. This 
allowed for the collection of skeletal muscle from mice undergoing drug trials in 
another lab. For this investigation the particular drug of choice was the histone 
deacetylase inhibitor (HDACi) suberolynalidehydroxamic acid (SAHA), which has 
been shown to increase Smn protein levels two-fold in P11 late symptomatic 
Taiwanese SMA gastrocnemius muscles (Mutsaers et al., 2011). Mice were treated 
twice daily from birth with a 2.5mg/kg dosing regimen. At P11 mice were sacrificed 
and skeletal muscles were collected for both morphological and molecular analysis. 
Having examined the morphological defects in the capillary bed in detail, the 
morphology of Taiwanese SMA skeletal muscle treated with SAHA was analysed 
first, starting with the most striking defect; the decrease in capillary density. 
 
4.3.2.1 Increase in capillary density in SAHA treated Taiwanese SMA mice 
When compared to control littermates, capillary density in P11 late symptomatic 
Taiwanese SMA gastrocnemius muscle was reduced by 81% (P<0.0001, unpaired, 
two-tailed, students t-test) (Figure 2). When Taiwanese SMA mice were treated 
twice daily with 2.5mg/kg SAHA the capillary density appeared, by eye, to be 
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improved in comparison to DMSO treated SMA mice (Figure 5B,C). When 
quantified the capillary density of SAHA treated Taiwanese SMA gastrocnemius 
muscle was 52% of the density measured in control littermates (Figure 5D). This 
represents a significant (P<0.05, One Way ANOVA with Tukey post hoc test) 2.6 
fold increase in capillary density when compared to DMSO treated Taiwanese SMA 
gastrocnemius muscle (Figure 5D). This suggests that treatment with the HDAC 
inhibitor SAHA is capable of significantly (P<0.05, One Way ANOVA with Tueky 
post hoc test) improving capillary density in Taiwanese SMA skeletal muscle. 
 
Figure 5 – Treatment with SAHA increases capillary density in late 
symptomatic Taiwanese SMA mice. Representative micrographs of PECAM 1 
labelled capillary bed in the gastrocnemius muscle of P11 control (A), SMA (B) and 
SAHA treated SMA (C)Taiwanese mice. Images are 20x magnification. Scale bar 
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equals 50µm. (D) Bar chart (mean±s.e.m) quantifying capillary density in P11 
gastrocnemius muscle of control, SMA and SAHA treated SMA Taiwanese mice. 




4.3.2.2 Improvement in capillary and muscle fibre alignment in SAHA treated 
Taiwanese SMA mice 
Having established that treatment with SAHA is capable of increasing capillary 
density in Taiwanese SMA skeletal muscle (Figure 5), the effect of SAHA treatment 
on other morphological defects in the capillary bed was then investigated.  
The capillaries within P11 late symptomatic Taiwanese SMA gastrocnemius muscle 
displayed a more disorganised association with their underlying muscle fibres than 
their control counterparts (Figure 3). With capillaries in control muscle displaying a 
regular, parallel arrangement while capillaries in SMA muscle showed little 
association with muscle fibre orientation and a more dispersed vessel arrangement 
(Figure 3). A small improvement in the arrangement of capillaries could be seen by 
eye in Taiwanese SMA skeletal muscle treated with SAHA (Figure 6). In these 
muscles, a greater number of capillaries were observed running in parallel with their 
underlying muscle fibres (Figure 6C). This suggests that treatment with SAHA not 
only increases capillary density in skeletal muscle but also improves the overall 
architecture of the capillary bed. A key feature of capillary bed architecture is the 
structure of the vessels themselves, in particular capillary diameter, a feature we 
know to be affected in SMA skeletal muscle. Along with delivering nutrients, 
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capillaries are involved in gas exchange across their vessel walls. The surface area 
available to take part in this exchange is directly proportional to the diameter of the 
vessel. Large vessels will have a smaller surface area available for this exchange than 
several smaller vessels. Alterations to the diameter of capillaries will impact upon the 
area available for gaseous exchange in the tissue. 
 
Figure 6 – Treatment with SAHA improves the relationship between capillaries 
and their underlying muscle fibres. Representative phase contrast micrographs of 
control (A), SMA (B) and SMA mice treated with SAHA (C). Representative 
micrographs of the PECAM 1 labelled control (D), SMA (E) and SMA mice treated 
with SAHA (F) capillaries directly overlying the corresponding phase captured 
muscle fibres. Images are 20x magnification. Scale bar equals 50 µm. 
 
4.3.2.3 Restoration of capillary calibre in SAHA treated Taiwanese SMA mice  
Capillary calibre was greater by 14% in P11 late symptomatic Taiwanese SMA 
gastrocnemius capillaries in comparison to control vessels (Figure 4). Capillary 
calibre in SAHA treated Taiwanese SMA gastrocnemius muscle was on average 
1µm. This is a significant (P<0.001, One Way ANOVA with Tukey post hoc test) 
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40% reduction in comparison to the 1.6µm average calibre recorded in DMSO 
treated Taiwanese SMA gastrocnemius muscle. This suggests that along with the 
increase in capillary density and improvements in capillary bed architecture, 
treatment with SAHA restores capillary calibre in P11 late symptomatic Taiwanese 
SMA skeletal muscle. 
 
Figure 7 – Treatment with SAHA restores capillary calibre in P11 Taiwanese 
SMA mice. Figure 4 - (A) Bar chart (mean ±s.e.m) quantification of capillary calibre 
in the gastrocnemius  muscle of P11 SMA Taiwanese mice (black bar) control mice 
(white bar) and SMA Taiwanese mice treated with SAHA (grey bar).One Way 
ANOVA, with Tukey post hoc test,  * = P<0.05, ***P<0.0001. N≥181 profiles from ≥6 
muscles from ≥3 mice for each bar. (B) Scatter plot of capillary calibres showing 
distribution of calibres for each condition. 
 
4.3.3 Measuring protein levels of the key endothelial marker, PECAM 1, is a 
reliable means of assessing capillary density 
Along with the fixed gastrocnemius muscle collected for morphological analysis of 
the capillary bed, fresh frozen quadriceps muscle were also collected and shipped to 
Edinburgh for analysis. This provided the opportunity to assess the capillary bed of 
skeletal muscle using molecular techniques, in particular quantitative fluorescent 
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western blotting. Initially, the accuracy and reliability of this method for assessing 
capillary density had to be determined. 
4.3.4. Significant decrease in PECAM 1 protein levels in late symptomatic 
Taiwanese SMA mice 
Throughout this work PECAM 1 has been successfully used to visualise the capillary 
bed of skeletal muscle, in both flat muscles of the body wall and the gastrocnemius 
muscle of the hindlimb. Given the reliability of the endothelial marker PECAM 1 
(primary antibody R&D Systems Cat. No. AF3628) to label the capillary bed in a 
variety of skeletal muscles, it was chosen to conduct western blot analysis of the 
quadriceps muscles using this antibody. 
Western blots for the PECAM 1 protein in quadriceps muscles of P11 late 
symptomatic Taiwanese SMA and control littermates showed abundant levels of the 
PECAM 1 protein in control quadriceps and reduced levels in SMA muscles (Figure 
8). When quantified, in arbitrary fluorescence units, PECAM 1 protein expression in 
Taiwanese SMA quadriceps was found to be significantly (P<0.001, unpaired, two-
tailed, students t-test) reduced by 82% in comparison to control littermates (Figure 
8B). This reduction is almost identical to the 81% reduction in capillary density 
observed in the P11 late symptomatic Taiwanese SMA gastrocnemius muscles 
reported earlier in this chapter (Figure 2). This near identical measurement of 
capillary density by morphological means and molecular determination of PECAM 1 
protein presence suggests that measuring PECAM 1 protein levels in tissue is an 
accurate and reliable means of assessing capillary density. 
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Figure 8- Western blotting of PECAM 1 reliably detects reductions in skeletal 
muscle capillary density. (A) Western blot of PECAM 1 (~130kDa) and β Actin 
(~42kDa) of P11 Control and Taiwanese SMA quadriceps muscles. A western blot 
was carried out to measure the expression of the endothelial cell junctional protein 
PECAM 1. An antibody against PECAM 1 was used to probe protein samples 
extracted from P11 quadriceps muscles. In the control sample a strong band was 
detected at approximately 130kDa, the molecular weight of PECAM 1 protein. In the 
SMA sample a fainter band was present at 130kDa. β Actin was used as a loading 
control, with bands of similar intensity and weight present in both control and SMA 
samples.(B) Bar chart (mean±s.e.m) quantifying PECAM 1 expression in P11 
control (white bar) and SMA (black bar) quadriceps muscles. Unpaired, two-tailed t-
test, ***=P<0.0001. N 3 mice and n≥6 muscles for each bar. 
 
4.3.5 Treatment with SAHA significantly increases capillary density in late 
symptomatic Taiwanese SMA mice 
Initial western blots determined that measurement of PECAM 1 protein expression is 
a reliable means of assessing capillary density. Analysis of protein levels in SAHA 
treated quadriceps muscle revealed the sensitivity of the method in detecting changes 
in the capillary bed. 
On first inspection, a band of intermediate intensity was observed in the blot of 
Taiwanese SMA quadriceps muscles treated with SAHA when compared to control 
and DMSO treated SMA mice (Figure 9A). While not as intense as the band 
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produced in the control protein sample, the 130kDa band observed in the SAHA 
treated Taiwanese SMA sample was larger and brighter than that observed in the 
DMSO treated Taiwanese SMA mice (Figure 9A). PECAM 1 protein expression 
measured in arbitrary fluorescence units was significantly greater in SAHA treated 
Taiwanese SMA mice than in DMSO treated Taiwanese SMA littermates (P<0.05, 
One Way ANOVA with Tukey post hoc test). In comparison to DMSO treated 
Taiwanese SMA mice, PECAM 1 protein expression was increased by 2.6 fold in 
SAHA treated Taiwanese SMA mice. This is almost identical to the 2.5 fold increase 
in capillary density measured by morphological methods in SAHA treated Taiwanese 
SMA gastrocnemius muscles. Taken together these findings suggest that treatment 
with the HDAC inhibitor SAHA significantly improves the capillary defect observed 
in P11 late symptomatic Taiwanese SMA skeletal muscle. And also, that capillary 
density can be reliably and accurately assessed by quantitative fluorescent western 
blot measurement of PECAM 1 protein expression. 
 
Figure 9 – Treatment with SAHA increases PECAM 1 protein expression in 
Taiwanese SMA skeletal muscle. (A) Western blot of PECAM 1 (~130kDa) and β 
Actin (~42kDa) of the quadriceps muscles of P11 Control, SMA and SMA mice 
treated with SAHA. β Actin was used as a loading control, with bands of similar 
intensity and weight present in all three samples. Images for control and SMA 
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samples are reproduced from Figure 8. The band detected at approximate 130kDa 
in the SAHA treated SMA sample was of intermediate intensity, being brighter than 
the untreated SMA sample the band but not as intense as the band detected in the 
control sample.(B) Bar chart (mean±s.e.m) quantifying PECAM 1 expression in P11 
quadriceps muscle of control (white bar), SMA (black bar) and SMA mice treated 
with SAHA (grey bar).One Way ANOVA, with Tukey post hoc test, **=P<0.001, 
*=P<0.05.N 3 mice and n≥6 muscles for each bar. 
 
4.3.6 Treatment with the novel HDACi JNJ produces a small but not 
significant improvement in capillary density 
These investigations highlighted the beneficial effects of HDAC inhibitor treatment 
on the capillary defect observed in SMA skeletal muscle. The HDAC inhibitor used, 
SAHA, is an FDA approved drug and is currently involved in phase two clinical 
trials (Riessland et al., 2010). These factors make it a highly attractive therapeutic to 
investigate. Another potential HDAC inhibitor of interest is the novel HDAC 
inhibitor JNJ, which is far more potent in action than SAHA. To investigate the 
effects of this novel HDAC inhibitor on the capillary defects in SMA skeletal 
muscle, the TVA muscle of JNJ treated mice were collected and analysed. 
The TVA muscle from P5 early symptomatic JNJ treated Taiwanese SMA mice, 
DMSO treated Taiwanese SMA mice and their control littermates were dissected and 
the capillary bed labelled with the fluorescently labelled GSL -1 isolectin. Capillary 
density of the TVA muscle was then measured as previously described (Chapter 2). 
Initial observations of the stained capillary bed revealed a reduction in capillary 
density in Taiwanese SMA TVA muscle when compared to control littermates 
(Figure 10B,C). When quantified, capillary density in Taiwanese SMA mice was 
reduced by 30% in comparison to control littermates (Figure 10A). Inspection of the 
PhD The University of Edinburgh 2014 
  189 
JNJ treated Taiwanese SMA TVA muscle revealed no readily observable difference 
in the capillary bed when compared to DMSO treated Taiwanese SMA muscle, with 
JNJ treated muscle showing no real improvement in organisation or arrangement. 
Capillary density in the JNJ treated Taiwanese SMA TVA muscle also appeared to 
be unaffected. When analysed capillary density in JNJ treated Taiwanese SMA TVA 
muscle was found to be 6% greater than that recorded in DMSO treated SMA 
muscle, a small but not significant increase in capillary density (ns, One Way 
ANOVA with Tukey post hoc test).  
 
Figure 10 – Treatment with JNJ provides a small but not significant 
improvement in skeletal muscle capillary defects. (A) Bar chart (mean±s.e.m) 
quantifying capillary density in P5 TVA muscle of control (white bar), SMA (black 
bar) and SMA Taiwanese mice treated with JNJ (grey bar). One Way ANOVA, with 
Tukey post hoc test, **=P<0.001, ns= no significant difference. Representative 
micrographs of PECAM 1 labelled capillary bed of the TVA muscle of P5 control (B), 
SMA (C) and SMA mice treated with JNJ (D). Images are 20x magnification. Scale 
bar equals 50µm. 
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4.4 Discussion  
The findings of this chapter show that ubiquitously increasing Smn protein levels via 
treatment with the HDAC inhibitor SAHA ameliorates the skeletal muscle capillary 
defect in SMA mice. Initially the results of this chapter show that the skeletal muscle 
capillary bed of SMA hindlimb muscles show a similar reduction in capillary density 
and display similar alterations to the architecture of the bed as flat muscles from the 
body wall. Taken together with the results of earlier chapters this work confirms that 
the capillary defect we observe in SMA mice is present in muscle tissue regardless of 
fibre type or body position. 
Secondly these findings show that measuring tissue levels of the endothelial marker 
PECAM 1 is a sensitive and robust means of assessing capillary density. Quantitative 
fluorescent western blotting techniques detected an approximately 82% reduction in 
the levels of the endothelial marker PECAM 1 in SMA quadriceps muscles. This 
reduction in PECAM 1 protein is almost identical to the approximately 81% 
reduction in capillary density observed in SMA gastrocnemius muscles when 
capillary density was analysed morphologically by PECAM 1 immunostaining. 
When analysing SAHA treated tissue, blotting was able to detect a two fold increase 
in PECAM 1 levels. The same two fold increase in density that was determined by 
morphological analysis of the gastrocnemius muscle. These data suggest that 
quantitative fluorescent western blotting of PECAM 1 protein is a sensitive and 
reliable means by which to assess capillary density in tissue. Blotting for PECAM 1 
can be used not only to confirm morphological assessments of capillary density but 
given the reliable and robust results it produces could also be used to assess tissue 
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capillary density independent of other assessment techniques. This may be of 
particular use to tissues which do not easily lend themselves to histological analysis. 
Thirdly this work shows that daily dosing with the HDAC inhibitor SAHA, which is 
known to increase SMN levels two fold in muscle (Mutsaers et al., 2011), increased 
capillary density and improved the architecture of the skeletal muscle capillary bed. 
This increase in capillary density was observed when hindlimb muscles were 
assessed both morphologically and molecularly.  A 2.6 fold increase in capillary 
density was observed in the sectioned gastrocnemius muscles of SAHA treated SMA 
mice when compared to DMSO dosed SMA mice. A similar 2.5 fold increase in the 
protein levels of the endothelial marker PECAM 1 in SAHA treated SMA 
quadriceps muscles when compared to DMSO dosed SMA quadriceps was also 
observed. This increase in capillary density is directly proportional to the increase in 
Smn levels previously reported by the same SAHA dosing regimen (Riessland et al., 
2010, Mutsaers et al., 2011) and suggests that the severity of the capillary defect is 
directly linked to the level of Smn protein in muscle. 
SAHA treatment was also shown to improve the architecture of the SMA skeletal 
muscle capillary bed. In SMA gastrocnemius muscle the arrangement of the capillary 
bed was found to be altered. SMA capillaries showed poor alignment with 
underlying muscle fibres and had larger calibre than control capillaries, both 
alterations that have been reported in previous chapters in the flat muscles of the 
body wall. Here it was seen that treatment with SAHA improved these alterations, in 
particular rescuing the enlarged calibre of SMA capillaries. The improvement of 
these alterations by SAHA treatment, which increases Smn protein levels, suggests 
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that active molecular signalling downstream of Smn regulates various aspects of 
capillary morphology. 
Lastly it was observed that treatment with the novel HDAC inhibitor JNJ produced a 
small but not significant increased in capillary density in the transverses abdominus 
(TVA) muscle. Based on its potency (Delue et al., 2009) and ability to significantly 
increase the levels Smn protein in vitro and in vivo (Schreml et al., 2013) we 
hypothesised that JNJ treatment would improve the capillary defect in SMA mice.  
While JNJ treatment resulted in a 2 % increase in capillary density of TVA in 
Taiwanese SMA mice this was not significantly different from the  29% density seen 
in DMSO treated SMA mice. Failure of JNJ treatment to significantly improve the 
capillary defect may be due to the shorter JNJ treatment regimen determined by the 
earlier time point at which the animals were sacrificed in the JNJ study (P5) in 
comparison to the SAHA study (P10). 
4.4.2 Linking Smn and the vasculature 
The results of this chapter suggest that increasing Smn levels ameliorates the 
capillary bed defect observed in SMA skeletal muscle. This suggests a link between 
Smn and the signals which control the development and growth of capillaries. As 
previously described in earlier chapters (Discussion of Chapter 2), many of the 
signals which control vascular development are also used by the nervous system and 
vice versa. This cooperative use of patterning, outgrowth and developmental signals 
between the two systems is termed the neurovascular link. Given this evidence that 
neural and vascular systems share key signalling molecules and growth factors 
during development, it is reasonable to suggest that Smn, which has been shown to 
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play key roles in the development of skeletal muscle (Fidzianska and Wado 1990, 
Shafey et al., 2008, Rajeda et al., 2007, Stahas et al., 2008, Walker et al., 2008,Lee et 
al., 2011, Mutsaers et al., 2011) may also share molecular mechanisms with the 
vascular system. One potential candidate for such interaction is the Notch signalling 
pathway. 
The Notch receptor and its ligands form a cell-cell communication pathway which 
plays vital roles in the development of the nervous system (Louvi and Artavanis-
Tsakonas 2006, Cau et al., 2008, Pierfelice et al., 2011) and in the regulation of 
angiogenesis in the vascular system (Carmeliet 2005, Bray 2006, Roca and Adams 
2007, Benedito et al., 2009, Ehling 2013). In both systems Notch signalling links the 
fate decision of one cell to those surrounding it. In the nervous system this is key in 
determining the neuronal or glial fate of progenitor cells during embryonic 
development (Louvi and Artavanis-Tsakonas 2006). In the vascular system Notch 
signalling determines the fate of endothelial cells at the leading edge of the growing 
vascular front (Ehling 2013), pushing cells to an actively sprouting “tip cell” nature 
or a quiescent “stalk cell” (Benedito et al., 2009), controlling where new vessels arise 
and so determining formation of the vascular network. Investigations have shown 
that disruption of notch signalling can drastically alter the formation of the 
developing vascular network (Benedito et al 2009). 
Over-activation of the Notch signalling pathway has been shown to result in reduced 
branching of vessels, a delay in the extension of the growing vascular front to reach 
its target and an impairment in the structural organisation of vessels within networks 
(Benedito et al., 2009). Importantly, a similar over-activation of the Notch signalling 
pathway has recently been reported in SMA. 
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In astroglioma cells transduced with a lentiviral shSMN construct, used to deplete 
Smn protein levels, the expression of the Notch ligand and its receptors were found 
to be increased (Caraballo-Miralles et al., 2013). Significantly, in SMNΔ7 SMA 
mice increased Notch signalling was observed in the motor neurons of the spinal 
cord (Caraballo-Miralles et al., 2013). This study suggests that decreased levels of 
Smn can result in over expression of the constituents of the Notch signalling pathway 
and over activation of the pathway itself. 
Taken together these studies suggest a possible link between Smn protein and the 
Notch signalling pathway, where decreased levels of Smn protein results in the over 
activation of the Notch signalling pathway (Caraballo-Miralles et al., 2013), which 
has been shown to cause drastic defects in angiogenesis (Benedito et al., 2009). 
4.4.3 Weaknesses of Study 
Although every attempt was made to ensure that this study was as robust as possible, 
there are areas of weakness that should be noted.  Ideally, Smn protein levels in the 
quadriceps muscles should have been measured along with PECAM 1 levels. Given 
the young age of the mice (P10) the muscles collected were particularly small in size. 
This meant that a relatively small volume (30µl) of RIPA buffer was used to isolate 
total protein from homogenised muscle. Once centrifuged this resulted in a small 
volume of sample, which only permitted enough blots to measure PECAM 1 and 
loading control (β Actin) levels to be measured. As the tissue for this study was 
generously provided by a group out with our lab which no longer ran SAHA mice 
trials, collection of more tissue to perform this experiment was not possible. 
However, we can be confident that Smn protein levels were increased in the tissue 
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we examined as the muscles we analysed were taken from the exact same mice 
which were shown to have a twofold Smn increase in adjacent hindlimb skeletal 
muscles in the study by Mutsaers et al., in 2011. 
Another point to note is the length of the JNJ trial. Ideally, to compare the 
effectiveness of SAHA and JNJ both HDAC inhibitor treatment regimens should be 
the same. Again the tissue for this study was generously provided by the same group 
as the SAHA tissue, out with our lab. While their study encompassed a longer 
treatment window, they required later time point muscle tissue for their own work 
and analyses. However, the small improvement that we see, even with the shortened 
treatment regimen, suggests that given a lengthier treatment timeline JNJ could well 
have a significant effect on capillary density in SMA skeletal muscle. 
4.4.4 Conclusion 
From these results we can conclude that ubiquitously increasing Smn levels using the 
HDAC inhibitor SAHA significantly increases capillary density and improves the 
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Chapter 5: Endothelial cell culture and retinal vasculogenesis in a mouse 
model of SMA 
5.1 Introduction 
In the previous chapters of this thesis we have identified and characterised a severe 
defect in the capillary bed of skeletal muscle and the spinal cord, in a variety of 
mouse models of SMA. While our studies involving HDAC inhibitor treatment of 
SMA mice have suggested a link between Smn protein levels and the severity of 
these defects, the underlying mechanism responsible for the capillary defects 
observed has not been established. In this chapter we present a selection of 
experimental paradigms which will help to determine the root cause of capillary 
defects in SMA.  
Investigations of vascular development and control have been undertaken using a 
range of experimental approaches in a variety of animal models. Classical 
observations routinely utilise the transparent nature of chick embryos and xenopus 
larvae (Clark, 1918; Clark, 1939) to study the formation and growth of vessels in fine 
detail (Clark, 1919; Clark, 1939). Similar advantages are found in the transparent 
zebrafish embryo (Dodd et al., 2000) where organ and tissue development are well 
characterised and understood. This combined with the relative ease of genetic 
manipulation and protein knockdown, resulting in a large mutant zebrafish library, 
makes zebrafish a popular and advantageous model for the study of vascular 
development. While a zebrafish model of SMA is available (McWhorter et al., 
2005), we have chosen to utilise experimental approaches which will allow us to 
investigate vascular development in our chosen model species, the mouse.  
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First, Taiwanese SMA and control endothelial cells will be examined in culture. This 
will establish if the defects in structure and number that we observe at the vessel 
level are a result of inherent defects in the growth and morphology of the constituent 
cells of capillaries themselves. Second, the capillary network of the retina in 
Taiwanese SMA and control littermate mice will be investigated. In mice the entire 
capillary network of the retina forms postnatally, making it a particularly useful 
preparation for investigating angiogenesis and the signalling pathways involved. 
Together these investigative tools should provide insight into the cause of capillary 
defects in SMA. 
5.1.2 Endothelial Cells 
All blood vessels are lined by a monolayer of endothelial cells. In the larger veins 
and arteries, blood vessel walls are composed of multiple layers of cellular and 
extracellular materials, while capillary walls are composed solely of endothelial cells 
covered by a loose scattering of pericytes (Figure 1).  
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Figure 1 – Figure taken from Cleaver & Melton 2003 to show the difference in vessel 
wall composition between arteries, veins and capillaries. 
 
This endothelial lining is important in all vessels, regulating vascular homeostasis via 
the release of vasodilating and vasoconstricting factors, with the balance of these 
factors ensuring appropriate organ perfusion. Alterations to normal endothelial 
function is critical in many pathological conditions and can lead to the development 
of atherosclerosis, thrombosis and vasospasm (Shimokawa, 1999). Any defects in the 
endothelium will be particularly pertinent in capillaries, which are comprised almost 
solely of endothelial cells. 
Endothelial cells are highly diverse showing regional specifications depending on the 
size of the vessel and the organ their vessels are found in (Cleaver & Melton, 2003). 
The endothelial cells found in capillaries are flat and elongated while the endothelial 
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cells of large vessel endothelium are polygonal and much thicker (Thorin & Shreeve, 
1998). In skeletal muscle, brain, spinal cord, heart and lungs endothelial cells form a 
continuous endothelium with no gaps between cells, forming continuous capillaries. 
In endocrine and exocrine glands and the small intestine 80-100nm gaps called 
fenestrations are present between endothelial cells resulting in fenestrated capillaries. 
Discontinuous capillaries, such as the sinusoids of the liver, have large lumens, 
numerous fenestrations and almost no basal lamina (Pasqualini et al., 2002). These 
differences in endothelial cell association reflect the different functions of the tissue 
the capillary bed resides in. Continuous capillaries are found in the nervous system 
where they contribute to the formation of the brain and spinal cord blood barriers to 
protect the nervous system from toxic substances. While the liver readily involved in 
filtering the blood, requires discontinuous, permeable sinusoids. These tissue specific 
differences in the capillary bed are a result of signals sent from the surrounding 
tissue to the endothelial cells. 
Evidence of this tissue micro-environment signalling to endothelial cells comes from 
heterotopic transplantation experiments in quail embryos. Blood vessels taken from 
neural tissue of very young embryos, which had yet to be vascularised, was 
transplanted into host chick embryos and mesoderm which had yet to be vascularised 
was grafted into the brain of chick embryos. Peripheral vessels which grew into the 
grafted neural tissue developed the morphology and histology of the blood brain 
barrier, while neural vessels growing into a graft of mesodermal tissue lost their 
barrier characteristic (Stewart et al., 1981). This suggests that the structural 
characteristics of endothelial cells develop in response to factors in their local 
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environment. Similar findings were reported in a later study using heart tissue 
grafting in mice (Aird et al 1997). 
Von Willebrand Factor (vWF), a binding protein important in platelet adhesion, is 
expressed solely by endothelial cells, although not by all endothelial cells. The 
differential expression of vWF by endothelial cells was revealed by transgenic mice 
in which the vWF gene was coupled to a LacZ reporter. vWF expression was 
observed in the brain, heart and skeletal muscle endothelial cells but not a variety of 
other tissues including in the liver, spleen, lung or kidney (Aird et al., 1997). These 
findings show endothelial cell specialisation at the gene expression level, alongside 
the structural specialisations described earlier in the introduction (Thorin & Shreeve, 
1998; Pasqualini et al., 2002). In further experiments using this mouse line, the heart 
of a donor mouse was transplanted subdermally into the ear of a host mouse. The 
presence of the heart in the ear resulted in the LacZ expression of vWF in the 
auricular blood vessels of the host that was not observed prior to transplant. This 
suggests that not only are the structural characteristics of endothelial cells influenced 
by their surrounding environment but that gene expression in endothelial cells is 
determined by their surrounding environment. Not only can the surrounding tissue 
environment influence the nature of endothelial cells, it can also regulate vessel 
architecture and organisation. This is achieved by signalling through endothelial cells 
via local angiogenic agents, specifically the VEGF family (D’Amore & Ng, 2002). 
Vascular Endothelial Growth Factor (VEGF) regulates multiple endothelial cell 
behaviours including the initial patterning of endothelial cells in the embryo, the 
recruitment of endothelial cells during wound healing and in tumour angiogenesis, 
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along with the maintenance of endothelial cells in normal tissue (Ferrara & Alitalo, 
1990). Locally secreted VEGF signals have also been shown to drive endothelial cell 
development (Stone et al., 1995; Ng et al., 2001; Mukouyama et al., 2002). 
VEGF from the alveoli of the lungs has been shown to pattern pulmonary vasculature 
formation (Ng et al., 2001). In situ hybridisation for the VEGF188 isoform in the 
lungs revealed high levels of expression in Type II alveolar epithelial cells. Targeted 
deletion of the VEGF188 isoform resulted in defects in the formation of the 
pulmonary vasculature, including a reduction in the number of capillaries in the lung 
and a miss-localisation of larger vessels which were found uncharacteristically close 
to the pleural surface (Ng et al., 2001). This reduced capillary number and 
disorganisation of the vascular network is reminiscent of the capillary defects we 
have previously described in the skeletal muscle (Chapter 2) and spinal cord 
(Chapter 3) of SMA mice. Similar patterning of blood vessels by local VEGF is 
observed in the skin (Mukouyama et al., 2002). 
Mukouyama and co workers observed that arteries were aligned with peripheral 
nerves in embryonic mouse limb skin. To determine if this alignment was the result 
of coordinated nerve and vessel growth several mutant mouse lines were examined. 
Neurogenin1/Neurogenin2 null mice lacking peripheral sensory nerves showed 
improper arteriogenesis, with altered vessel morphology and a reduced expression of 
arterial markers. This suggests that peripheral arteries and nerves follow the same 
pattern of growth. To test this potentially linked system further, the pattern of limb 
arteries were studied in mice with mutations in the axon guidance gene Semaphorin 
3A. These mice displayed disorganised peripheral nerve growth but despite this 
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disorganisation the blood vessels still aligned with the nerve (Mukouyama et al., 
2002). This suggests that signals secreted from the nerves pattern blood vessel 
growth in skin. Similar to the lungs this signal was identified by immunological, RT-
PCR and in vitro cell experiments, as VEGF (Mukuoyama et al., 2002). 
Taken together these experiments show that the tissue surrounding endothelial cells 
is important in determining endothelial cell characteristics, gene expression and the 
structure of the vessels they form. Studies have revealed that endothelial cells are not 
passive recipients of external tissue signals but actively signal their local tissue 
environment. Endothelial cells produce multiple growth factors and cytokines and 
possess a variety of cell-surface molecules (Vapaatalo & Mervaala, 2001). All of 
which suggest that endothelial cells are readily capable of participating in 
communication with their surrounding tissues. In particular, disruption of endothelial 
derived VEGF results in defects in the surrounding organ (Kimato et al., 1997; Zeng 
et al., 1998). 
Loss of VEGF signalling has been shown to cause defects in the structure and 
function of the kidney (Kitamoto et al., 1997; Gerber et al., 1998). Blocking 
endogenous VEGF signalling in the kidney epithelium causes a reduction in nephron 
number (Gerber et al., 1998) and abnormal glomerular structure which resulted in 
systemic oedema (Kitamoto et al., 1997). Overexpression of endothelial VEGF has 
been shown to be just as damaging to the organisation and structure of the lung 
(Zeng et al., 1998). Enhanced VEGF expression in the developing lung endothelium 
resulted in an increase in the size of the main pulmonary vessels, suggesting 
enhanced vasculogenesis. However, the branching morphology of the lung was 
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adversely affected, with a decrease in the number of terminal buds along with an 
inhibition of alveolar cell differentiation (Zeng et al., 1998). These studies suggest a 
role for endothelial cell signalling in the normal development of the kidney and 
lungs. The necessity of endothelial cells in the normal functioning of multiple organs 
including the heart (Rouleau et al., 1993; Brutsaert et al., 1998), pancreas (Lammert 
et al., 2001) and liver (Matsumoto et al., 200; LeCouter et al., 2003) has been 
reported in multiple studies. Importantly, defects in the structure and function of 
these organs have been reported in SMA patients (Rudnick-Schoneborn et al., 2008; 
Bowerman et al., 2012) and mouse models of the disease ( Vilte et al., 2004; Bevan 
et al., 2010; Heier at al., 2010; Hau et al., 2011; Shababi et al., 2010, Bowerman et 
al., 2014). 
Defects in both the structure (Rudnick-Schoneborn et al., 2008; Shababi et al., 2010) 
and coordinated beating (Heier et al., 2010; Bevan et al., 2010) of the heart are 
commonly reported in SMA patients and mice. 75% of Type I patients display atrial 
and septal defects and a high incidence of hypoplastic left heart syndrome (Rudnik-
Schoneborn et al., 2008). Arrhythmia and bradycardia are also reported in mice 
models of the disease (Heier et al., 2010) with this impaired function leading to early 
heart failure (Bevan et al., 2010). Similar defects in structure and function are 
reported in zebrafish and mice where the endothelium of the heart, the endocardium, 
has been disrupted (Strainer et al., 1996). 
Deletion of the endocardium in zebrafish embryos disrupts normal cardiac 
development and results in defects of the heart chambers, with smaller ventricles and 
dilated atria in the mutant fish. A reduced contractility of the heart is also noted in 
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these mutants (Stainer et al., 1996). This suggests that the endocardium is important 
for not only the proper development of cardiac structure but also cardiac function. 
This role of the endocardium in cardiac contractility is also suggested by studies 
involving physical disruption of the endocardium in mice (Roulea et al., 1993). 
When the endocardium of mouse hearts was physically disrupted, by injection of 
Triton-X-100 into the coronary arteries of the heart, the contractile properties of the 
ventricular papillary muscles were affected (Roulea et al., 1993). Both the duration 
and strength of papillary muscle contraction was reduced, suggesting that the 
endocardium is capable of modulating the contractility of the myocardium. 
Taken together these studies suggest that the endocardium is critical in ensuring the 
proper structural development and normal functioning of the heart. Any defects in 
the endothelial cells, which form the endocardium, could precipitate structural and 
functional defects in the heart. Given the defects we have observed in SMA 
capillaries it is possible to suggest that defects of their comprising endothelial cells 
could be a contributing factor to the structural and functional defects seen in SMA 
patients and mice models. Endothelial cells are also crucial in the development of the 
pancreas and liver, two other organs that display abnormalities in SMA (Vitte et al., 
2004; Hau et al., 2011; Bowerman et al., 2012; Bowerman et al., 2014). 
Severe impairment of liver development is seen in mice where the exon 7 element of 
murine Smn has been specifically deleted in the liver (Vitte et al., 2004). Atrophy of 
the liver was evident along with a failure of the tissue to regenerate which resulted in 
late embryonic death (Vitte et al., 2004). These findings suggest that Smn is essential 
for the normal development and growth of the liver. Similar defects regarding 
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development and growth of the liver are observed in mutant mice lacking endothelial 
cells in the liver (Matsumoto et al., 2001). 
In mutant mice where endothelial cells were prevented from forming in the liver the 
overall growth of the organ was reduced. Defects were also observed at the cellular 
level when hepatocytes failed to differentiate (Matsumoto et al., 2001). 
Communication between endothelial cells and differentiated hepatocytes is essential 
for the release of growth and survival factors (LeCouter et al., 2003). Defects in the 
release of circulating factors could have potentially widespread systemic effects, 
such as those caused by the pancreatic defects observed in SMA (Bowerman et al., 
2012). 
In 2B model SMA mice, an imbalance in pancreatic cell type is observed, with a high 
number of glucagon releasing α cells resulting in a reduced number of insulin 
producing β cells (Bowerman et al., 2012). Along with this alteration in the cellular 
composition of the pancreas several defects in glucose homeostasis were also 
reported including hyperglycemia, hyperglucogonemia and glucose resistance 
(Bowerman et al., 2012). Importantly similar cellular and metabolic defects are also 
found in SMA patients (Bowerman et al., 2012). Endothelial cells have also been 
reported to be particularly important in the proper development of pancreatic cells 
(Lammert et al., 2003). Removal of abdominal aorta region endothelium in 
developing Xenopus embryos resulted in the absence of pancreatic gene expression 
in the mesoderm and a failure of pancreatic cells to differentiate (Lammert et al., 
2003). 
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Taken together these studies imply that the endothelium is a source of developmental 
signals in organogenesis. This suggests that as well as ensuring appropriate nutrient 
delivery and waste removal, the endothelium, and its constituent endothelial cells, is 
a key modulator of organ formation and development. These studies suggest that 
systemic impairment in the functioning of the endothelium could cause widespread 
organ defects, a situation that is observed in multiple mouse models of SMA 
(Hamilton & Gillingwater 2013) and is increasingly apparent in SMA patients (Dahl 
et al., 1975; Musch et al., 1975; Crawford et al., 1998; Rudnick-Schonebon et al., 
2008; Araujo et al., 2009; Bowerman et al., 2012).  
Our previous findings have detailed a dramatic capillary defect in SMA mice in 
comparison to control littermates. Based on the knowledge that endothelial cells are 
the major cellular component of capillaries and on the evidence that perturbations in 
endothelial cells can cause organ abnormalities similar to those observed in SMA 
patients and animal models, we hypothesised that the form and function of 
endothelial cells could be altered in SMA. Therefore, endothelial cells were isolated 
from symptomatic Taiwanese SMA and control littermate mice and grown in culture. 
The morphology, growth and histological characteristics of the cells were analysed 
using immunohistochemical staining and fluorescent and light microscopy. SMA 
endothelial cells were found to express reduced levels of the Smn protein when 
compared to control endothelial cells. When compared to control endothelial cells, 
the morphology, growth rate and expression of the endothelial marker PECAM 1 in 
SMA endothelial cells was found to be no different. 
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5.1.3 The Retina 
The murine retina has long been the preferential experimental preparation for 
studying vascular development. This is due to the fact that the entire retinal 
vasculature develops postnatally, with the majority of vessel development occurring 
with the first two weeks of postnatal life (Blanks & Johnson, 1986). This postnatal 
development allows for the observation of vascularisation from its initial stages until 
completion. In addition to this, murine retinas are small and very thin, allowing for 
the visualisation of their entire vascular system in flat, whole mount preparations 
without the need for sectioning. Multiple studies have capitalised on the advantages 
of the retina to study vasculogenesis and angiogenesis in detail.  
The initial blood supply within the developing eye is a transient capillary network 
within the hyaloid. The hyaloids vascular network extends from the back of the eye, 
where the hyaloids artery emerges with the optic nerve, to the developing lens. This 
network of capillaries supplies the lens and the primary vitrous of the developing 
eye. In mice the hyaloid network forms at E10.5 and is completed by E13.5. By P16 
the entire hyaloids vessel network is completely regressed (Albè, et al., 2009). 
During this period of postnatal regression the vessels of the retina form. 
The blood vessels of the retina are arranged in two planar layers and formed by three 
stages of vascular differentiation (Connolly et al., 1988). In the initial phase the 
superficial layer of the retina is vascularised. This stage occurs between P0 and P10 
where retinal vessels begin to extend radially from the optic disc to the peripheral 
edge of the retina. Between P2 and P8 the growth of the vessels lags behind the 
growth of the retina and so the peripheral edge of the retina remains temporarily 
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avascular. By P10 the retina has reached its mature dimensions and the vessels 
extend to the edge of the retina. By this stage the vessels also display the 
characteristic radial arrangement seen in the retina (Connolly et al., 1988).  
In the second phase of development the vascularisation of the deeper retinal layers 
occurs. By P4 primordial vessels appear in the deeper layer of the retina. These 
primitive vessels are polygonal in appearance and so can be differentiated from the 
more mature superficial layer vessels which assumed a more radial appearance 
(Connolly et al., 1988).  
In the third phase of vascularisation the capillary network in the retina beings to 
mature. By P7 a primitive capillary network is readily observable in the nerve fibre 
layer of the retina. This primitive network is made purely of capillaries. As the 
capillary plexus matures the vessels are remodelled, with some vessel walls 
thickening to form arteries, arterioles, veins and venules and some vessels regressing. 
This process of remodelling then moves to the deeper layers of the retina to form 
mature vascular networks throughout the layers of the retina (Connolly et al., 1988). 
By P14 this remodelling is complete and the vascular network in the retina has the 
appearance of an adult vascular pattern. In this pattern a variety of vessel diameters 
are seen with large vessels radiating from the optic disc to the ora serrata with 
smaller vessels branching between them to form a highly arborised pattern. Although 
the retina retains this appearance into adult life remodelling of the retina vasculature 
is observed as late as P45 (Connolly et al., 1988). This highlights the dynamic nature 
of the retinal vasculature which can also be seen in the response of the retinal 
vasculature to pathology and disease. 
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As the vasculature of the retina forms in response to hypoxia and hypoxic signalling, 
any disruption of the oxic conditions of the eye results in drastic alterations in the 
retinal vasculature and can result in Retinopathy of Prematurity (ROP), a common 
cause of blindness in  premature infants (Dorrell & Friedlander, 2006). In humans, 
retinal vasculogenesis occurs during the second and third trimester and so can be 
incomplete in premature infants. Hyperoxia treatment is common in the care of 
premature infants, in an effort to ease respiratory distress. However, these high levels 
of oxygen can disturb normal retinal vascular development (Dorrell & Friedlander, 
2006) Hyperoxia blunts vessels and causes pre-existing vessels to regress. When the 
infant is returned to normal oxygen conditions this underdeveloped vasculature 
results in retinal hypoxia, which induces pathological neovascularisation (Madan & 
Penn, 2003). Without normal developmental regulation, these new vessels are 
structurally and functionally compromised and these defects eventually lead to 
retinal detachment and significant visual impairment (Patz, 1986).  As the 
developmental stage of the vasculature of the retina in newborn mice approximates 
that of premature human infants (Connolly et al., 1988), neonatal mice are an ideal 
system to model ROP. 
In mice models of ROP, newborn pups are subjected to hyperoxic conditions for the 
first 5 days of postnatal life. In these hyperoxic conditions the hypoxia normally 
experienced by the retina following increased neural activity does not occur and so 
the hypoxia induced VEGF expression that drives retina vascularisation is 
downregulated. As a result no central retinal vessels are formed (Smith et al., 1994). 
Once the mice are returned to normoxic conditions the under-perfused retinal tissue 
becomes overtly hypoxic. This extreme hypoxia induces a strong and uncontrolled 
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secretion of VEGF. This excessive VEGF expression leads to pathological 
neovascularisation in the retina, including the formation of vascular buds in the 
avascular vitrous humor of the eye (Smith et al., 1994). Pathological vessel growth is 
also observed in forms of Age-Related Macular Degeneration  (AMD: Saint-Geneiz 
& D’Amore, 2004). 
Exudative AMD is characterised by the pathological growth of vessels into the sub-
retinal space. These new vessels are particularly leaky in comparison to the retinal 
vasculature which possess a more barrier like nature given the position of the retina 
within the central nervous system (Connolly et al., 1988). The leaky nature of these 
invading vessels leads to the accumulation of blood and fluid in the posterior portion 
of the retina. This swelling eventually leads to detachment of the retina and the loss 
of vision (Saint-Geneiz &D’Amore, 2004). Alterations to the composition and 
structure of retinal vessels are also observed in Diabetic Retinopathy (Saint-Geneiz 
& D’Amore, 2004). 
Of the variety of ocular complications that arise in diabetes, Diabetic Retinopathy is 
classed as the most severe (Frank, 2004). In its earliest forms the condition is present 
in almost all Type 1 and Type 2 patients who have lived with the disease for 20 years 
(Frank, 2004). In the condition the structure and organisation of retinal blood vessels 
is altered. Vessels appear torturous and irregular is diameter, with thickened 
basement membranes. Vessels also show a loss of pericytes and an increase in 
permeability which results in multiple microaneurysms and haemorrhages which 
cause visual loss (Frank, 2004).  
PhD The University of Edinburgh 2014 
  211 
The pathological growth of vessels observed in these conditions results from 
interference in the fine control of vessel growth and development. Angiogenesis, the 
growth of new vessels, is a complicated, multi stage process with each stage 
requiring the control and interaction of numerous signalling systems.  In early 
angiogenesis, endothelial cells must respond to external proliferative growth factor 
and cytokine signals (Provis et al., 1997). These new endothelial cells must then 
organise themselves into a vessel like structure. This involves the finely controlled 
breakdown of the extracellular matrix (ECM: Stetler-Stevenson and Yu 2001) which 
the endothelial cells must then navigate through to reach their desired location. To do 
so the endothelial cells must communicate with ECM receptors and then utilise cell-
cell adhesion molecules to form primitive vessels (Ingber, 2002). These primitive 
vessels must then be remodelled to form the mature vascular network. This involves 
pruning of excess vessels (Ishida et al., 2003) and structural alterations of the 
remaining vessels, including thickening of the basement membrane and acquisition 
of appropriate mural cells (Das & McGuire, 2003). This process requires the 
interaction of multiple cell types and signalling pathways. Due to its multiple 
advantages, the retina provides an ideal preparation for the study of this complex 
control of vascular development, which involves the action of growth factors, 
signalling pathways and the influence of non vascular cells (Dorrell & Friedlander, 
2003). 
In addition to the crucial role of VEGF in initiating vascular development, numerous 
studies utilising the retina have identified a variety of growth factors which are also 
involved in initiating vascular development. Placental growth factor (PGF) (Feeny et 
al., 2003), platelet derived growth factor (PDGF) (Fruttiger et al., 1996) and basic 
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fibroblast growth factor (bFGF: Friedlander et al., 1995) have all been identified as 
key initiators of vascularisation. Along with this initiating role, growth factors also 
play a regulatory role in angiogenesis, in particular, insulin-like growth factor (IGF) 
which regulates VEGF signalling (Smith et al., 1999). Interruption of IGF action, by 
antagonism of the IGF-1 receptor, prevents the proliferation and migration of 
endothelial cells delaying retinal vascularisation (Smith et al., 1999) and resulting in 
a retinal phenotype similar to that observed in ROP (Hellstrom et al., 2001). In 
addition to growth factor signalling, several other signalling pathways are crucial to 
the formation and development of the retinal vasculature, in particular the Notch 
signalling pathway which controls angiogenesis (Krebs et al., 2000; Carmeliet 2005; 
Bray 2006; Hoffman & Iruela –Arispe 2007; Roca and Adams 2007; Benedito et al., 
2009; Ehling 2013;). 
Initial studies involving Notch mutant mice revealed the importance of Notch 
signalling in angiogenesis, with mice lacking the Notch 1recpetor displaying severe 
defects in angiogenic vascular remodelling (Krebs et al., 2000). These defects began 
embryonically with mutant embryos being able to form primary vascular networks 
but failing to remodel these putative structures into mature vascular networks (Krebs 
et al., 2000). Further studies investigating the localisation and distribution of the 
Notch 1 receptor ligands hinted at the complexity of the Notch signalling pathway 
(Hofman & Iruela-Arispe, 2007). The Notch 1 receptor has multiple ligands 
including Jagged 1 (Jag1) and Delta-like 4 (Dll4). Immunological analysis of their 
distribution during the postnatal development of the retinal vasculature revealed a 
widespread expression of Dll4 in the vasculature but a more restricted pattern of Jag1 
expression, (Hofman & Iruela-Arispe, 2007) suggesting distinct roles for the ligands 
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during angiogenesis. These ligands were later found to have opposing effects in 
angiogenesis. While Jag1 is highly pro-angiogenic, Dll4 inhibits endothelial tip cell 
sprouting (Benedito et al., 2009). Disruptions to the balance of these ligands results 
in drastic angiogenic defects (Benedito et al., 2009). 
Specific loss of the Jag1 ligand in endothelial cells results in a reduced retinal 
vasculature. In mice lacking endothelial Jag1 the area of retina covered by vessels 
was reduced and the vessel present had fewer branch points and a decrease in tip cell 
number at the growing angiogenic front (Benedito et al., 2009). Overexpression of 
Jag1 in endothelial cells promoted endothelial cell sprouting and increased the 
number of tip cells (Benedito et al., 2009). Similar alterations to the retinal 
vasculature are observed when the normal astrocyte population of the retina is altered 
(Fruttiger et al., 1996; Dorrell et al., 2002). 
In the embryonic retina, astrocytes emerge from the optic nerve and radiate to the 
peripheral edge of the retina forming a template which endothelial cells colocalise 
with and follow during their postnatal expansion across the retina (Dorrell et al., 
2002). When this astrocyte network is prevented from forming, the vascular network 
also fails to develop (Fruttiger et al., 1996). Conversely, excessive astrocyte number 
results in an overly dense vascular pattern (Dorrell et al., 2002). These findings 
highlight the importance of cells beyond the vascular system in normal retinal 
vascular development. 
Taken together these studies not only highlight the multitude of factors involved in 
initiating, controlling and regulating angiogensis in the retina, but they also 
emphasise how alterations in any single factor can result in drastic alterations to 
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normal vascular network formation and development. Interestingly many of the 
elements involved in retinal angiogenesis have been implicated in SMA (Caraballo-
Miralles et al., 2013) 
Alterations to the Notch signalling pathway have been reported in Smn deficient 
cells in vitro and in vivo. When Smn protein levels were reduced in astroglioma cells, 
using lentiviral shSMN,  the expression of the Notch receptor and it’s ligands  in the 
cells were found to be increased (Caraballo-Miralles et al., 2013). Importantly, a 
similar pattern of increased Notch pathway expression was also reported in vivo. 
When analysed, the motor neurons of SMNΔ7 SMA mice displayed increased levels 
of Notch signalling (Caraballo-Miralles et al., 2013).  This study suggests that 
decreased levels of Smn can result in over expression of the constituents of the Notch 
signalling pathway and over activation of the pathway itself, which has been shown 
to result in drastic angiogenic defects in the retina (Benedito et al., 2009). As well as 
this increase in signalling pathway activation, an increase in the number of glial cells 
is a commonly reported feature of SMA (Araki et al., 2003; Garcia-Cabezas et al., 
2004; Kuru et al., 2009; Caraballo-Miralles et al., 2013). 
Gliosis in the spinal cord has been reported in Type I and Type II SMA patients 
(Araki et al., 2003; Garcia-Cabezas et al., 2004; Kuru et al., 2009) and has also been 
reported in the SMNΔ7 mouse model of SMA (Caraballo-Miralles et al., 2013). If 
this increase in glial cell number is consistent throughout the nervous system, a 
significant impact on the retinal vasculature could be observed, given that both an 
increase and a decrease in astrocyte number can alter the formation and structure of 
the retinal vasculature (Fruttiger et al., 1996; Dorrell et al., 2002). 
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Our previous findings have shown a significant capillary defect in SMA skeletal 
muscle and spinal cord, in comparison to control littermate tissue.  Based on the 
advantages of the retina as an experimental tool we chose to investigate vascular 
development in SMA mice using the retina. Based on our previous findings of 
capillary defects in multiple tissues and the evidence that signalling pathways which 
control retinal vascular development are altered in SMA, we hypothesised that the 
retinal vasculature could be altered in SMA. Therefore, retinas were collected from 
Taiwanese SMA mice and control littermates at varying stages of disease 
progression. The development of the retinal vasculature was analysed using 
immunohistochemical staining and fluorescent microscopy.  Significant defects were 
observed in the form and extent of the vasculature of SMA mice in comparison to 
control retinas. These defects were observed at a presymptomatic disease timepoint 
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5.2 Methods 
5.2.1 Ethics Statement 
All animal experiments were approved by a University of Edinburgh internal ethics 
committee and were performed under license by the UK Home Office (Project 
License number 60/3891). 
5.2.2 Animal Husbandry 
(SMN2)2Hung Smn1
tm1Hung
/J mice (originally received from Brunhilde Wirth in 
Koln) on a congenic FVB background were maintained as heterozygous breeding 
pairs under standard SPF conditions in animal care facilities in Edinburgh. All 
animal procedures and breeding were performed in accordance with Home Office 
and institutional guidelines. Retrospective genotyping was carried out using standard 
PCR protocols detailed in previous chapters (Chapter 2). 
5.2.3 Genotyping of Taiwanese SMA mice 
Retrospective genotyping of Taiwanese SMA and control littermates was performed 
as previously described in earlier chapters (Chapter 2). 
5.2.4 Isolation and Culture of Mouse Endothelial Cells 
Isolation and culture of mouse lung endothelial cells was performed by modifying 
protocols described by Lim & Luscinskas (2006). 
5.2.4.1 Preparation of Plates 
Collagen Type I (BD Biosciences) was diluted in acetic acid at a concentration of 
50µg/ml. This solution was deposited onto 13mm glass coverslips in individual wells 
of sterile 24 well plates at a concentration of 5µg/cm
2
. The coverslips were left under 
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sterile conditions for 2 hours before being washed twice with sterile PBS 
(Invitrogen) and left under sterile conditions to air dry before use. Coverslips were 
coated fresh on the day of tissue collection. 
5.2.4.2 Tissue Collection 
P7 Taiwanese SMA mice and control littermates were sacrificed by an overdose of 
anaesthetic administered via intraperitoneal (IP) injection of sodium pentabarbitol 
(Euthenal). Lungs were removed from the mice under sterile conditions and 
immersed in sterile PBS. Taiwanese SMA and control lungs were separated into two 
groups. Once in sterile PBS,the lungs were gently minced using fine scissors before 
being lysed Collagenase A (Roche). The minced lung was added to 5 mls of 0.1% 
Collagenase A (Roche) and heated in a water bath at 37°C for one hour. Tubes were 
periodically agitated by hand during incubation. 
5.2.4.3 Culture System 
Following incubation with Collagenase A (Roche) the resulting lung cell suspension 
was passed through a round end glass cannula 12 times before being filtered through 
a 100µm cell sieve (BD Falcon SLS 352360) which was then washed with 5mls of 
EGM2 media (Lonza CC-3162). The sieved suspension was then centrifuged at 
400G for 15 minutes with the resulting pellet re-suspended in fresh EGM2 media. 
120µl of the cell suspension was added to each coverslip which were then incubated 
at 37°C with 5% CO2 for at least 4 hours before an additional 250µl of EGM2 media 
was added to each well. Cells were incubated for 24 hours at 37°C with 5% CO2 
before the media was removed and replaced with 350µl of fresh media. Cells were 
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incubated at 37°C with 5% CO2 until cells reached 90% confluence, normally 
achieved by 10 days. During this period media was changed every two days. 
5.2.4.4.Immunohistochemistry 
When cells had reached the desired confluence, coverslips were rinsed 3 times with 
0.1M PBS and fixed with 4% PFA for 10 minutes at room temperature. Cells were 
then permeabilised by incubating coverslips with ice-cold methanol for 15 minutes at 
-20°C. Coverslips were then rinsed 3 times with 0.1M PBS to remove any remaining 
methanol. The cells were then incubated with modified blocking buffer (1% BSA in 
0.1M PBS) for an hour at room temperature. Following blocking, cells were 
incubated with primary antibodies against PECAM 1, Vessel Endothelial Cadherin 
(VE-cadherin) and SMN for one hour at room temperature: PECAM 1 (R&D 
Systems, AF3628) at a concentration of 1:500, VE-Cadherin (Abcam ab7047) at a 
concentration of 1:50 and SMN (BD Biosciences) at a concentration of 1:100 made 
up in blocking buffer. Following this incubation cells were rinsed 6 times with 
blocking buffer before being incubated with secondary antibodies for one hour at 
room temperature: donkey anti-goat Cy 3 conjugated secondary antibody (Jackson 
ImmunoResearch Laboratories Inc) at a concentration of 1:250  and anti-mouse 
dylite 488 conjugated secondary antibody (Dako) at a concentration of 1:100 made 
up in blocking buffer. The cells were then rinsed 6 times with blocking buffer. For 
nuclear staining DAPI was applied to the cells for 3 minutes before being washed 
rinsed 6 times with 0.1M PBS.  Coverslips were then mounted on glass slides with 
mowiol (Calbiochem) and left overnight at room temperature, in the dark to set 
before imaging the following day. 
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5.2.4.5 Imaging 
Phase contrast images of growing cells were captured using a standard inverted 
epifluorescence microscope (Olympus 1X71) combined with a chilled CCD camera 
(Hammamatsu C4742-95) and OpenLab (Improvision) image capture software. 
Micrographs for cell purity and protein expression were captured using a Zeiss LSM 
710 laser scanning confocal microscope (20 x objective/ 0.4 NA; 40 x objective/ 1.3 
NA oil objective). 488nm,543nm and 633nm laser lines were used for excitation. All 
images were captured using identical confocal settingsto allow for the comparison of 
expression levels between Taiwanese SMA and control cultures. Resulting images 
were prepared using Adobe Photoshop CS 6. 
5.2.4.6 Quantification and Analysis 
A minimum of two confocal images were captured per slide. Cell number was 
counted using the Cell Counter plugin for Image J (NIH). Endothelial cell culture 
purity was calculated as the percentage of cells in representative micrographs that 
were immunostained by all three markers (PECAM 1, VE-Cadherin and DAPI). 
SMN and PECAM 1 expression levels in Taiwanese SMA and control cells were 
measured using Image J (NIH). Using Image J (NIH) the area, integrated density and 
mean grey value of individual cells in a 20 x magnification image were measured. To 
obtain a measurement of background, area, integrated density and mean grey value 
were measured in multiple regions lacking fluorescence. To calculate Corrected 
Total Cell Fluorescence (CTCF) the following formula was used: 
CTCF = Integrated Density – (Area of selected cell x Mean fluorescence of background 
readings 
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All data were collected using Microsoft Excel software and were graphed and 
analysed using GraphPad Prism software. Charts shown are mean ± s.e.m. In all 
analyses statistical significance was considered to be p < 0.05. Tests used are detailed 
in figure legends. 
5.2.5 Investigating Retinal Vasculature  
5.2.5.1 Tissue Collection 
Neonatal SMA mice and control littermates up to the age of P5 were sacrificed by 
immersion in ice followed by decapitation. Pups above the age of P5 were sacrificed 
by an overdose of anaesthetic administered via intraperitoneal (IP) injection of 
sodium pentabarbitol (Euthenal).   The mice were monitored closely following 
injection until no breath was observed and no footpad or tail responses were evoked. 
5.2.5.2 Dissection 
To expose the eye, a small incision was made in the skin adjacent to the eyelid. The 
skin was then reflected to reveal the eyeball. The eyeball was then removed by 
inserting forceps into the socket and gently pulling. The eyeball was then fixed in 4% 
paraformaldehyde (PFA) for two hours, at room temperature, on a rocking platform. 
Following fixation the preparation was repeatedly rinsed in 0.1M PBS to remove 
excess fixative. All post-fix dissection was performed in 0.1M PBS. 
The eyeball was pierced with a syringe needle at the edge of the lens. Small scissors 
were inserted into this hole and the initial incision was continued around the 
circumference of the lens allowing it to be freed from the eyeball. The aqueous 
humour, which had solidified as a result of fixation, was removed and any fibrous 
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hyaloid vessels were gently cleaned away. At this point the eyeball was fixed for a 
further two hours in 4% PFA, at room temperature, on a rocking platform. Following 
this second period of fixation the outer pigment layer of the eyeball was gently 
removed from the inner retinal layer, leaving the retina free for staining. 
5.2.5.3.Immunohistochemistry 
Retinas were permeabilised overnight in 1% BSA 0.5% PBS at 4° on a rocking 
platform. The following day retinas were rinsed twice in 0.1M PBS and were washed 
for 2x5 mins in PBlec (1% triton PBS containing 0.1Mm CaCl2, 0.1Mm MgCl2 and 
0.1Mm mNCl2). Retinas were then incubated in rhodamine conjugated GSL-1 at a 
concentration of 1:25 made up in PBlec for 4 hours at room temperature on a rocking 
platform. The retinas were then washed for 5x5 minutes in 0.1M PBS before being 
left overnight in fresh 0.1M PBS at 4° on a rocking platform to additionally wash the 
samples. Following overnight washing the retinas were inspected under a microscope 
and any remaining hyaloids vessels were removed. Four cuts were made into the 
retinas which were then flat mounted in PBS on glass slides with glass coverslips 
ready for imaging. 
5.2.5.4 Imaging 
Micrographs were captured using a standard inverted epifluorescence microscope 
(Olympus 1X71) combined with a chilled CCD camera (Hammamatsu C4742-95) 
and OpenLab (Improvision) image capture software. Rhodamine labelled capillaries 
were imaged using 550nm excitation and 570nm emission optics. 
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5.2.5.5 Quantification and Analysis 
Any retinas with poor quality staining or those that had been damaged during 
dissection were excluded from analysis. 10 x magnification images of whole retinas 
were captured and were enhanced for contrast and brightness in Photoshop CS 6. 
This ensured that definite vessel borders were visible and also prevented any fine 
capillary structures from being lost and discounted. Any out of focus images where 
capillaries appeared blurred or those where background was too high to completely 
isolate capillary structures were excluded from further analysis. The resulting images 
were analysed using AngioTool software (National Cancer Institute) which was used 
to semi-automatically calculate: the area of retina covered by capillaries, the total 
number of branch points in the capillary network and the total number of capillary 
end points to provide quantitative values with which to compare retinal vascular 
development. All images were analysed blind. 
All data were collected using Microsoft Excel software and were graphed and 
analysed using GraphPad Prism software. Charts shown are mean ± s.e.m. In all 
analyses statistical significance was considered to be p < 0.05. Tests used are detailed 
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5.3 Results 
Having identified and characterised defects in the development and morphology of 
capillaries in SMA mice, we sought to investigate the underlying cause of such 
alterations to vessel number and structure. Here we examine the growth and 
morphology of the major cellular constituent of capillaries, the endothelial cell, 
which were isolated from the lungs of P7 symptomatic Taiwanese SMA mice and 
control littermates. Observing any differences in growth rates or morphology 
between control and Taiwanese SMA endothelial cells in vitro could provide insight 
into the differences between control and SMA capillaries in vivo.  
5.3.1 Comparable growth rate and morphology of Taiwanese SMA and 
control endothelial cells  
In the first 5-6 days following isolation the cells in both the control and Taiwanese 
SMA cultures displayed elongated and irregular cytoplasm with a large single 
nucleus (Figure 2) This is consistent with previous reports of endothelial cell 
morphology early in culture (Pomerate & Slick, 1963). The P1 post isolation these 
cells were spread widely over the surface of the coverslip, with few neighbouring 
cells in contact (Figure 2 A,D). By 5 days post isolation small islands of more closely 
associated cells were apparent in groups across the surface of the coverslip (Figure 2 
B,E).  
Between P5 to P10 post isolation these islands of cells became more densely packed 
and the morphology of the cells altered. Cells still contained a single nucleus, but 
which now appeared more oval in shape. The cytoplasm became broader with less 
distinct borders than was seen in the younger cells. These changes are consistent with 
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previous reports of endothelial cell morphology as the culture period progresses 
(Gimbrone et al., 1973). As the cells reached confluency, both the Taiwanese SMA 
and control cultures displayed the classical, characteristic cobblestone morphology of 
endothelial cells in culture (Figure 2 C, F). Here cells formed single layer mats with 
densely packed cells at the centre, radiating out to more loose association at the edge 
of cell islands. These islands of cobblestone cells covered the majority of the cover 
slip surface with only a few regions of more irregular shaped cells separating the 
islands. The cobblestone morphology observed in these cultures is consistent with 
the morphology described in cultured endothelial cells obtained from both human 
(Gimbrone et al., 1973) and murine (Lim & Luscinskas, 2006) tissues and isolated by 
both magnetic bead (Marelli-Berg et al., 2000) and FACs sorting (Fehrenbach et al., 
2009) techniques.  
Figure 2- Comparable growth and morphology of control and Taiwanese SMA 
endothelial cells. Representative phase contrast micrographs of control (littermate) 
and Taiwanese SMA cultures at 1 (A, D), 5 (B, E) and 10 (C, F) days post isolation. 
By 10 days post isolation the characteristic cobblestone morphology of Endothelial 
Cell mats is apparent in both control (C) and Taiwanese SMA (F) cultures.  Images  
A and D are 20 x magnification. Images B,C,E and F are 10 x magnification. Scale 
bars for all images equal 50µm. 
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5.3.2 Purity of Endothelial Cells 
Having established that the isolated cells from both Taiwanese SMA mice and 
control littermates displayed the morphological characteristics of endothelial cells in 
culture we next examined the histological characteristics of the cells. To determine 
the purity of the cultures, Taiwanese SMA and control endothelial cells were double 
labelled the endothelial cell markers PECAM 1 and VE-Cadherin (Lim and 
Luscinskas, 2006) (Figure 3). PECAM 1, the endothelial tight junctional protein used 
in previous investigations to label skeletal muscle and spinal cord capillaries, and 
VE-cadherin another junctional protein specific to endothelial cells. Cells were also 
labelled with the nuclear marker DAPI (Figure 3). Endothelial cell purity was 
calculated as a percentage of cells that were immunostained for all three markers, 
with DAPI labelled cells counted as the total number of cells present. Taiwanese 
SMA and control endothelial cell purities were 91.73% and 92.45% respectively 
(Figure 4). These results represent a relatively high level of purity in each culture and 
also show no significant difference in purity levels between Taiwanese SMA and 
control endothelial cell cultures (P>0.05, unpaired, two-tailed t –test) (Figure 4). 
Importantly these results showed no obvious differences in the staining pattern of the 
endothelial markers PECAM 1 and VE-Cadherin between Taiwanese SMA and 
control endothelial cells (Figure 3). 
PECAM 1 and VE-Cadherin expression appeared identical in both control and 
Taiwanese SMA endothelial cells. Both markers can be seen throughout the 
cytoplasm but are absent from the nuclei, which is consistent with previous reports of 
these markers in isolated endothelial cells (Fehrenbach et al., 2009). In addition to 
similar distribution and localisation, the intensity of expression is also comparable 
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between control and Taiwanese SMA endothelial cells. All images of the endothelial 
cells were taken using identical confocal settings. These results suggest that the 
presence of these two endothelial cell markers is not altered in SMA. This is 
consistent with our previous work where we were able to identify the SMA capillary 
bed both immunohistochemically and via quantitative fluorescent western blotting 
using PECAM 1. Absence or dysfunction of PECAM 1 in SMA mice would have 
prevented these investigations. 
 
Figure 3 – Taiwanese SMA and control littermate endotheial cells express key 
endothelial markers. Representative confocal micrographs of Endothelial Cells 
immunostained with PECAM 1 (red), VE-Cadherin (green) and DAPI (blue). Images 
are 20 x magnification. Scale bar equals 50µm. 
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Figure 4 –Endothelial cell purity. Bar chart (mean ± s.e.m) quantification of triple 
labelled cells in control (white bar) and Taiwanese SMA (black bar) cultures. 
Unpaired, two-tailed t-test, ns = no significance P>0.05. N≥9 mice, n≥36 coverslips 
and n≥72 images per bar. 
 
5.3.3 Decreased Smn expression in Taiwanese SMA Endothelial Cells 
Having identified a high level of purity in and consistency between Taiwanese SMA 
and control endothelial cell cultures, we next sought to investigate the expression of 
Smn in the isolated endothelial cells.  Cells were labelled for Smn protein along with 
PECAM 1 and DAPI as in previous studies (Figure 5). When imaged, using identical 
confocal settings, a clear difference could be seen between the level of Smn 
expression in Taiwanese SMA and control endothelial cells, with control endothelial 
cells appearing far brighter than their Taiwanese SMA counterparts (Figure 5 B, F). 
When quantified, Smn expression was significantly greater in control than Taiwanese 
SMA endothelial cells (P<0.05, unpaired, two-tailed, t test) (Figure 6). Smn 
expression in Taiwanese SMA endothelial cells was reduced by 67% in comparison 
to control endothelial cells (Figure 6). This is consistent with the approximately 60% 
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reduction in Smn expression reported in isolated Taiwanese SMA Schwann cells 
(Hunter et al., 2014).  This suggests that the reduction in Smn levels observed in the 
endothelial cells is in line with the reduction of Smn protein observed in other SMA 
body tissues and regions. 
 
Figure 5 – Smn expression in Taiwanese SMA and control littermate 
endothelial cell cultures. Representative confocal micrographs of Endothelial Cells 
immunostained with PECAM 1 (red), SMN (green) and DAPI (blue). Images are 20 x 
magnification. Scale bar equals 50µm. 
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Figure 6 – Reduced Smn expression in Taiwanese SMA endothelial 
cells in culture. Bar chart (mean ± s.e.m) quantification of Smn expression 
in cells in control (white bar) and Taiwanese SMA (black bar) cultures. 
Unpaired, two-tailed t-test, . N≥9 mice, n≥36 coverslips and n≥72 images per 
bar. 
 
5.3.4 Severe defects in capillary network of Taiwanese SMA retinas 
Having identified no obvious defects in the growth, morphology and 
immunohistochemical profile of Taiwanese SMA endothelial cells, other than SMA 
levels, we sought to further investigate the development of capillary networks in 
SMA mice. Here we examine the growth of the retinal vasculature of Taiwanese 
SMA and control littermate mice from a variety of disease stages. Observing any 
differences in the morphology and growth of the capillary network between 
Taiwanese SMA and control retinas could provide insight into how the capillary 
defects we have observed in other tissue have arisen. 
Upon initial inspection of P11 retinas, dramatic differences between the vasculature 
of control and Taiwanese SMA mice were readily observable (Figure 7). In control 
retinas the vascular network could been seen extending all the way to the peripheral 
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edge of the retina while in Taiwanese SMA mice a large portion of the retina 
remained avascular (Figure 7). Along with this reduction in vessel coverage, striking 
alterations to the morphology of the vascular network were also apparent. In control 
retinas large, almost straight vessels could be seen radiating from the centre of the 
retina to the periphery. From these large radiating vessels, numerous branching 
vessels arise forming the densely packed, tight looped capillary network similar to 
that observed in control skeletal muscle. No such similar organisation was observed 
in the Taiwanese SMA littermate retinal vasculature. Here, instead, a much more 
loose and open vascular network was apparent. Unlike their control counterparts no 
large radiating vessels were observed, instead a collection of poorly organised 
vessels were seen. These vessels had few branches, which were separated by large 
open spaces, resulting in a sparse network appearance.  To analyse these 
morphological differences in more detail, the images from both control and 
Taiwanese SMA retinas were analysed using AngioTool software. 
AngioTool is free software, developed by the National Cancer Institute, specifically 
to analyse the morphology of vascular networks and key elements of their structure 
and development. Given the particular differences in the vascular that we observed 
by eye, and our knowledge of capillary defects in SMA from our previous findings, 
we chose four particular important elements of retinal vasculature to measure; the 
area of the retina covered by vessels, the number of vessel branch points, the number 
of endpoint vessels at the vascular front and finally lacunarity. Lacunarity is a 
measure of how patterns fill gaps, where patterns with high numerical value for 
lacunarity, have large gaps between their constituent elements. 
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When measured, the area of retina covered by vessels was significantly reduced in 
P11 Taiwanese SMA mice when compared to control littermates (P<0.0001 
unpaired, two-tailed t test) (Figure 8A). In control mice 39.4% of the retina was 
covered by vessels, this was reduced to only 17% in Taiwanese SMA littermates, 
amounting to a 57% reduction in the total vessel area in P11 Taiwanese SMA retinas. 
This reduction is in line with the 45% and 61% reduction in vessel density recorded 
in P11 SMA skeletal muscle and spinal cord respectively. This suggests that the 
reduction in vessel number is consistent across tissues and importantly, given that 
SMA is classed as a motor neuron disease, at a consistent level in a tissue which 
lacks skeletal muscle or motor neurons. Along with this overall reduction in area, 
other important structural components of the retinal vascular network were also 
reduced in P11 Taiwanese SMA mice (Figure 8A). 
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Figure 7 – Severe capillary defects are present at presymptomatic and late 
disease stages in Taiwanese SMA retinas. Representative micrographs of GSL-1 
labelled capillary bed of the retina in presymptomatic P3, symptomatic P8 and late 
symptomatic P11 Taiwanese SMA mice and control littermates. 
The number of vessel branch points was significantly reduced in P11 Taiwanese 
SMA mice when compared to control littermates (P<0.0001, unpaired, two-tailed t 
test) (Figure 8B). In P11 control retinas the average number of vessel branch points 
was 506, in P11 Taiwanese SMA mice this was reduced to 94.5, representing a 
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dramatic 81% reduction (Figure 8B). Along with this reduction in vessel branch 
number, the number of terminal vessels at the vascular front was also significantly 
reduced in P11 Taiwanese SMA mice in comparison to control littermates 
(P<0.0001, unpaired, two-tailed t test) (Figure 8C).  
The average number of terminal vessels in P11 control retinas was 301.3 compared 
to an average of 85 in Taiwanese SMA retinas, calculated as a large, 72% reduction 
in endpoint vessels between control and Taiwanese SMA retinas (Figure 8C). 
Taken together these findings detail a reduction in the number of vessels in the retina 
and a decrease in the branching of vessels. This results in a more open, loose 
arrangement of vessels seen in the P11 Taiwanese SMA retina in comparison to the 
dense, tightly packed capillary loops seen in their control littermate retinas (Figure 
7). This is reflected in a 450% increase in average lacunarity in P11 Taiwanese SMA 
mice (0.9) in comparison to control littermates (0.2) (Figure 8D). 
These alterations to the vascular network of P11 Taiwanese SMA mice are dramatic. 
P11 is a late symptomatic timepoint in the Taiwanese mouse model of SMA. To 
identify is such drastic alterations are present at earlier timepoints in disease 
progression two further timepoints were analysed; the symptomatic P8 and 
presymptomatic P3 timepoints. 
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Figure 8 – Significant alterations to key vascular network features in P11 
Taiwanese SMA mice. Bar chart (mean ± s.e.m) quantification of the vessel area 
(A), branch number (B), endpoint number (C) and average lacunarity (D) of late 
symptomatic P11 Taiwanese SMA and control littermate retinas. Unpaired, two-
tailed, t-test. **** = P<0.0001 N≥3 mice and n≥3 retinas for each bar. 
Initial observations of P8 Taiwanese SMA and control littermate retinas revealed a 
similar pattern of alterations to the retina vasculature in Taiwanese SMA mice as that 
seen at P11 (Figure 7). In P8 control retinas, almost all of the vessels have reached 
the periphery of the retina, with only small isolated pockets of the periphery not 
possessing a vessel covering. Again in the P8 Taiwanese SMA retinas, as was 
observed at P11, the vessels have failed to reach the periphery of the retina, with a 
large peripheral section of the retina remaining avascular, suggesting a reduction in 
overall vessel area similar to that observed at P11. In fact, a 56% reduction in vessel 
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area between P8 control and Taiwanese SMA retinas was recorded (Figure 9A), 
almost identical to the 57% reduction seen at P11 (Figure 8A). To add to this, further 
analysis of the structure of the vascular network revealed comparable defects in the 
P8 Taiwanese SMA mice as those found in P11 Taiwanese SMA mice. 
Average vessel branch number in P8 control mice was 550.8 while P8 Taiwanese 
SMA retinas had an average of 142.3 vessel branch points (Figure 9B). This is 
equivalent to a 75% reduction in vessel branch number, on a smaller but similar scale 
to the 81% reduction in branching recorded at P11 (Figure 8B). Analysis of the 
number of endpoint vessels followed a similar trend (Figure 9C). 
The average number of end vessels in P8 control retinas was 233.4, while this 
number was reduced to 93.5 in P8 Taiwanese SMA mice, a reduction of 60% (Figure 
9C). Again, such dramatic alterations to these factors will impact upon the lacunarity 
of the P8 Taiwanese SMA retinal vasculature. Here, as was seen at P11, a large 
increase in lacunarity was observed, with lacunarity in P8 Taiwanese SMA mice 
being 318% greater than that of control littermates (Figure 9D). These findings at P8, 
although not as severe as those measured at P11, still reflect dramatic alterations to 
the retinal vasculature. This suggests that these defects are not merely a disease end 
stage symptom but that they are present at earlier timepoints in the disease 
progression. To assess if vascular defects in the retina are present prior to the onset 
of disease symptoms, the retinas of presymtpomatic P3 Taiwanese SMA and control 
littermate mice were examined. 
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Figure 9 - Significant alterations to key vascular network features in P8 
Taiwanese SMA mice. Bar chart (mean ± s.e.m) quantification of the vessel area 
(A), branch number (B), endpoint number (C) and average lacunarity (D) of 
symptomatic P8 Taiwanese SMA and control littermate retinas. Unpaired, two-tailed, 
t-test. **** = P<0.0001 N≥3 mice and n≥3 retinas for each bar. 
In control P3 retinas the vascular network appeared less well developed than the 
control P8 and P11 retinas (Figure 7). This would be expected given the postnatal 
developmental time course of the retinal vasculature (explained in detail in the 
introduction of this chapter). Vessels can be seen emerging from the optic disc and 
extending across the more central regions of the retina (Figure 7). Unlike the P8 and 
P11 control retinas, no large radiating vessels are observed, with the majority of 
vessels retaining an immature, polygonal plexus appearance. This, again, is 
consistent with the normal time course development of the retina vasculature. At first 
glance the P3 Taiwanese SMA retinas appear more similar to the control vascular 
PhD The University of Edinburgh 2014 
  237 
network that at any other timepoint investigated (Figure 7). However, closer 
inspection reveals that the P3 Taiwanese SMA vasculature is markedly different 
from that of their control littermates. 
P3 control vessels may still possess more loosely packed vessels at the growing 
vascular front than the P8 and P11 control networks but they do display the 
beginnings of the mature, densely packed vascular network in their more central 
regions (Figure 7). The P3 Taiwanese SMA mice however display the open looped, 
loose structure throughout their networks (Figure 7). Large gaps between adjacent 
vessels are evident, even at this early stage, in the P3 Taiwanese SMA retinas, which 
are not present in the more developed regions of the control retina networks (Figure 
7). The smaller vascular network in the P3 control mice is reflected in the smaller 
vessel area value of 16.8% (Figure 10A). This however is still 45% greater than the 
9.4% the P3 Taiwanese SMA retina covered by vessels (Figure 10A). Here we see 
that even at this early, presymptomatic timepoint a significant 55% reduction in 
vessel area is observed in Taiwanese SMA mice when compared to control 
littermates (P<0.0001, unpaired, two-tailed, t test) (Figure 10A). Significant 
reductions were also observed in vessel branch number (P<0.0001, unpaired, two-
tailed, t test) (Figure 10B) and the number of endpoint vessels (P<0.0001, unpaired, 
two-tailed, t test) (Figure 10C) in P3 Taiwanese mice when compared to control 
littermates. 
Average vessel branch number in P3 control retinas was 135.6 (Figure 10B). This 
was reduced by 50% to 68.8 in Taiwanese SMA littermates (Figure 10B) and a 
40%reduction in the total number of endpoint vessels was also seen in Taiwanese 
SMA mice when compared to control littermates (Figure 10C). Along with these 
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alterations, lacunarity was also significantly different between control and Taiwanese 
SMA mice (P<0.0001, unpaired, two-tailed, t test) (Figure 10D). The lacunarity of 
P3 control retinas, 0.9, was much greater than that recorded at the older P8 and P11 
timepoints, 0.22 and 0.2 respectively. This is due to the much less densely packed, 
immature vascular network present in the P3 control retinas. However, the lacunarity 
of P3 Taiwanese SMA retinas was still almost double that measured in control 
retinas, totalling 1.7. Even at the early developmental stage of P3 the retinal 
vasculature of the Taiwanese SMA mice is drastically altered from that of control 
mice. This suggests that defects in the SMA retinal vasculature occur early in its 
development.  
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Figure 10 - Significant alterations to key vascular network features in P3 
Taiwanese SMA mice. Bar chart (mean ± s.e.m) quantification of the vessel area 
(A), branch number (B), endpoint number (C) and average lacunarity (D) of 
presymtpomatic P3 Taiwanese SMA and control littermate retinas. Unpaired, two-
tailed, t-test. **** = P<0.0001 N≥3 mice and n≥3 retinas for each bar. 
 
When data from these three timepoints is presented together (Figure 11) it can clearly 
be seen that the vascular defects in SMA retinas are established early in the disease 
and that they become progressively worse as the disease progresses (Figure 11). 
Drastic alterations in all of the key points measured are already evident at the 
presymptomatic P3 timepoint (Figure 10. Figure 11) and these differences increase in 
magnitude as the disease progresses (Figure 11). At each timepoint examined a 
significant difference is observed between control and Taiwanese SMA mice for 
each point of interest measured ( P<0.0001, One Way ANOVA with post hoc Tukey) 
(Figure 11). While the reduction in total vessel area remains relatively constant (50% 
at P3, 56% at P8 and 57% at P11) (Figure 11A), the values for branch number 
(Figure 11B), end vessel number (Figure 11C) and lacunarity (Figure 11D) all 
increase in magnitude as the disease progresses.  
The percentage reduction in branch number increases from 50% at P3, to 75% at P8, 
to 81% at P11 (Figure 11B). Similarly, the reduction in end vessel number increases 
from 40% at P3, to 60% at P8, to 72% at P11 (Figure 11C). Finally, the increase in 
lacunarity increases from 188% at P3, to 318% at P8, to 450% at P11. This pattern 
could provide insight into how the vascular defects in the retina arise and progress, 
particularly with regard to the decrease in vessel branching and the reduction in the 
number of vessels at the growing vascular front of the developing vasculature. This 
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suggests that the mechanisms responsible for controlling these two processes would 
be particularly interesting to investigate in Taiwanese SMA retinas. 
 
 
Figure 11 – Retinal capillary defects are established presymptomatically in 
Taiwanese SMA mice and persist as the disease progresses. (A) Bar chart 
(mean ± s.e.m) quantification of the vessel area in presymptomatic P3, early 
symptomatic P8 and  late symptomatic P11 Taiwanese SMA retinas (black bars) 
and control littermates (white bars). (B) Bar chart (mean ± s.e.m) quantification of 
vessel branch number in presymptomatic P3, symptomatic P8 and late symptomatic 
P8 Taiwanese SMA retinas (black bars) and control littermates (white bars). (C) Bar 
chart (mean ± s.e.m) quantification of vessel endpoint number in presymptomatic 
P3, symptomatic P8 and late symptomatic P11 Taiwanese SMA retinas (black bars) 
and control littermates (white bars). (D) Bar chart (mean ± s.e.m) quantification of 
average lucanarity in presymptomatic P3, early symptomatic P8 and symptomatic 
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P11 Taiwanese SMA retinas (black bars) and control littermates (white bars). One 
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5.4 Discussion 
5.4.1 Isolation and culture of SMA endothelial cells 
In this first part of the chapter endothelial cells were, for the first time, isolated from 
SMA mice and cultured. The findings of this chapter show that the morphology, 
growth and complement of endothelial cell markers of SMA endothelial cells is 
comparable to that of control endothelial cells. 
Initially the results of this chapter show that endothelial cells isolated from P7 
symptomatic SMA lungs are viable and can be successfully cultured in a sufficient 
density and at a high percentage purity for in excess of 10 days. This suggests that 
primary cultures of murine SMA lung endothelial cells are a reliable investigative 
tool for future study in SMA. 
Second, these findings show that Smn expression is reduced in SMA endothelial 
cells in comparison to control endothelial cells. This is consistent with the ubiquitous 
nature of the Smn protein and further confirms the systemic reduction of Smn in 
SMA and the utility of this culture system for studying a relatively homogeneous, 
primary cell culture system in SMA research. 
Third, this work has shown that SMA endothelial cells in culture express the 
endothelial cell marker PECAM 1 in a comparable fashion to control endothelial 
cells. This is consistent with our previous findings where we were able to label 
capillaries in SMA skeletal muscle and spinal cord using PECAM 1 and along with 
our use of GSL-1 labelling of the capillary beds, suggests that the reduction in 
capillary density we observe in these tissues is not an artefact of staining. 
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Forth, it was observed that SMA endothelial cells grow at the same rate as control 
endothelial cells in culture. Endothelial cells isolated from SMA lungs reached the 
desired confluency after the same number of days post-isolation as those isolated 
from control lungs.  
Finally, this investigation revealed that SMA endothelial cell morphology does not 
differ from control endothelial cells, with both groups displaying the characteristic 
cobblestone morphology of endothelial cells in culture. These findings suggest that 
the growth and form of endothelial cells is not altered in SMA. Given that SMA 
endothelial cells display the classical endothelial cell morphology and grow at the 
same rate as control endothelial cells it is possible to suggest that defects in the 
growth and structure of endothelial cells are not responsible for the defects we 
observe in SMA capillaries. Rather, it is possible that either the response of the 
endothelial cells to exogenous factors is different or perhaps their ability to branch in 
response to such factors is compromised. However, studies to investigate these 
possibilities were beyond the limits of the current study. 
5.4.1.2 Weaknesses of Study   
Although every attempt was made to ensure that this study was as robust as possible, 
there is an area of weakness that should be noted: the crude isolation of endothelial 
cells.  
In an initial study magnetic dynabead isolation protocols were used to isolate 
endothelial cells. In brief, sheep anti-rat IgG Magnetic dynabeads (Invitrogen Life 
Technologies 11035) were coated overnight with anti-rat PECAM 1 primary 
antibody (BD Pharmigen 558736) and incubated with the lung suspension for affinity 
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binding of the beads to endothelial cells. The endothelial cells were then separated 
from the suspension using a DynnaMag
TM
-15 magnet (Invitrogen Life Technologies 
12301D). After several magnetic isolation and washing steps the resulting bead and 
cell pellet was resuspended in EGM2 media and cultured in the same manner as 
described earlier in the methods section of this chapter. 
On the first attempt this protocol produced endothelial cells from P7 control mice but 
no cells in the Taiwanese SMA suspension were found to bind to the beads. This was 
attributed to faults in the preparation of the Taiwanese SMA lung tissue, particularly 
over-mincing. To optimise tissue preparation and handling techniques the experiment 
was repeated multiple times in P7 CD1 litters. CD1 mice were chosen as they 
produce large litters of mice, all of which are the same genotype. During these trial 
experiments the number of cells in the suspension was counted using Trypan Blue 
dye (Sigma T6146) and a Haemocytometer (Sigma Z359629-1EA). Cell number was 
counted after incubation with collagenase, following centrifugation and 
resuspension, after incubation with the beads and after magnetic separation and 
resuspension. Cell number was found to be consistent, on average 42,050 cells per 
µl, at every stage up until magnetic separation. Following separation of the beads 
from the suspension, no cells were observed in the suspension. This suggested that 
endothelial cells were not binding to the beads. To ensure proper coating of the beads 
with the PECAM 1 antibody, trial experiments were run increasing the length of 
incubation time of beads and antibody and separate experiments where the method of 
incubation was altered from rocking to rolling and end-over-end incubation. In each 
trial a failure of cell and bead binding was observed.  This suggested that the 
antibody was no longer binding to the beads. At this time a fresh batch of PECAM 1 
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antibody was purchased and trial experiments using CD1 litters were repeated. Again 
high numbers of cells were recorded at every stage of the protocol up until magnetic 
separation. Following magnetic separation no cells were observed in the suspension. 
At this point, due to time constraints, it was decided to abandon the use of the 
magnetic isolation protocol and to culture the cells obtained directly from the 
centrifuged lung suspension. The data presented in the results section of this chapter 
is from these experiments. 
Direct culturing of the lung suspension produced cultures of a high density and 
purity, with 92% of cells in culture being identified as endothelial cells. Using this 
method we were able to analyse the growth and morphology of SMA endothelial 
cells in culture, obtaining consistent data across multiple cultures. While this method 
was appropriate for these preliminary investigations into the basic nature of SMA 
endothelial cells, more in depth future experiments may require a more stringent 
isolation technique. 
5.4.1.3 Future Work 
The results of this chapter show that endothelial cells isolated from symptomatic 
Taiwanese SMA mouse lungs not only survive in culture but that they are 
comparable in appearance and basic characteristics to endothelial cells isolated from 
control littermate pups.  Taiwanese SMA endothelial cells grow at a similar rate to 
control endothelial cells, achieve the characteristic morphology of endothelial cells in 
culture and express the endothelial markers PECAM 1 and VE-Cadherin despite a 
60% reduction in Smn expression. These results are not entirely unexpected, given 
the findings of the previous chapters of this thesis.  
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Despite the defects in vessel density, organisation and calibre observed in SMA 
skeletal muscle and spinal cord, the capillaries present in SMA tissue appear intact 
and robust (Chapter 2, Chapter 3). The capillaries present were can be labelled with 
both PECAM 1 and GSL-1, with consistent staining patterns in control and SMA 
tissue (Chapter 2). This suggests that the endothelium of SMA capillaries itself is 
similar to that of control capillaries. This is consistent with the findings of this 
chapter which show no difference between the nature of Taiwanese SMA and control 
endothelial cells in culture. 
The preliminary investigations undertaken in this chapter have established that it is 
possible to isolate and culture murine SMA endothelial cells.  Here we have begun to 
characterise SMA endothelial cells, observing their initial growth, morphology and 
the expression of key markers and proteins.  Any further studies should seek to 
characterise SMA endothelial cells in more detail, particularly their expression of 
important angiogenic factors and their ability to form endothelial tubes. 
In this chapter we have analysed the expression of two endothelial markers and the 
Smn protein in Taiwanese SMA endothelial cells.  Observing expression of both 
PECAM 1 and VE-Cadherin in our cultured cells, along with their characteristic 
morphology, allowed for the confident identification of the cells as endothelial in 
nature. Measuring the intensity of Smn staining showed that endothelial cells isolated 
from Taiwanese SMA mice express reduced level of Smn in comparison to control 
cells, confirming the ubiquitous loss of Smn in SMA. Future studies should expand 
this profile to include critical components of the signalling pathways which initiate 
and regulate vascular development, in particular the Notch signalling pathway 
warrants future investigation. 
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Endothelial cell targeted alterations in the expression level of the Notch 1 receptor 
and its ligands cause dramatic alterations in vascular development, with 
overexpression being as detrimental as loss of function (Benedito et al., 2009).  The 
loss of the Jagged 1 Notch 1 receptor in endothelial cells resulted in a decrease in 
vascular density and a reduction in vessel branching (Benedito et al., 2009). This 
phenotype is very similar to that observed in SMA capillary beds, making the Jagged 
1 ligand an attractive target for future investigation. 
Initially, the expression of Jagged 1 could be investigated morphologically in SMA 
endothelial cells using immunohistochemical staining. This would allow for the 
localisation of Jagged 1 in endothelial cells to be examined and the measurement of 
Jagged 1 staining intensity. To further validate these morphological measurements, 
quantitative fluorescent western blot techniques could be used to determine the 
expression of Jagged 1 at the protein level. These experiments would provide insight 
into a key regulator of angiogenesis in SMA. Importantly, the culture of isolated 
endothelial cells also allows for the process of angiogenesis itself to be examined. 
Maintained under the correct conditions, endothelial cells will form networks of 
endothelial tubes, which appear almost identical to in vivo capillary beds (Folkman 
and Haudenschild, 1980). These tubes first appear approximately 20 days after initial 
plating of endothelial cells. The tubes form from the alignment of as few as 5-10 
endothelial cells (Folkman and Haudenschild, 1980). Vacuoles appear in these cells 
which extend from one cell to the next, joining together to form a single, continuous, 
longitudinal lumen (Kamei et al., 2006). These tubes then undergo remodelling, 
similar to that observed in in vivo angiogenesis, with the appearance of new and the 
retraction of unwanted branches (Folkman and Haudenschild, 1980). Future 
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investigations should aim to extend the culture period described in this chapter to 
examine the formation of endothelial tubes by SMA endothelial cells. Our 
preliminary findings suggest that the growth and morphology of SMA endothelial 
cells in culture appears normal. This proposed experiment would determine if 
cultured SMA endothelial cells are also capable of forming endothelial tubes. 
Previous studies have shown that endothelial cells require no other cell type to form 
endothelial tubes in culture (Folkman and Haudenschild, 1980). Examining the 
ability of SMA endothelial cells form endothelial tubes would be a relatively simple 
further investigation, requiring little alteration to the current culturing methodology. 
5.4.1.4 Conclusion 
From these results we can conclude that the growth and morphology of isolated 
Taiwanese SMA endothelial cells in culture is comparable to that of control 
endothelial cells. Isolated SMA endothelial cells express lower levels of Smn protein 
than control endothelial cells, but show no apparent differences in endothelial marker 
presence.  
5.4.2 The Retina as an investigative tool 
In the second part of this chapter the developing vascular network of the retina was 
examined in Taiwanese SMA mice. The findings of this chapter show significant and 
dramatic defects in the form and extent of the retinal vascular network in Taiwanese 
SMA mice. 
Initially the results of this chapter show drastic defects in the vascular network of late 
symptomatic P11 Taiwanese SMA retinas. These alterations include a reduction in 
total vessel area, a decrease in the number of vessel branching points, a decrease in 
PhD The University of Edinburgh 2014 
  249 
the number of terminal endpoint vessels and an increase in the lacunarity of 
Taiwanese SMA retinas when compared to control littermates. Observing such 
dramatic alterations in the vasculature of a tissue devoid of skeletal muscle and 
motor neurons suggests that the vascular defects observed in SMA mice are not a 
consequence of the neuromuscular pathology present in the disease. This implies the 
presence of an independent systemic defect in the vascular system of Taiwanese 
SMA mice. 
Second, analysis of younger mice revealed that these defects are present in SMA 
retinas at earlier disease timepoints.  Symptomatic P8 Taiwanese SMA retinas 
appeared very similar to late symptomatic P11 Taiwanese SMA retinas, displaying 
an almost identical reduction in vessel area and comparable alterations in branching, 
end vessel number and lacunarity. Importantly these defects were also observed at a 
presymptomatic timepoint. Presymptomatic P3 Taiwanese SMA retinas showed 
significant alterations in vessel area, branching, end vessel number and lacunarity 
when compared to control littermates. These alterations, while on a smaller scale 
than those observed at a later timepoint, were dramatic. This suggests that the defects 
observed in Taiwanese SMA retinal vasculature begin early in the development of 
the retinal vascular network and worsen as the disease progresses.  
5.4.2.1 Disruption of Retinal Angiogenesis 
The results of this chapter suggest that the development of the retinal vasculature is 
disturbed in SMA mice. Similar defects to those that we observe in SMA retinas 
have been reported in the retinas of mice where the key cell-fate determining Notch 
signalling pathway has been disrupted (Benedito et al., 2009). Loss of the Notch 1 
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ligand Jagged 1 from endothelial cells results in a phenotype very similar to that seen 
in Taiwanese SMA retinas, with a reduction in the area of the retina covered by 
vessels, a reduction in the number of vessel branch points and a decrease in the 
number of endothelial tip cells at the growing angiogenic front of the developing 
vascular network (Benedito et al., 2009).  Immunohistochemical studies of the Notch 
ligands have revealed specific expression patterns of the Jagged 1 and the Dll4 Notch 
ligands in the developing retina (Hoffman and Iruela-Arispe, 2006). 
The expression of the Jagged 1 is restricted to stalk cells of the growing vasculature 
and arterial branch points (Hoffman and Iruela-Arispe, 2006). The Dll4 ligand 
however is found throughout the retinal vascular network in stalk cells, capillaries 
and arterial endothelial cells. Crucially Dll4 is the only Notch ligand found in the 
endothelial tip cells leading vessel sprouts at the growing vascular front ((Hoffman 
and Iruela-Arispe, 2006). This suggests a key role for Dll4 in sprouting angiogenesis. 
D114 is responsible for determining the fate of sprouting endothelial tip cells 
(Hellstrom et al 2007; Suchting et al., 2007). High expression of Dll4 in tip cells 
activates the Notch signalling pathway and suppresses tip cell phenotype in adjacent 
stalk cells preventing them from forming capillary sprouts. The ratio of tip to stalk 
cells in the developing vascular network is crucial for its proper formation. The 
correct balance of quiescent stalk cells and sprouting tip cells ensures the formation 
of proper capillary loops allowing for proper tissue perfusion (Hellstrom et al., 
2007). This balance is achieved through the negative regulation of tip cell formation 
by Dll4-Notch signalling (Hellstrom et al., 2007; Suchting et al, 2007). 
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Over-activation of the Dll4-Notch signalling pathway in the retina results in a 
phenotype very similar to that observed in Taiwanese SMA retinas, with a 35% 
decrease in the number of sprouts at the growing vascular front and an overall 
reduction in vessel density of 45% (Hellstrom et al., 2007). In contrast, the reduced 
Dll4-Notch signalling found in Dll4
+/- 
mice results in a 75% increase in sprouting tip 
cells at the vascular front, a 125% increase in vessel branching and an 80% increase 
in the area of retina covered by vessels (Suchting et al., 2007). These studies 
emphasise the importance the fine control of Notch signalling in angiogenesis. These 
studies describe how an alteration to Notch signalling level, be that enhanced or 
suppressed activation, can lead to aberrant vessel network formation. In particular, 
how enhanced Notch signalling, via the Dll4 ligand, results in a vascular phenotype 
very similar to that observed in SMA mice. Importantly, increased activation of the 
Notch signalling pathway has recently been reported in Smn depleted cells and SMA 
mice (Caraballo- Miralles et al., 2013). 
When Smn protein level was depleted in astroglioma cells using lentiviral shSMN, 
the expression of the Notch ligands Jagged1 and Delta 1 was increased by 5 to 6 fold 
and the expression of the Notch receptor itself was increased 4 fold (Caraballo- 
Miralles et al., 2013). Similar increases in ligand and receptor expression were found 
in the spinal motor neurons of SMNΔ7 SMA mice. Expression of Jagged 1, Delta 1 
and Notch were increased by 281%, 249% and 215% respectively, in comparison to 
control motor neurons (Caraballo- Miralles et al., 2013). To determine if the 
increased expression of these components of Notch signalling pathway resulted in 
activation of the Notch pathway the expression of Ngn3 was measured as activation 
of the Notch signalling pathway inhibits Ngn3 expression. In SMA motor neurons 
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Ngn3 expression was reduced by 54% in comparison to control motor neurons 
(Caraballo- Miralles et al., 2013), suggesting an activation of the Notch signalling 
pathway in SMA motor neurons.  
In combination with the findings of this chapter, these studies provide an interesting 
avenue for future investigation: Notch signalling in vascular development in SMA. 
5.4.2.2 Future Work 
In this chapter severe defects were found in the development of the retinal 
vasculature in Taiwanese SMA mice. These defects are consistent with those 
observed in a variety of studies where the signals controlling of angiogenesis have 
been disturbed (Hellstrom et al., 2007, Suchting et al., 2007, Benedito et al., 2009). 
One of these master control pathways, the Notch signalling pathway, shows aberrant 
activation in SMA motor neurons and cultured cells where Smn levels have been 
depleted (Caraballo-Miralles et al., 2013).  Inappropriate activation of this same 
Notch signalling pathway has been shown to result in a vascular phenotype which 
closely resembles the vascular defects we observe in SMA tissues (Hellstrom et al., 
2007, Benedito et al., 2009). Based on this evidence, the Notch signalling pathway is 
a prime candidate for further investigation in SMA. Given the many advantages of 
the retina as an investigative tool, it would be the most suitable experimental 
approach to utilise for these future studies.  
Given that previous studies have identified a highly specific expression pattern of the 
Notch 1 receptor and its ligands (Jagged 1, Dll4 and Delta 1), any future 
investigations should initially examine the distribution and location of the Notch 1 
receptor and its ligands in the developing Taiwanese SMA retina. Due to the 
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postnatal development of the retinal vasculature these expression profiles can be 
examined immunohistochemically at every stage of angiogenesis. This would 
determine if any miss-localisation of the key elements of the signalling pathway were 
present in Taiwanese SMA retinas. The intensity of receptor and ligand expression 
could also be analysed from these stained preparations. Previous studies have shown 
an increase of Notch ligand immunoreactivity in SMA tissue in excess of 200% in 
comparison to control tissue (Caraballo- Miralles et al., 2013). Similar measurements 
could be made in Taiwanese SMA and control littermate retinas. To further validate 
these morphological measurements quantitative fluorescent western blot techniques 
could be used to determine the expression of Notch signalling elements at the protein 
level in the retina.  
These investigations would identify any miss-localisation or altered protein 
expression levels of the Notch signalling pathway elements. To identify functional 
alterations of the Notch signalling pathway itself, the expression of the Ngn 3 protein 
could be examined. The expression of Neurogenin 3, a key protein in differentiation, 
is controlled by Notch signalling. Activation of the Notch signalling pathway results 
in the suppression of Ngn 3 expression (Caraballo- Miralles et al., 2013). A 54% 
reduction in Ngn 3 expression has previously been reported in SMA tissue where the 
Notch signalling pathway was aberrantly activated (Caraballo- Miralles et al., 2013). 
Ngn 3 expression could be analysed both morphologically and molecularly in the 
retina using western blotting, giving insight into the activation status of the Notch 
signalling pathway in Taiwanese SMA mice.  Results from this study could then 
form the basis of investigations into if and at what stage the Notch signalling 
pathway is actively disrupted. 
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In several studies, enhanced activation of the Notch signalling pathway has resulted 
in a vascular phenotype that mirrors the phenotype we observe in SMA tissue 
(Hellstrom et al., 2007, Suchting et al., 2007, Benedito et al., 2009). Based on this, 
investigating the effects of Notch inhibitor administration on SMA vasculature 
would be an interesting future experiment to conduct in Taiwanese SMA mice. 
These particular potential future studies are attractive routes of investigation as they 
could all be conducted in the Taiwanese SMA mouse line and would require no 
additional mouse lines. Much of our understanding of vascular defects in SMA 
comes from our work in the Taiwanese mouse line and in the wider SMA field the 
Taiwanese SMA line is well characterised and appreciated.  These proposed 
experiments would take advantage of the previous knowledge we have gained 
working with the Taiwanese SMA mice and combine it with well established 
experimental approaches used in angiogenic research. 
5.4.2.3 Conclusion 
From these results we can conclude that the form and extent of capillary bed is 
altered in SMA mouse model retinas, a tissue which lacks muscle and motor neurons. 
The percentage area of retina covered by capillaries in SMA mice is reduced in 
comparison to control retinas and the organisation of the capillary network within the 
SMA retina is impaired. These alterations were observed at a presymptomatic 
disease timepoint and increased in magnitude as the disease progressed. 
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5.4.3  Overall Conclusion 
Further work is required to identify the underlying mechanisms responsible for the 
capillary defects observed in SMA model mice.  The experimental approaches 
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General Discussion 
6.1 Overview of Results 
The work presented in this study has described novel, significant and robust defects 
in widespread capillary beds in SMA. Specifically, the form and extent of skeletal 
muscle, spinal cord and retinal capillary beds are significantly reduced in both extent 
and complexity in SMA mice. Analysis of postnatal development in these tissues 
revealed that capillary beds appear normal at birth with defects developing after birth 
and either slightly prior to or in parallel with the signature neuromuscular pathology 
seen in SMA mouse models. Similar capillary defects were also described in the 
retina, a tissue devoid of skeletal muscle and motor neurons, and also in skeletal 
muscles resistant to denervation and which show no neuromuscular pathology. These 
findings imply that the defects observed in the vascular system of SMA mice are not 
a secondary consequence of neuromuscular pathology, but rather are the result of 
defects intrinsic to the vascular system. Further investigation of the growth and 
morphology of endothelial cells, the major cell component of capillaries, suggested 
that these defects are not in the basic properties of endothelial cells. This suggests a 
more complex interaction between endothelial cells and surrounding or supporting 
cells. One important question is whether these dramatic defects in the capillary bed 
of tissues, where reductions in vessel density are close to 50%, result in 
compromised blood supply. Investigations of tissue hypoxia in vivo in SMA mice, 
revealed that these reduction in vessel density do in fact result in a significantly 
increased number of hypoxic cell bodies in the spinal cord of SMA mice. This 
increase in tissue hypoxia was seen at an early symptomatic timepoint and suggests a 
novel and exciting, possible sequence of events leading up to motor neuron damage. 
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Here tissue hypoxia could contribute to damage in the neuromuscular and other 
systems. Experiments in which levels of Smn protein were artificially increased 
using HDAC inhibitors, resulted in an amelioration of vascular defects suggesting 
that the severity of these vascular defects is linked to the level of tissue Smn, and 
therefore likely amenable to therapies which increase Smn levels.  
 
6.2 Investigating mechanisms underlying the SMA capillary phenotype 
In this thesis, the capillary phenotype in SMA mice models has been identified and 
characterised. Future work should look to elucidating the molecular and cellular 
mechanisms underlying the aberrant vascularisation observed. To examine such 
mechanisms microarray and proteomic techniques could be employed. 
In previous chapters a method for isolating and culturing endothelial cells from SMA 
mice and control littermates was described (Chapter 5). This technique presents an 
opportunity to determine the molecular consequences of Smn depletion in 
endothelial cells at both the genetic and proteomic level.  Previous microarray 
analysis of Severe SMA mouse model tissue has been performed on neurological 
tissue, notably the spinal cord (Murray et al., 2010). Analysis of SMA spinal cord 
revealed significant changes in gene expression when compared to control 
littermates. At presymptomatic timepoints only three genes were significantly altered 
by more than 1.5 fold but by the P5 late symptoamtic timepoint the expression of 160 
genes was significantly changed by 1.5 fold or more (Murray et al., 2010). A similar 
high degree of change in expression is also observed in Severe SMA mice at the 
protein level. 
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In a recent study iTRAQ comparative proteomics was used to analyse hippocampal 
synaptosomes form pre and late symptomatic Severe SMA model mice (Wishart et 
al., 2014). In comparison to controls, the expression of 52 of the 150 unique proteins 
identified in the synaptosome were altered by more than 20% in SMA synaptosomes 
(Wishart et al., 2014). Critically, analysis of raw proteomics data using software such 
as Ingenuity Pathway Analysis (IPA) software allows for the grouping of related 
proteins into functional clusters. This means that changes in individual proteins can 
be linked to modifications in functional pathways. Applying this protocol to SMA 
and control endothelial cells would highlight not only the presence of any altered 
proteins in SMA endothelial cells in comparison to controls but also how these 
changes might impact on critical molecular pathways. A similar approach has 
recently been applied cells isolated from the nervous system of SMA model mice. 
In their 2014 work Hunter et al., performed iTRAQ comparative proteomics and IPA 
software analysis on Schwann cells isolated and cultured from Taiwanese SMA mice 
and control littermates. This work showed similar robust results as those obtained 
from SMA tissue samples (Mutsaers et al., 2011), suggesting that proteomics is an 
appropriate and potentially illuminating procedure to investigate SMA endothelial 
cells. 
Future experiments should refine the endothelial cell primary culture methodology to 
produce consistent purity and yield of endothelial cells. These cells should then be 
subjected to both microarray and proteomic analysis. These experiments would allow 
for the quantification and comparison of the genome and proteome of SMA and 
control endothelial cells, potentially highlighting genes and proteins for further 
examination. Here the pathway analysis software would be particularly useful in 
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identifying any changes in functional pathways that could underpin the capillary 
defect. Any differences seen in gene or protein expression could be validated in a 
variety of ways. 
To confirm any differences in gene expression quantitative real time PCR could be 
used. This technique could be applied first to the isolated endothelial cells and then 
to a variety of other tissues in SMA model mice. These may include the larger 
vessels of the vascular system, the tissues known to display capillary defects (skeletal 
muscle, spinal cord and retina) and other organs which are known to display defects 
in SMA (see Hamilton and Gillingwater, 2014 for review).  After evaluating the 
expression of the selected genes the effects of over- or under-expressing the same 
genes on the vascular system could be screened in zebrafish. 
Any genes found to be upregulated in SMA endothelial cells, in comparison to 
control cells, could be over-expressed in zebrafish using over-expression constructs 
introduced into developing zebrafish embryos. Genes found to be down-regulated in 
SMA endothelial cells, in comparison to control cells, could be knocked down by 
injecting zebrafish embryos with oligonucleotide morpholinos which would reduce 
the expression of that gene by blocking transcription or modification of the target 
mRNA. In both cases the effects of the over-expression or knock down of the genes 
on the development of the zebrafish vasculature could be assessed using confocal 
microscopy techniques such as live imaging. This would help to determine if the 
identified genes were involved in the development of the aberrant vasculature seen in 
the SMA mouse models. Any such interesting results from the zebrafish studies 
could then be carried forward into murine models. 
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Mouse models could be generated which lack or over-express genes seen to cause 
effects in the vascular system in the zebrafish. These models would determine if such 
genetic alterations could result in a similar capillary phenotype as that observed in 
SMA model mice. Investigations could also be conducted involving targeted 
replacement or removal of genes in existing SMA model mice. These studies would 
determine the effect of restoring or blocking such genes on the capillary defect in 
SMA. Tissue specific approaches could also be employed to tease apart the 
involvement of the capillary defect in the neuromuscular pathologies seen in SMA.  
At the protein level, any differences highlighted between the proteome of SMA and 
control endothelial cells could be validated using western blotting. Again this 
confirmatory technique could be applied first to the isolated endothelial cells and 
then to a variety of other tissues in SMA model mice. These could include the 
vessels, heart, liver, lung, small intestine and spleen which are known to have altered 
proteomes (Wishart et al., 2014) along with alterations in their structure and function 
(see Hamilton and Gillingwater, 2014 for review). Having analysed molecular 
expression, it would be prudent to examine the morphological expression of any 
indentified proteins of importance using immunohisto- and immunocytochemistry.  
This could be performed on the isolated endothelial cells and then expanded to the 
other tissues of interest. In this incidence the retinal preparation described in previous 
chapters (Chapter 5) would be particularly useful. Using this preparation the 
expression of any indentified protein of interest could be followed throughout the 
entire process of vascularisation. Such experiments would provide information about 
the presence, absence or mislocalisation of highlighted proteins during the process of 
vasculogenesis. This could provide insight into the involvement of these proteins in 
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the development and progression of the capillary defect. Importantly, examination of 
the retina in human SMA patients would be a non-invasive and relatively simple 
procedure to conduct. This would require capturing images of the retina which is 
performed as part of routine eye examinations. This would provide a rapid means of 
assessing the morphology of the capillary bed in SMA patients.  This could help 
determine if the capillary phenotype observed in multiple mouse models translates to 
the human disease. This study should be combined with molecular analysis of any 
key genes and proteins identified by mouse microarray and proteomics data. This 
would determine if the same pathways and mechanisms which underpin the murine 
capillary defect are translated into the human disease. 
 
6.3 Importance of Systemic Defects in SMA 
While numerous studies, using a variety of therapeutic approaches, report 
improvements in motor phenotypes and pathologies in mouse models of SMA, in 
many of these the survival of these animals is only minimally extended. 
Studies using Antisense Oligonucleotides targeting the erroneous splicing of the 
SMN2 gene have been reported to increase the expression levels of full length Smn 
protein and improve the SMA phenotype (Osman et al., 2012; Passini et al., 2012). 
ASO treated mice show improved weight gain, reduced loss of motor neuron cell 
bodies and an improved motor function as a result of improved muscle physiology 
and function (Osman et al., 2012; Passini et al., 2012). However, ASO treated 
SMNΔ7 SMA mice only survive for an additional 2 (Osman et al., 2012) to 5 
(Passini et al., 2012) days in comparison to untreated SMNΔ7 SMA mice. A 
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comparable 4 day extension of survival is seen in SMNΔ7 SMA mice treated with 
aminoglycosides used to enhance translation of full length Smn from the SMN2 gene 
(Mattis et al., 2009). Viral delivery of the SMN1 gene has dramatically different 
effects on survival, depending on the route of administration (Azzouz et al., 2010; 
Foust et al., 2010,Valori et al., 2010; Dominguez et al., 2011). 
The survival of SMNΔ7 SMA mice was extended by 3 to 5 days when the scAAV9 
viral vector was used to deliver the SMN1 gene to the central nervous system 
(Azzouz et al., 2010; Foust et al., 2010). When the SMN1 gene, within the scAAV9 
viral vector, was delivered systemically via the vasculature, SMNΔ7 SMA mouse 
survival was increased by between 60 (Valori et al., 2010) and 200 days (Dominguez 
et al., 2011). These studies suggest that SMA therapeutics must be delivered 
systemically to have a major impact on survival. However, therapeutics with a 
systemic activation, such as histone deacetylase inhibitors, show a varying degree of 
success in extending lifespan (Chang et al., 2001; Avila et al., 2007; Narver et al., 
2008; Riessland et al., 2010; Schreml et al., 2013).  
Early HDAC inhibitor trials using Sodium Butyrate improved SMA mouse survival 
by an average of 7 days (Chang et al., 2001). Investigations combining another 
HDAC inhibitor, Trichostatin A, and nutritional support showed an increase in 
lifespan of over 3 weeks (Narver et al., 2008). However, other studies using HDAC 
inhibitor treatment show only a mild 3 day increase in lifespan (Avila et al., 2007; 
Riessland et al., 2010) or no improvement at all (Schreml et al., 2013). While these 
studies demonstrate the variability in the outcome of HDAC inhibitor treatment, they 
also began to identify the presence of non neuromuscular pathologies in treated SMA 
mice (Chang et al., 2001; Avila et al., 2007; Schreml et al., 2013). 
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Treatment with Sodium Butyrate was seen to increase full length Smn protein and 
improve SMA symptoms but the longer surviving, treated mice developed necrosis 
of the tail (Chang et al., 2001) and SMA mice, whose survival was extended using 
Trichostatin A, developed diarrhoea (Avila et al., 2007). This extension of survival, 
although brief, revealed the presence of defects beyond the neuromuscular system in 
SMA mice. Since these studies, exploratory autopsies and histological investigations 
of SMA mice have revealed widespread  organ defects (Vitte et al., 2004; Bevan et 
al., 2010; Heier et al., 2010; Shababi et al., 2010; Wishart et al, 2010; Hua et al., 
2011; Bowerman et al., 2012; Gogliotti et al., 2012  Schreml et al., 2013). 
Development of the brain is compromised in SMA mice (Wishart et al, 2010), along 
with the development and function of the heart (Shababi et al., 2010; Heier et al., 
2010; Bevan et al., 2010; Gogliotti et al., 2012), the formation and growth of the 
liver (Vitte et al., 2004, Hua et al., 2011) and the cell fate and function of the 
pancreas (Bowerman et al., 2012). In depth histological analysis has also revealed 
compromising structural defects in the lungs and intestine of SMA mice (Schreml et 
al., 2013). Importantly, while potent HDAC inhibitor treatment was able to improve 
motor function in SMA mice, no improvement in any of these significant organ 
defects was observed and the survival of SMA mice was not increased (Schreml et 
al., 2013). A recent study has suggested that differences in the molecular basis of 
organ and neuromuscular pathologies could explain why neuromuscular phenotypes 
are improved in certain treatments and organ pathologies are not (Wishart et al., 
2014). 
A recent study has revealed widespread disruption of ubiquitin homeostasis in SMA 
mice, which in turn results in disturbances of β-catenin signalling in the 
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neuromuscular system (Wishart et al., 2014). Inhibition of β-catenin signalling was 
seen to alleviate neuromuscular pathology including improved motor function, 
reduced motor neuron loss, restored muscle fibre size and reduced NMJ pathology. 
However, weight gain was not improved and survival was not increased. Post-
mortem examination revealed widespread gross organ defects. When β-catenin 
signalling was investigated, the perturbations found in the neuromuscular system 
were not seen in the organs. This suggests that pathology in the neuromuscular 
system and the organs are driven by distinct mechanisms (Wishart et al., 2014). 
These studies emphasise the need for the systemic treatment of SMA. Therapeutic 
approaches which target only the neuromuscular system will not fully treat SMA. 
These studies suggest that systemic pathologies are life limiting factors in the course 
of SMA. Therefore a better understanding of the involvement of organ and systemic 
pathologies in SMA is required. This would not only improve current standards of 
patient care but would also lead to a re-evaluation of the therapeutic approaches used 
in SMA treatment. 
 
6.4 Conclusion 
The work described in this study characterises vascular defects in SMA and has 
taken the first steps to address the mechanisms underlying them. In summary, it has 
shown that; 
1) The form and extent of capillary beds in skeletal muscle, spinal cord and 
retina are dramatically altered in mouse models of SMA. 
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2) These vascular defects are postnatal phenomena which occur independently 
of neuromuscular pathology. 
3) The capillary defects seen do not appear to be a consequence of defects in 
endothelial cell morphology or growth. 
4) The reduction in vessel density in tissue has physiological consequences. 
5) The severity of these vascular defects is linked to the level of Smn in tissues 
and these defects are amenable to therapies which increase Smn levels. 
This study will hopefully aid future work aimed at defining the underlying cause of 
vascular defects in SMA, and be of benefit for the development of clinically relevant 
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Appendix 2: Conference Abstracts 
The Joint Meeting of the Anatomical Society & Sociedad Anatómica Española 
Edinburgh 2012: 
Increasing SMN levels using histone deacetylase inhibitors ameliorates the skeletal 
muscle capillary bed defect in a mouse model of severe Spinal Muscular Atrophy. 
E Somers, J Schreml, M Riessland, B Wirth, S.H Parson. 
Development of the capillary bed in spinal cord and peripheral nerve: Implications 
for the study of Motor Neuron Diseases. 
K Hoban, E Somers, S.H Parson. 
 
The Scottish Neuroscience Group Meeting Edinburgh 2013: 
Significant reductions in spinal cord vascularity, including the ventral horn, in a 
mouse model of severe Spinal Muscular Atrophy  
E Somers, K Hoban, S.H Parson. 
 
 
 
 
 
 
 
